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The present study evaluated aspects of the class-specific antibody response
of rabbits experimentally infected with Trypansoma evansi.
Using sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE)
and "Western" blotting adapted to detecting class-specific antibody response and
optimized for the T. evansi system, humoral responses to T. evansi were observed
to be directed to both the surface and non-surface components of the parasite.
Using 125l-iodination, two components with molecular weights of 67,000 and 60,500
daltons were found to be associated with the surface of the parasite with their detection
varying between different stocks of T. evansi. Both the surface and non-surface
components elicited skin reactions in animals, with the most intense reactions observed
with the surface components and in animals drug c\ired of T. evansi infections.
Class-specific antibody response to the surface components involved the
production of the three immunoglobulin classes studied - IgG, IgM and IgA while
responses to the non-surface components were predominantly IgG, an observation
that was thought to be linked with the role of IgM in bringing about trypanolysis
and IgG in neutralising the products of such lysis.
Based on clinical signs, animals were classed as resistant or susceptible with
the serum from the resistant animals detecting more antigens of T. evansi and
earlier than those of the susceptible animals. The detection of the surface and many
non-surface components of the parasite was associated with resistance. Cross-
infection studies demonstrated absolute protection of animals to homologous challenge,
which was found to be associated with the production of specific antibodies.
Partial protection to heterologous challenge was associated with the presence of
cross-reacting antibodies to one of the surface and some of the non-surface components.
There were also indications that non-antibody factors may be important in the
induction of protection while complete absence of antibodies to antigens of the
challenge parasites was associated with non-protection.
/ Studies on complement demonstrated the depletion of C3 during infection with C3
in circulation returning to near preinfection levels after drug treatment and during
periods of low parasitaemia. C3 activation was observed in infected animals and
using an in vitro system, C3 was activated mainly through the classical and also
the alternative pathways, with the complexes formed with IgG being more efficient
in activating C3 than those formed with IgM. C3 was also found to be important
during secondary responses as rabbits with depleted C3 responded poorly by pro¬
ducing lower levels of antibodies than C3 intact, control animals.
Histopathological studies revealed that changes in organs of infected animals
could be the direct effect of the parasites or consequences of the host defence
response, some of which could lead to the depression of the host's immune responses.
Observations warranting an investigation of a possible transmission of T. evansi
through a sexual mode and also the importance of an integrated approach in the
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ABSTRACT
The present study evaluated aspects of the class-specific antibody response
of rabbits experimentally infected with Trypanosoma evansi.
Using sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-
PAGE) and "Western" blotting adapted to detecting class-specific antibody
response and optimized for the T. evansi system, humoral responses to T.
evansi were observed to be directed to both the surface and non-surface com-
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ponents of the parasite. Using I-iodination, two components with molecu¬
lar weights of 67,000 and 60,500 daltons were found to be associated with the
surface of the parasite with their detection varying between different stocks of
T. evansi. Both the surface and non-surface components elicited skin reactions
in animals with the most intense reactions observed with the surface com¬
ponents and in animals drug cured of T. evansi infections.
Class-specific antibody response to the surface components involved the
production of the three immunoglobulin classes studied - IgG, IgM and IgA
while responses to the non-surface components were predominantly IgG, an
observation that was thought to be linked with the role of IgM in bringing
about trypanolysis and IgG in neutralising the products of such lysis.
Based on clinical signs, animals were classed as resistant or susceptible
with the serum from the resistant animals detecting more antigens of T. evansi
and earlier than those of the susceptible animals. The detection of the surface
and many non-surface components of the parasite was associated with resis¬
tance. Cross infection studies demonstrated absolute protection of animals to
homologous challenge, which was found to be associated with the production
of specific antibodies. Partial protection to heterologous challenge was associ¬
ated with the presence of cross-reacting antibodies to one of the surface and
some of the non-surface components. There were also indications that non-
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antibody factors may be important in the induction of protection while com¬
plete absence of antibodies to the antigens of the challenge parasites was associ¬
ated with non-protection.
Studies on complement demonstrated the depletion of C3 during infection
with C3 in circulation returning to near preinfection levels after drug treatment
and during periods of low parasitaemia. C3 activation was observed in
infected animals and using an in vitro system, C3 was activated mainly through
the classical and also the alternative pathways, with the complexes formed with
IgG being more efficient in activating C3 than those formed with IgM. C3
was also found to be important during secondary responses as rabbits with
depleted C3 responded poorly by producing lower levels of antibodies than C3
intact, control animals.
Histopathological studies revealed that changes in organs of infected
animals could be the direct effect of the parasites or consequences of the host
defence response, some of which could lead to the depression of the host's
immune responses. Observations warranting an investigation of a possible
transmission of T. evansi through a sexual mode and also the importance of an
integrated approach in the investigation of host/parasite relationships in T.





Trypanosomes and trypanosomiasis have attracted the attention of
investigators since the days of Antony Van Leewenhoek in the latter part of
the 17th Century. Since then attempts made to control trypanosomiasis,usually
by trying to apply lessons learnt from other diseases3"^ particular through
vaccination have been largely unsuccessful. The principle reason for the failure
to develop immunoprophylactic control measures for trypanosome infection
stems largely from the trypanosome's ability to alter the biochemical nature of
their outer covering through a process known as antigenic variation (Soltys,
1963; Vickerman, 1969; Stephen, 1986).
The scourge of trypanosomiasis on man and his livestock along with the
association of the disease with the bite of tsetse flies were known to the
indigens of Africa long before the arrival of the first Europeans on the
continent. This can be seen from the discussion between the missionary,
David Livingstone and Chief Sebituane, when the Chief warned Livingstone
that his cattle had already been bitten by the tsetse and that they would
certainly die. Later, Livingstone's medical training probably assisted him to
describe with admirable accuracy the way that the tsetse fly bites, the progress
of the disease in infected cattle and the postmortem appearances (Goodwin,
1978). Two major points were emphasized by Livingstone as important aspects
of the disease - namely poisons in the blood which probably refers to anaemia,
and the insertion of the proboscis. These aspects continue to be the most
important aspects for the establishment of trypanosome infection and
pathological effects on the mammalian host.
A wide range of protozoan organisms are classified as trypanosomes. Of
these the organisms belonging to the order Kinetoplastida, and Family
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Trypanosomatidae are strictly parasitic. Within this family there are nine
genera. Most of the parasites in the Genus Trypanosoma, are of immense
veterinary and medical importance causing widespread disease throughout
many tropical and subtropical countries. Hoare (1964) further subdivided
trypanosome genera infecting mammalian hosts into two broad sections - the
Stercoraria and Salivaria each characterised by their mode of development in
their respective vector and the mammalian hosts. The section Stercoraria
contains genera in which the parasite completes its developmental cycle in the
"posterior station" of the vector, in that the stage infective for the mammalian
host appears in the faeces of the vector, and transmission is by the
contaminative route. The Salivaria contains genera whose developmental cycle
in the vector is completed in the "anterior station" of the vector, in that
transmission from vector to host occurs by inoculation of the infective stage of
the parasite, metacyclic forms, through the bite of an infected vector.
In consideration of the classification of trypanosomes based on
morphological criteria Hoare (1972) concluded that "it is usual to separate
trypanosomes differing morphologically as species when the characters
distinguishing them do not overlap, so that there is a gap between the species
but, if the characters of various populations integrate, they can be regarded as
subspecies of the same species!' Most of the characteristics of trypanosomes,
however, do overlap, presenting many practical problems in the differentiation
of trypanosomes. Furthermore, the lack of a clearly defined sexual
reproductive cycle in trypanosomes limits the application of conventional
Darwinian concepts of speciation in classifying trypanosomes into species.
Many characteristics of the brucei subgroup overlap in the Trypanozoon
group, for example, T. rhodesiense and T. gambiense are considered as
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subspecies of T. brucei,. T. evansi and T. equiperdum also belong to the brucei
subgroup but are considered as separate species because of their mode of
transmission (Hoare, 1972). Despite the fact that the metacyclic stages have
not been described in T. evansi and T. equiperdum, they are traditionally
retained within the subgenus for historical reasons, based largely on their
postulated evolution from T. brucei. The separation of the various
trypanosome species within the genus Trypanosoma is illustrated in Figure 1.1
and is based on the proposal made by Hoare (1964) and later adapted by
Stephen (1986).
TRYPANOSOMA EVANSI
Trypanosoma evansi was the first trypanosome to be described from the
blood of an infected animal and identified as the causative agent of
mammalian trypanosomiasis. The causative agent of the disease now referred
to as T. evansi was first described by Evans (1880, 1881-1882) who associated
the parasite with an endemic disease in equines and camels known as "Surra"
in the Derra Ismail Khan in the Punjab in India (Mahmoud and Gray, 1980).
Despite the early description of this parasite and its association with
disease in domestic livestock, relatively little research has been conducted
specifically on T. evansi, the majority of studies on trypanosomiasis of
animals in the last 30 years concentrating on the varieties of trypanosomes
transmitted by the tsetse flies. It is likely that the relative obscurity of the
disease and speculated evolution of T. evansi from T. brucei as postulated by
Hoare (1972) has blinkered research on T. evansi with many workers labouring
under the notion that the results from studies carried out on organisms such as
T. brucei would be equally applicable to T. evansi.














Radical differences however, exist between the fundamental properties of
T. brucei and T. evansi. Principally T. brucei undergoes a cycle of
development in the tsetse, while T. evansi does not, being transmitted
mechanically through biting flies. Such a difference implies that the two
parasites could be exposed to quite different selection pressures for their
survival. T. brucei is maintained in two hosts, the arthropod vector and the
mammalian host, while T. evansi only develops in the mammalian host, which
reduces its probability of survival and transmission in the event of the death of
the host. These differences are likely to affect the parasite at many other
levels, particularly those controlling its relationship with the host. The
differences could be subtle and only revealed from results of studies conducted
specifically on T. evansi, hence the need for T. evansi specific studies to be
conducted.
Following on from the earliest reports of T. evansi infections in equines
and camels in India by Evans (1880, 1881-1882), several other workers
reported outbreaks of diseases in other part of the world with similar clinical
signs. According to Lingard (1894) John Henry Steel observed the outbreak
of a similar disease in transport mules in Burma in 1885. Other sources
(Blanchard, 1888) claim that outbreaks similar to those described by Evans
were reported in mules in 1888 in North Vietnam and in Java, Indonesia in
1899. It was Balbiani (1888) however,who first referred the flagellate
causing the disease to the genus Trypanosoma which he at the time spelt as
"Tripanosoma". This was amended to Trypanosoma after several years because
of the confusion it introduced to the nomenclature of this parasite, as many
workers referred to it with different names. Trypanosoma evansi was finally
chosen as the official name of the pathogen causing the disease'that was first
described by Evans, 1880, 1881-1882.
Other early reports on the outbreak of 71 evansi infections include those
of Schat (1902) concerning an outbreak in Sumatra in 1901 while Yakimoff
(1921, 1923) reported outbreaks of 71 evansi in Russia and claimed that it
caused high mortalities in camels. He also attributed the first reported
outbreak of 71 evansi in Russian camels to Feinschmidt in 1912 in the
Astrakhan and Saratov regions.
Since the initial reports in the late 19th and early 20th Centuries there
have been numerous reports of diseases with similar clinical signs caused by
trypanosomes which are morphologically indistinguishable from 71 evansi in
various parts of the New and Old World (Mahmoud and Gray, 1980; Losos,
1980). Diseases attributed to 71 evansi or 71 evansi-like parasites are known by
more than 33 different names in different parts of the world. A feature
common to all of these names is their recogpition of the chronic and wasting
nature of the disease. The name "Purana", meaning chronic or old; "tibarsa",
meaning three-year disease and "dubla", meaning emaciated are some of the
names that have been widely used by livestock owners in the eastern block to
describe the disease caused by 71 evansi infection (Luckins, 1988). The
"Hindi" term "Surra", meaning rotten or emaciated is, however, the name
commonly accepted and now used universally to describe the disease caused by
71 evansi in all species of domesticated livestock in many different countries
(Gill, 1977). Surra has also been used for some other disease syndromes in
South America such as "Murina" (T. hippicum infections), "Mai de Caderas"
(71 equinum infections) and "Derrengadera" (71 venezuelensis infections) caused
by trypanosomes that are morphologically indistinguishable from 71 evansi
(Gutierrez, 1958). Hoare (1940, 1950, 1956, 1965, 1967) considered that
there were no scientific grounds for accepting the validity of any of these
names other than 71 evansi and these names are, therefore, used as synonyms
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for T. evansi and diseases caused by them referred generally to as "American
Surra".
The effect of T. evansi infections on livestock in some endemic regions of
the world is extreme in that a large proportion of animals die from the
infection or fail to attain their full economic potential. The recognition of the
importance of T. evansi infection as a constraint on livestock development
stimulated the establishment of centres in countries such as India as far back as
1940 for the monitoring of infections and treatment of infected livestock
(Luckins, 1988). Mortalities attributed to T. evansi infections can be very
high. Reports of 90% mortality were attributed to T. evansi infections in
buffaloes moved from the mountains to the delta zone of Vietnam's Red River
(Wells, 1982). Furthermore, the author estimated the total number of animals
killed by Surra in this zone at approximately 20,000 buffaloes annually in the
years between 1978 and 1980.
In the case of other species of economically important livestock such as
goats, up to 60% mortality has been reported in an infected herd (Mahmoud
and Malik, 1978). In horses mortality rates of up to 100% are often reported,
with death occurring 4-8 weeks after infection (Rodenwaldt and Doewes, 1921;
Bakkar, 1930). Although the high mortalities are spectacular and reportable
most animals suffer chronic infection, often going unreported but reducing
their economic potential including reduced meat/milk yield, work output and
depressed reproduction.
Despite the widespread effect of T. evansi infection on different animal
species of economic importance, research and control of T. evansi have not
attracted the degree of co-ordination, discussion and international co-operation
that has been a feature of African trypanosomiasis research programmes.
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Recently, however, steps have been taken to try to address this anomaly, with
recognition of the need to obtain adequate and up-to-date information on the
incidence and economic importance of Surra (Luckins, 1988). One of the
consequencies of this increased interest in T. evansi has been the establishment
of an international working group of T. evansi by the Office International des
Epizooties (OIE), to provide a regular opportunity for discussion between
workers in the field. Such collaborative studies are, however, still in their
infancy.
ORIGIN OF T. EVANSI
One generally accepted theory of the origin of T. evansi is that postulated
by Hoare (1972) which suggests that T. evansi evolved from T. brucei by
adapting to a non-cyclical mode of transmission with consequential loss of
pleomorphism. Hoare suggested that camels coming into contact with tsetse
flies became infected with T. brucei but when these camels returned to tsetse-
free areas, the infections were perpetuated by other haematophagus insects.
Thereafter, camels were thought to have further disseminated the parasite
when camel caravans travelled through North Africa into the Middle East and
Asia. Curasson (1943) had, however, suggested earlier that the use of
dromedaries by the ancient Egyptians in their military campaigns could have
been responsible for the introduction of T. evansi into Mesopotamia, Persia
and Baluchistan. The introduction of T. evansi into the New World is often
credited to the importation of horses by the Spanish conquistadores for their
cavalry (Hoare, 1972). The high mortality due to T. evansi infections
recorded in these imported animals by the Spanish however, suggests that T.
evansi was already present, possibly introduced into the region much earlier in
cattle, from the Iberian Peninsula during the 16th Century (Rouse, 1977).
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GEOGRAPHICAL DISTRIBUTION
Unlike the tsetse-transmitted trypanosomes, the distribution of T. evansi is
not restricted to that of a particular vector species. T. evansi infections,
therefore, enjoy a widespread distribution in both the New and Old World. It
has an extremely wide geographical range in countries with uniform hot and
warm temperate climates. In Africa T. evansi infects a range of livestock
along the Atlantic and Mediterranean littorals of North Africa where it is
reported from Morocco, Algeria, Tunisia, Libya and Egypt. From here its
distribution extends across the Sahara into Senegal, Mali, Chad and parts of
West Africa lying north of 15°-16°N. In the East, the disease spreads further
south to about 13°N in Sudan and almost up to the Equator in northern Kenya
and Somalia (Barotte, 1925; Hoare, 1956; 1970).
In the Near and Middle East, T. evansi infections have been reported
from Israel, Lebanon and Syria, the northern half of the Arabian Peninsula,
Asia Minor, Iraq and Iran. In Europe, it has been reported in Turkey, and a
few cases in Bulgaria. In the Volga regions of the Soviet Union, the area
chiefly affected by the disease reaches the northern-most point of its
distribution near Kuibyshev on the Volga (53°N) and the southern-most point
in the Caucasus (44°N). From here it passes into Soviet Middle Asia
(formerly Turkestan). T. evansi is especially prevalent in Iran, India, Burma
and presents particular problems to livestock owners in S.E. Asian countries
such as those in Malay, Indochina and parts of Southern China. It also occurs
in islands of the Indian Ocean, the islands of Indonesia and Philippines
(Hoare, 1972; Topacio and Acevado, 1938). In the New World countries such
as Mexico, all those of Central America, and Venezuela, Columbia, Brazil
livestock can be affected by diseases caused by trypanosomes that are
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morphologically indistinguishable from T. evansi (Hoare, 1972).
HOSTS OF T. EVANSI
T. evansi infections tend to affect different animal hosts in different parts
of the world. Overall it infects a wide range of economically important
livestock in particular equids, camels, cattle, buffalo, goats, sheep and pigs
(Luckins, 1988). Those that experience high mortalities due to T. evansi
infections include horses and camels while chronic infections are usually
associated with bovines, donkeys, goats and sheep. A range of different wild
animals are known to be infected in different parts of the world but the exact
impact of T. evansi on such wildlife is not known (Losos, 1980).
T. evansi like many other parasites infects a range of hosts that can be
considered as reservoir hosts. Such hosts continue to harbour the parasite but
as
do not show any clinical signs of the disease, often remamingAcarriers for long
periods of time and serving as sources of infection for other animals. Many
animals species have been implicated as reservoir hosts of T. evansi, in
particular wild animals, ranging from animals as diverse as the mongoose
(Herpestes palustris) to tigers and jaguars (Choudhury and Misra, 1972;
Marinkelle, 1976; Reddy et al., 1975; Sinha et al., 1971). Despite the fact that
wild animals can be infected with T. evansi, it is unlikely that they could serve
as important sources of infection for domestic livestock. Successful
transmission of T. evansi depends on factors such as vector preferences and
closeness of donor to recipient host (Payne, 1988) which are unlikely to be
satisfied with these wild animals under normal livestock management practices.
In South America, the vampire bat (Desmondus rotundus) plays a uniquely
important role in the transmission of T. evansi and is considered to represent a
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carrier host (Hoare, 1965) because they carry the parasites in their blood
without showing any clinical signs of the disease.
All species of domestic animals, in particular cattle, buffalo, sheep and
goats can develop a chronic form of T. evansi infections and become carriers
and consequently reservoir hosts (Losos, 1980). Experimental evidence of
chronic infections in donkeys and cattle (Ilemobade, 1971), goats and sheep
(Khasanov and Ivanitskaya, 1974; Chand and Singh, 1971; Malik and
Mahmoud, 1978) further confirms that these animals could act as reservoir
hosts. It is more likely that conditions necessary for successful transmission of
T. evansi can be achieved with these animals rather than with wild animals. In
reality, therefore, it is more likely that domestic reservoir hosts, such as cattle,
buffalo, sheep and goats carrying a chronic T. evansi infection are more likely
to constitute important sources of infection to other domestic livestock rather
than the wild fauna, particularly as they are more likely to be herded together
than with wild animals. Animals such as horses and camels often develop
acute infections characterised by high parasitaemia and act as a source of
highly infective blood for a short period before they die. These animals
probably serve as an efficient source of infection to susceptible animals,
fuelling short-term epidemics. Domestic livestock running a chronic form of
the infection, with parasites circulating in their blood for long periods, are
probably the most important sources of parasites maintaining the trypanosome
in a particular area.
TRANSMISSION OF T. EVANSI
The greatest difference between T. evansi and the tsetse-transmitted
trypanosomes infecting livestock such as T. brucei, T. vivax and T. congolense
is that T. evansi can be transmitted in the absence of any form of cyclical
development in arthropod vectors. Such a fundamental difference has
probably played a significant role in the evolution of T. evansi affecting its
survival and distribution.
In the absence of any proven cyclical transmission mechanisms, the
accepted mode of transmission T. evansi is through the bite of blood-sucking
A
Diptera such as the horse-fly (Tabanus sp.) which had previously fed on an
infected animal. As early as 1899, Lingard suspected that horse-flies could be
the vehicle of transmission of T. evansi infection from infected to uninfected
animals via their blood soiled piercing organs. It was not until 1901, however,
that the ability of these flies to transmit T. evansi was confirmed
experimentally by Rogers (1901) who observed that when flies which had been
feeding on a dog suffering from Surra were interrupted in their meal and then
allowed to bite a healthy dog, the latter became infected. Rogers (1901) also
noted that if the interval between bites was extended to 1-4 days after the
initial bite, transmission of the organism did not occur, demonstrating a
limited survival time for the parasites on the fly mouthparts.
Stable flies (Stomoxys sp.) have also been incriminated as a possible vector
of T. evansi. Results obtained from attempted experimental transmission
between a range of hosts such as horses, guinea pigs and dogs however, have
shown that these flies do not appear to be important vectors as the
trypanosomes were found to die very rapidly in the mouthparts of the flies.
One and a half minutes after a successful bloodmeal all parasites were found
either dead or in a form incapable of transmitting infections (Mitzmain, 1913).
Other genera of haematophagus insects such as Haematopota, Chrysops and
Lyperosia have been shown to be capable of transmitting the parasite
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(Nieschulz, 1927; Nieschulz and Ponto, 1927; Nieschulz, 1930), however,
results from attempts to use these flies to transmit infections from horses or
buffaloes to susceptible recipient animals showed that none of them were
efficient vectors of T. evansi.
Other arthropod vectors such as ticks which are important in the
transmission of other protozoa are inefficient transmitters of T. evansi.
Trypanosomes die rapidly in the mouthparts of ticks and no adult engorged
ticks have been reported as harbouring viable trypanosomes capable of
infecting mammalian hosts (Kirmse and Taylor-Lewis, 1978).
Alternative routes to direct transmission of T. evansi via arthropods
include the epidemiologically important transmission through the bite of
vampire bats (Desmondus rotundus) in South America (Hoare, 1965) and
through the feeding of carnivores on infected meat particularly dogs feeding on
infected wild deer (Adams and Lionett, 1933; Curasson, 1943; Kasansky,
1957; Galuzo and Noviskaja, 1960). This latter mode of transmission could be
the method through which predator animals such as tigers and jaguars acquire
infection.
EPIDEMIOLOGY OF T. EVANSI
The epidemiology of T. evansi like those of other parasite systems depends
on a balance between infected and susceptible animals within a particular area.
In classical animal disease models, infected animals eventually become immune
animals, which in turn can lose their immunity and revert to susceptible
animals. The role of the immune system, therefore, can be seen to play an
important role in the epidemiology of the parasite system. In the case of
trypanosomiasis, animals once infected probably do not become immune in the
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classically accepted way due to antigenic variation (Soltys, 1963), a factor that
influences the epidemiology of the disease.
The limited time the parasite can survive in the mouthparts of the fly
(Rogers, 1901) makes interrupted feeding an important factor in successful
transmission. The interruption of feeds is closely linked to the host's response
to the fly which in turn is dependent on how the fly disturbs the host. The
closeness of the donor and recipient hosts, attractiveness of the host to the
flies, the level of parasitaemia in the donor host, chemotherapy and climate are
some of the other factors that affect the epidemiology of T. evansi discussed in
detail by Payne (1988).
Course of Infection
The course of infection of T. evansi in the vertebrate host is affected by a
number of factors such as the susceptibility of the host, the strain of the
parasite and the severity of the disease which differs according to the host
species and location (Hoare, 1972).
The most extreme response to T. evansi infection can be seen in horses in
which high mortality occurs after an incubation period of four to nine days.
Chronic forms of the disease characterised by a succession of crises and
relapses with infected horses dying after a period ranging between two to three
months, have also been reported (Barotte, 1925; Galuzo and Novinskaja, 1960;
Gutierrez, 1958). Usually the mortality rate in horses is very high with
mortality rates of 100% reported in horses infected with T. evansi and death
occurring as soon as four to eight days after infection (Rodenwaldt and
Doewes, 1921; Doewes, 1923; Bakkar, 1930).
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T. evansi infection also develops into an acute infection in dogs with an
incubation period of five to ten days. Trypanosomes may appear in the blood
periodically or persist throughout the infection (Barotte, 1925; Galuzo and
Novinskaja, 1960; Gomez Rodriguez, 1956). The syndrome is usually very
acute but in some cases could run up to six weeks. T. evansi infection in dogs
is fatal, particularly in imported breeds (Hoare, 1972). During the period
these animals are alive they could serve as short-time sources of highly
infective blood for disease transmission to susceptible animals in a particular
environment. The common practice of herdsmen using dogs for guarding their
animals suggests that the dogs and livestock are close together. In the presence
of an appropriate vector such closeness between a donor dog and the recipient
livestock would facilitate disease transmission.
Acute forms of T. evansi infection also occur in camels although the
disease tends to become chronic more often in these animals than in horses.
At the onset of infection the disease may be acute with an incubation period of
about seven days with parasitaemia fluctuating at high levels for three to four
months. This can end fatally, but in those animals that survive the acute
phase, it passes into a chronic phase, where parasite relapses become rare, and
the animal can remain in apparently good health for up to several years
(Barotte, 1925; Yakimoff, 1931; Boid et al., 1986). Mortality rates in camels
range between 50-100% but occasionally the camels are considered to recover
spontaneously (Sergant et al., 1918).
The chronic nature of T. evansi infections in bovines characterised by
sporadic parasite appearances in the blood make it difficult for the course of T.
evansi infection in these animals to be very well characterised. Trypanosomes
are only occasionally detectable in the blood of such animals, their presence
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only being revealed by inoculation of susceptible animals with blood samples
from animals suspected of carrying infection (Lingard, 1907; Cross, 1921;
Edwards, 1926; Gutierrez, 1958; Hoare, 1956). The complex nature of the
outcome of infection with T. evansi illustrated in studies where trypanosomes
causing a particular type of disease in one animal species have been transferred
to another species show that severity of the disease varies from one host to
another. For example, experimental infections in cattle inoculated with strains
of T. evansi producing acute diseases in camels and horses and kept under
observation for more than two years, only revealed the predominance of
chronic infections (Galuzo and Novinskaja, 1960). This result demonstrates
the importance of the host factors in determining the outcome of infection in
these animals rather than parasite specific factors. However, when these
cameline and equine strains of T. evansi were injected into calves, the acute
form of the disease appeared with high mortalities, a probable indication of
existence of an age effect on the course of T. evansi infections in bovines.
Further evidence of the chronic nature of T. evansi infections in cattle came
from Musgrave and Clegg (1903) who examined hundreds of cattle for T.
evansi infection using parasitological techniques and found very few cases of
infection. They concluded that the disease in cattle was chronic in nature with
a low mortality rate and furthermore, that trypanosomes were so scarce in the
peripheral blood that they could only be detected with certainty by inoculating
susceptible laboratory animals with suspect blood.
The course of T. evansi infections in buffaloes is similar to that reported
for cattle, although buffaloes are usually considered to be generally more
susceptible. This difference may be due to factors such as stress, as buffaloes
are often worked much harder than cattle and are also less likely to be well fed
(Payne, 1988). In a survey carried out in the Philippines by Topacio and
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Acevado (1938) on the prevalence of T. evansi in cattle and buffaloes, the
authors used the complement fixation test to examine sera from the animals for
the presence of T. evansi antibodies. They found that the prevalence of T.
evansi antibodies was higher in buffaloes than in cattle and noted that although
buffaloes were frequently serologically positive, it was nevertheless difficult to
find trypanosomes in the peripheral blood of both animals. Trypanosomes
were, however, always found to be present in antibody positive buffaloes when
blood from these animals was inoculated into white rats compared to blood
from cattle. These authors also reported that T. evansi infections in buffaloes
ran a protracted course and although infected animals remained apparently
unaffected by oscillations in parasite numbers, episodes of parasitaemia could
continue for several months. This observation led these authors to suggest that
buffaloes could serve as an important source of infection to susceptible animals
in a particular environment.
IMMUNOLOGY OF T. EVANSI
Antigenic Variation
Antigenic variation is an outstanding and well documented feature of
trypanosome species infecting man and domestic livestock. At the cellular
level antigenic variation results from the continual changes in the chemical
composition of a 12-15 nm thick layer of glycoprotein which covers the surface
of the trypanosomes, throughout the course of infection (Soltys, 1963;
Vickerman, 1969; Cross, 1975). T. evansi, in common with other species of
African trypanosomes pathogenic to man and domestic livestock, uses antigenic
variation as a means to evade the immune response of their host (Cross, 1975).
Apart from ensuring the survival of the parasites and the continuity of the
infection, antigenic variation also plays a principal role of rendering the use of
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immunoprophylaxis in the control of trypanosomiasis improbable because of
the specificity of the host antibody response and the large number of
antigenically different parasite populations that can develop during the course
of the disease (Vickerman, 1978; Cardoso de Almeida and Turner,1983", Gray ^
and Luckins, 1976).
Trypanosome infections are characterised by successive waves of
parasitaemia each one consisting of immunologically distinct parasite
populations. The ability of the immune system of the host to eliminate the
parasite completely from the blood is compromised by the fact that by the time
that specific antibodies have been produced against the major surface
component of one particular trypanosome population, other parasites bearing
different antigens on their surface emerge, evade the host immune system and
proliferate. This emerging parasite population is not affected by the antibodies
produced by their host against any previous major parasite population because
antibody responses to each parasite population, commonly referred to as
Variable Antigenic Types (VAT) (Cross, 1975) are only specific to parasites
bearing the homologous variant surface glycoprotein VSG and therefore,
confers no protection against antigenically different trypanosomes, (Laveran
and Mesnil, 1902; Ehrlich et al., 1909; Weisenhutter, 1970; Wellde et al.,
1981; Seed, 1972; Campbell and Phillips, 1976; Murray and Urquhart, 1977;
Morrison et al., 1982a). The sequential emergence of antigenically different
trypanosome populations often continues until the parasites overwhelm the
immune system of the host resulting in death if chemotherapy is not instituted
(Gray, 1965; Cross, 1978a; Donelson and Turner, 1985).
The range of individual VATs that a parasite population expresses during
the course of the infection constitutes the VAT repertoire of that trypanosome
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stock. Although each trypanosomal line has the potential to produce a large
number of different VATs, during the course of infection, there is a tendency
for stabilisation of the VAT repertoire to occur during the early infection
period in naive hosts. In the case of tsetse-transmitted trypanosomes there is a
tendency for a certain VAT to occur in the first wave of parasitaemia
irrespective of the VAT used to infect the fly. This antigenic type is being
referred to as the basic antigen and is characteristic of the particular stock
(Gray, 1965). After the appearance of the basic antigen, a tendency exists
then for certain VATs from the repertoire to appear regularly during the early
stages of infection in different hosts infected with the same stock of parasites.
These later VATs are termed the predominant VATs (pVATs) (Lumsden,
1982) and are also characteristic of particular stocks.
In the case of T. evansi due to the absence of the metacyclic stage in its
life cycle, basic antigen type does not occur by definition but the pVATs
develop in the same way as when the tsetse-transmitted species of
trypanosomes are propagated by syringe transmission (Jones and McKinnell,
1984). As in the case of tsetse transmitted trypanosomes, particular VAT
sequences (VAT repertoire) are associated with particular trypanosome stocks
of T. evansi . This association offers a potential means for the classification of
trypanosome stocks into pVAT serodemes on the basis of their pVAT
repertoires (Jones and McKinnell, 1984).
The number of pVAT serodemes of T. evansi circulating in nature
appears more limited than in the case of tsetse-transmitted trypanosomes such
as T. brucei where very many serodemes have been recorded (Jones and
McKinnell, 1985b). The apparent limited antigenic diversity seen in T. evansi
could be linked to the lack of cyclical transmission in T. evansi. There is
- 21 -
mounting evidence that genetic exchange takes place during cyclical
transmission of trypanosomes such as T. brucei (Tait, 1980). Such genetic
exchange could provide the opportunity for the greater antigenic diversity seen
in the case of tsetse transmitted trypanosomes than the non-cyclically
transmitted T. evansi.
The apparent restriction in the number of pVAT repertoires of T. evansi
circulating in nature also may be to the advantage of the host and indirectly to
the parasite. In situations where the number of serodemes is limited, constant
challenge of the animal with the same range of VATs would result in a build¬
up of immunity to those particular antigenic types. As long as this antigenic
stability is maintained and animals continue to receive sufficient challenge to
maintain antibody levels to the range of pVATs then it is unlikely that animals
would suffer from disease. Should the animals be exposed to trypanosome
stocks that express different pVAT sequences or should the antibody levels
wane in the absence of a continuous rechallenge, the animals could suffer
severely on rechallenge. Such a situation could explain the sporadic nature of
T. evansi epidemics, in which there are frequent flare-ups of T. evansi diseases
in the field. This suggests that the physical act of infection need not be the
only factor in the development of disease. Some factors influencing the
immunological balance within the animal population could be equally or more
important.
The limited antigenic diversity amongst T. evansi stocks also suggests that
the protection of animals from infection with vaccines containing the different
pVAT antigen components could be a more realistic possibility in the case of
T. evansi than with the tsetse transmitted trypanosome species. Prior to the
development of such a vaccine, however, specific characterisation of the
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dominant pVATs in any area would have to be carried out.
The process of antigenic variation has important consequences for the
epidemiology of trypanosomiasis. The antigenically distinct parasite
populations, which are continually emerging throughout the infection, renders
the infected animal a continuous source of infection to susceptible animals in
the environment. Unless the effects of antigenic variation are annulled by the
death of the infected animal or the institution of chemotherapy, infected
animals will continue to serve as a source of infection as long as transmission
conditions are suitable.
The studies conducted specifically on antigenic variation in T. evansi have
shown that T. evansi seems to behave like T. brucei with respect to the
development of the VAT repertoire (Jones and McKinnell, 1984). Other
studies by Jones and McKinnell (1985c) enabled them to classify 15 stocks of
T. evansi into three distinct serodemes based on their pVAT repertoires. Each
representative member of a particular serodeme being associated by the
presence of 6-7 particular VATs as a part of their pVAT repertoire. Of these
pVATs, two were found to be part of the pVAT repertoire of all 15 stocks and
were considered to represent the isoVAT of these T. evansi stocks, as have
been described from other trypanosome species (Meirvenne et al., 1977; Gray
and Luckins, 1976). Host species did not appear to influence the range of
VATs that were detected early in infection, although differences were seen in
the VAT composition of individual trypanosome populations isolated at similar
periods after infection of the different hosts (Jones and McKinnell, 1985b).
Horchner et al. (1984) made a similar observation in T. evansi infections in
rabbits and indicated that the parasite populations became antigenically more
heterogenous as the infection progressed. This led them to the conclusion that
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there may be important differences between the properties of early and late
appearing trypanosome populations and that parasite populations developing
later during an infection could be less antigenic than those developing earlier in
infection.
Few detailed studies have been made on the parasite components involved
in antigenic variation in T. evansi (Cross, 1978b; M. Onodera, personal
communication cited in Richards, 1984), unlike the extensive studies that have
been conducted on the surface glycoprotein coats of the tsetse-transmitted
trypanosomes such as T. brucei, T. congolense (Cardoso de Almeida and
Turner, 1983; Ross et al., 1987; Gurnett et al., 1986; Cardoso de Almeida et
al., 1984), T. vivax (Gardiner et al., 1987). Improved understanding of the
role of the parasite surface antigens in host/parasite relationship can come from
a detailed understanding of their physical and chemical properties. The fact
that surface antigens can also play an important role in diagnosis as reagents in
diagnostic tests designed to detect the presence of parasite antibody, provides
further impetus for a better understanding of their physical and chemical
characteristics. Despite the fact that the surface antigens are very
immunogenic (Le Ray, 1975) and antibodies are produced against them early
in infection which persist for long periods, their potential use as diagnostic
reagents is limited by their variable nature. Under certain circumstances
however, the surface components of the trypanosomes are used in some
diagnostic techniques, such as the card agglutination test (Magnus et al.,
1978). For this test to be effective, the VSG of the most widely distributed
isoVAT in the particular environment has to be used as the antigen.
The inherent variability in the composition of the trypanosome surface
antigens and its poor potential for use in the diagnosis of trypanosome
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infection has stimulated a search for alternative sources of parasite material for
diagnostic tests. The fact that animals infected with trypanosomes are known
to produce antibodies against both the surface and internal components of the
trypanosomes (Le Ray, 1975) and that the composition of internal components
are more stable than the surface components makes them better prospects as
antigens for diagnostic tests. One major disadvantage of the use of the internal
components is that they are made up of a large number of individual
components, many of which are common to all species of trypanosomes and
are likely to pose problems of cross reactions. Furthermore, it is possible that
only a few of these internal components could be antigenic, therefore, the use
of crude extracts containing all of them in an assay system would include the
many redundant components which could in turn affect the efficiency of the
test.
The basic immunology of T. evansi like that of other trypanosome species
is complicated by the multicomponent nature of the parasite antigens and the
potentially complex nature of the host immune response to the individual
antigens. Apart from the surface coat of the trypanosomes which is very
immunogenic and usually induces intense immunological reactions from the
host, there are numerous internal components of the parasite against which
antibodies are produced by the immune system of the host during the course of
an infection (Le Ray, 1975). Furthermore, the host immune system could
produce antibody belonging to one or more immunoglobulin class, IgG, IgM,
IgA, IgE or IgD to each parasite component. Such a complication makes the
interpretation of results from tests designed to evaluate host/parasite
interactions difficult unless particular immunological techniques, that are
capable of resolving the reaction of individual antigenic components with the
appropriate host antibody are used.
The general conclusion from the many reviews of studies carried out on
the host/parasite relationship in African trypanosomiasis over the last 80 years
(Roelants and Williams, 1982; Vickerman and Barry, 1982; Roelants and
Pinder, 1984; Nielson, 1985; Bancroft and Askonas, 1986; Shapiro and Pearson,
1986) is that the humoral immune response effected either directly through
antibody-dependent phagocytosis or indirectly through complement-mediated
lysis is the main method by which trypanosomes are eliminated by the host
immune system. Most of these authors of these reviews tended to consider at
great lengths the immunological importance of the variable glycoprotein coat of
the parasites in ensuring the parasite evasion of the immune system of the host
and also as the major obstacle to the use of immunoprophylaxis in the control
of trypanosomiasis paying scant attention to the role of internal or non-surface
antigens of the parasite. The importance of the host's specific antibody
response to the surface glycoprotein coat of the parasite for both the parasite
and the host are two aspects of trypanosomal immunobiology that all the
authors agreed upon. Less certain however, is the exact role of the host's
immune response to the non-surface components of the trypanosomes and the
importance of such a response to the host, in terms of protection, resistance
and susceptibility to infection. Le Ray (1975) suggested that the internal
components or the common antigens stimulate a relatively feeble antibody
response in comparison with that to the variable surface antigen. Roelants and
Pinder (1984) suggested that the limited response to the internal trypanosome
components could be due to the fact that they represented a minor part of the
total antigenic make-up of the parasite and in part to their lack of opportunity
to contact the relevant immunocytes as they are not usually exposed on the
surface of the parasites. Roelants and Pinder (1984) however, suggested that
these internal components could play a critical role in the pathogenes/s of the
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disease by triggering an immune response after the destruction of the parasite
by VSG specific antibodies and by the formation of immune complexes. The
immune response against the non-surface components of the parasite is one
aspect of the T. evansi immunology like that of other tsetse-transmitted
trypanosome species that has been neglected.
Cell-mediated responses directed against trypanosome antigenic
determinants have been demonstrated in trypanosomiasis but the relevance of
such a response is unclear not only in the elimination of parasites but also in
the protection of animals to reinfection.
The complement system plays an important role in the destruction of
microorganisms (Roitt et al., 1985). The importance of the complement
system in the host response to trypanosome infection was reviewed by Nielsen
(1985). Most reports on the role of complement in trypanosomiasis indicate
that complement plays an active role in the elimination of the parasites
principally through cell lysis (Murray and Urquhart, 1977). Furthermore, the
levels of complement were seen to decline during the course of trypanosome
infections in man and animals (Greenwood and Whittle, 1976; Nielsen and
Sheppard, 1977; Fruit et al., 1977; Nielsen et al., 1978b; Jarvinen and
Dalmasso, 1976). Although the complement system consists of more than 30
components (Lambris, 1988), most of these studies have been conducted on
the third complement component (C3) probably because of its pivotal role in
the activation of both the classical and alternative complement pathways by
which the complement system exerts its effect (Roitt et al.,, 1985). Both
pathways have been demonstrated to be important in the elimination of
trypanosomes (reviewed in Neilsen, 1985). Some studies on other complement
components associated with later stages of complement activation such as C8
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(Nielsen et al., 1978a) and C6 (Jarvinen and Dalmasso, 1976) indicated that
the levels of these components are not affected in trypanosomiasis unlike C3.
This observation led these authors to suggest that the completion of the
complement cascade might not be required for effective control of
trypanosomiasis as in other pathogens. No such studies however, have been
conducted specifically with T. evansi infected animals.
One feature of trypanosome infection that modifies and compromises the
host immune response in laboratory animals (Goodwin, 1970; Goodwin et al.,
1972; Murray et al., 1974a,b; Mansfield, 1978; Hudson and Terry, 1979),
cattle (Holmes et al., 1974), goats (Griffin, 1978) and man (Greenwood et al.,
1973) is immunosuppression. This renders the host susceptible to secondary
infection, diminishes their response to viral and bacterial vaccines, and possibly
the response to trypanosome infection itself.
The first evidence for trypanosome-induced immunosuppression came
from the observation that T. brucei-iniected mice and rabbits expressed an
impaired antibody response to sheep red blood cells (SRBC). (Goodwin, 1970;
Goodwin et al., 1972 and Longstaffe et al., 1973). Following this, several
other workers evaluated this phenomenon of immunosuppression in greater
detail. Hudson et al. (1976) demonstrated a reduction in the number of IgG
and IgM plaque forming cells in the spleen of trypanosome infected animals
while Ackerman and Seed (1976) and Murray et al. (1974b) demonstrated a
suppression of the ability of B-lymphocytes to respond to helper T cell
dependent antigens such as bovine serum albumin and T cell independent
antigens such as bacterial lipopolysaccharide. T-cell response induced by
oxazolone treatment of ear skin of infected rats and mice was also observed to
be depressed in animals infected with T. b. brucei and T. b. gambiense
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(Urquhart et al., 1973; Ackerman and Seed, 1976). Results of these studies
indicate that all the components of the host immune response, both humoral
and cell mediated, are suppressed during trypanosome infection. In effect,
apart from coping with the direct effect of trypanosome infection,
trypanosome-infected animals also have to cope with the problems of an
impaired immune system.
There is increasing evidence that the degree of immunosuppression is
related to the parasite burden of the host in that immunosuppression is most
marked in hosts that have high parasitaemias and least marked in hosts that
have a fewer parasites in their blood (reviewed in Vickerman and Barry,
1982). Furthermore, the elimination of trypanosomes by drug treatment of the
trypanosome infections restores immunocompetence and enables the host to
mount a full secondary response (Freeman et al., 1974; Murray et al., 1974c;
Wellhausen and Mansfield, 1980). Some of the mechanisms by which
trypanosomes are thought to bring about immunosuppression have been
reviewed by Vickerman and Barry (1982) and these include amongst other
factors, defective antigen handling/presentation and antigenic competition.
They suggested that as the induction of a response to T-dependent antigens
often depends upon macrophage presentation to T cells, a defect in antigen
handling and presentation could be responsible for the development of
immunosuppression. Evidence of damage to the macrophage system provided
by Mansfield and Bagasra (1978) showed that the serum of T. b. rhodesiense-
infected mice prevented the uptake of particulate antigens by macrophages,
and also that macrophages from infected mice were unable to initiate in vivo
plaque-forming cell response in syngeneic recipients following exposure to
sheep red blood cells (SRBC). A progressive depletion in the number of
antigen-presenting macrophage subpopulations has been observed to occur in
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the spleen, and lymph nodes and peritoneal cavity of trypanosome-infected
animals (Bagasra et al., 1981). Such a development could worsen the state of
immunosuppression in trypanosome-infected animals. The progressive
depletion of these cells with the progress of the disease could probably account
for the more serious forms of immunosuppression associated with the later
stages of infection.
Immunological memory, a fundamental property of the immune system
responsible for an enhanced response to secondary exposure to an antigen
appears to be affected in trypanosomiasis. Evidence is now emerging that
trypanosome infection can damage the mechanism of secondary reaction, for
example rats initially infected with Nippostrongylus brasilensis and then
infected with T. brucei immediately after the phase of immune expulsion of the
worms, lost the ability to expel a subsequent worm challenge. The elimination
of the trypanosome infection by chemotherapy, however, resolves the host's
secondary response. This result suggests that trypanosome infection blocks the
expression of a secondary immune response, rather than abolishing the
immunological memory of the infection (Urquhart et al., 1973).
Immunological memory may, however, become exhausted as a result of
trypanosome infection in that Askonas et al. (1979) reported that spleen cells
from T. brucei-infectcd mice were unable to confer the ability to mount a
response to a secondary infection to T dependent antigens when transferred to
irradiated recipient mice.
The five major immunoglobulin classes of antibody interact with the
antigens in different ways, therefore a knowledge of the range of
immunoglobulin (Ig) isotypes produced in response to trypanosome infection is
important in achieving a better understanding of the host/parasite
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relationship (Jenni , 1977; Murray and Urquhart, 1977; Nantulya et al., 1980;
Morrison et al., 1982a; Greenblatt et al., 1983; Ngaira et al., 1983). The
majority of studies on the immunoglobulin classes associated with trypanosome
infection have been undertaken on the IgM and IgG classes at the expense of
the other classes such as IgA, IgD and IgE. This concentration on IgM and
IgG probably stems from the fact that their assays are relatively easily
undertaken and the traditional association of these two classes with infections
such as those caused by trypanosomes. Each antibody class produced by the
host has a potentially different role to play in dealing with the parasites
through well established immune defence processes such as, complement
fixation, agglutination, neutralisation and cell lysis (Roitt et al., 1985).
Results from studies on antibody production in trypanosome-infected animals
suggest that early in infection IgM is a more efficient agent than IgG for the in
vitro neutralisation, agglutination and lysis of trypanosomes and for providing
protection in vivo (Seed, 1972; 1977; Takayangi and Enriquez, 1973; Luckins,
1976; Musoke et al., 1981). Other studies with different parasite systems such
as those of Smith et al. (19 6 7 ) working with Proteus mirabilis have
suggested that IgG antibody is superior to IgM in enhancing phagocytosis,
finding
This a is different and contradictory to the observation made with
which
trypanosomes considering that processes like agglutination Awere found by the
group of workers mentioned above to be better effected by IgM than IgG
enhance phagocytosis. This difference may be due to the fact that the
function of the immunoglobulins is influenced by the nature of the antigens.
Markedly elevated levels of IgM in animals infected with different species
of trypanosomes have been reported by several investigators (Seed et al., 1969;
Luckins, 1972; 1974; Clarkson et al., 1975; Kobayashi and Tizard, 1976;
Zahalsky and Weinberg, 1976; Luckins and Mehlitz, 1976). Kobayashi and
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Tizard (1976) observed an increase of 6-24 times the preinfection IgM levels in
animals infected with T. congolense and only an increase of 2.5 times the
preinfection IgG levels. Luckins (1974) in his study of immunoglobulin levels
in zebu cattle naturally infected with trypanosomes demonstrated a 2-9 times
increase of IgM and a two-fold increase in IgG levels respectively. The
mechanism responsible for these marked increased immunoglobulin levels is
not understood. Seed et al. (1969) attributed the increase in IgM levels to the
effect of antigenic variation, in which the continual emergence of new
antigenic types stimulate a typical IgM first response. Other workers have
suggested that the trypanosome parasitaemia stimulates the synthesis of non-
trypanosome specific IgM immunoglobulins. Evidence for this comes from
the fact that such IgM from trypanosome-infected hosts have been shown to
react with antigens to which the host had not been exposed previously, such as
sheep red blood cells and guinea-pig kidney extract (Houba et al., 1969). A
similar observation was reported by Hudson et al. (1976) who demonstrated
polyclonal B cell stimulation during trypanosome infection with a consequential
increase in non-specific immunoglobulin production. The production of such
immunoglobulins in trypanosomiasis questions the specificity, relevance and
importance of the elevated IgM levels in trypanosome infected animals
obtained by most of the workers cited above who studied the levels of the
different immunoglobulin classes in trypanosomiasis using assay systems that
could not relate the antibody specificity to the trypanosome.
Conclusions reached as to the relative importance of the different
immunoglobulin isotype in trypanosome-infected animals are often influenced
by the technique used for assessing antigen/antibody interaction. Results with
the trypanosome agglutination test as reported by Seed et al. (1969), Zahalsky
and Weinberg (1976) suggested that a predominant trypanosome specific IgM
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production during the early period of infection in rabbits infected with T. b.
gambiense and in rats or cattle infected with T. b. brucei. Furthermore,
Takayangi and Enriquez (1973) also reported that after primary challenge of
mice with T. b. gambiense, purified IgM was 200-fold more effective in a
neutralization of infectivity assay and 20-fold more effective when used in an
agglutination assay than IgG. Other investigators however, reported that the
primary trypanosome-specific response of mice and cattle to T. b. brucei or
mice to T. b. rhodesiense was predominantly IgG (Campbell et al., 1978;
Nantulya et al., 1979; Sacks and Askonas, 1980; Mansfield et al., 1981).
Nantulya and his colleagues used a radioimmunoassay employing purified VSG
as the antigen while the other investigators used a fluorescent antibody staining
technique with fixed trypanosomes as antigen, which they claim was VSG
specific.
The use of an agglutination test to evaluate trypanosome antibody activity
would bias the system towards IgM because IgM is considered to act as a more
efficient agglutinating agent than IgG (Roitt et al., 1985). Such agglutination
is enhanced with particulate antigens (Bowry, 1984) such as when whole
trypanosomes are used as antigen in an agglutination test. The use of purified
VSG as the antigen in radioimmunoassay or fluorescence on fixed
a test that
trypanosomes a is VSG specific should not bias the system towards any of
the immunoglobulin classes unlike the agglutination test. The results obtained
by the group that recorded IgG predominance probably reflect more closely the
contribution made by each Ig class to the overall trypanosome specific-response
than those reporting on IgM predominance.
Of the three other immunoglobulin classes that can be produced by the
host in response to infection, only IgA and IgE, have received a cursory
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mention in animals infected with trypanosomes. In one study, total serum IgA
levels were found to fall in cattle experimentally infected with T. congolense
(Nielsen et al., 1978a). The authors admitted their difficulty in interpreting
the finding but suggested that this might be resolved by evaluating changes in
IgA levels at external mucosal surfaces, where IgA is partly responsible for
protection against invading pathogens while evaluating changes in IgA levels in
the serum. Such invasions are common in trypanosome-infected animals
resulting in serious secondary infections which further compromise the host
(Losos and Ikede, 1972). The relationship between changes in the IgA levels
on the extravascular surfaces and IgA levels in the blood during the course of
infection could assist in a better understanding of the importance of IgA in
trypanosomiasis.
Studies on the dynamics of antibody levels in T. evansi infection are
limited in comparison with those that have been undertaken with the tsetse-
transmitted trypanosome species. Schoening (1924) used the complement
fixation test to demonstrate the presence of antibodies in T. evansi infected
camels. Following this observation, Bennett (1929) demonstrated the specific
increase in euglobulin levels in animals infected with T. evansi. Other studies
that demonstrated an increase in total antibody levels in animals infected with
T. evansi include those of Jatkar and Singh (1971) and Boid et al. (1981) using
standard serodiagnostic tests such as indirect haemagglutination and ELISA.
Studies on the levels of different classes of immunoglobulin production in
animals infected with T. evansi are even more limited. Results available from
such studies have demonstrated that IgM predominates in animals infected
with T. evansi (Luckins, 1977; Luckins et al., 1978, 1979; Boid et al., 1986) as
in the case of infection with other trypanosome species. The usefulness of
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results from such studies in helping to understand the dynamics of the
host/parasite relationship is, however, limited by the fact that the assay systems
used in such studies cannot associate the activities of any of the
immunoglobulin classes with any parasite specific antigen.
Despite the different and often conflicting results obtained from studies on
the levels of the immunoglobulin isotypes in animals infected with
trypanosomes, one aspect of which all workers appear to agree upon is that
specific trypanosome antibodies are important not only in controlling an
existing parasite infestation but also in protecting animals against reinfections
with homologous trypanosomes. Furthermore, all the workers highlighted the
importance of non-specific polyclonal B cell stimulation in trypanosomiasis
thought to be caused by the mitogenic effect of trypanosomes (Esuruso, 1976;
Assoku and Tizard, 1978) which could affect total immunoglobulin assays.
There are hardly any studies of comparable detail with those of the
humoral response on the importance of cellular immunity in trypanosomiasis
due to T. evansi despite the fact that Gomez Rodriguez (1956) suggested that
the cellular components of the host immune system could be important in the
destruction of T. evansi. He emphasized the possible importance of the
phagocytic cells found within the leucocyte population, the liver and the spleen
in the removal of the parasites.
Other manifestations of host response to trypanosome infection can be
obtained from observing changes taking place in organs that may have an
important role to play in regulating the immune response of the host.
Morphological changes from normality, or rather non-infection, in such organs
may not necessarily be pathogenic but could be more related to their role in
defence against the invading parasites. Such changes can provide important
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information on how effectively the host is coping with the infections. Changes
in organs such as the lymph node and the spleen, organs that play an
important role in the genesis or development of many effector cells such as the
B and T lymphocytes can provide basic information on the nature of the
defence mechanism, that is of paramount importance in a particular parasite
system. Changes in organs such as the liver may be important in
understanding the effect of the infection on accessory systems like the
complement system because the liver produces more than 90% of complement
component (C3) which is central to the two pathways, classical and alternative,
through which the effector functions of the complement system is achieved
(Lambris, 1988). Any changes in the liver could therefore, affect the amount
of this substance available for the destruction of trypanosomes by the immune
system.
Clearly over the past 80 years the role of the immune system of a host
suffering from trypanosomiasis has attracted a lot of attention from scientists.
Most of the attention has been directed to the humoral immune response,
particularly against the surface antigen of the parasite with very little attention
paid to the non-surface component. Very little information of practical use
has emerged from these studies in reality for the control or eradication of
trypanosomiasis, apart from the development of diagnostic techniques.
Furthermore, the tendency for studies on the host/parasite relationship in
trypanosomiasis have become polarised towards the surface antigen or to
responses considering the organism as a single antigenic entity rather than
examining the complex multicomponent nature of trypanosome antigen and
host response to individual parasite components. This experimental trend
could compromise other parts of the parasite that are non-surface in origin and
other aspects of the host response that are not antibody-dependent that could
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provide important alternative strategies to solve the problems of
trypanosomiasis. The tendency to isolate the immune response to specific
effector functions such as agglutination, or systems such as antigen/antibody
interaction at the expense of changes in important accessory systems such as
complement, may further hinder our better understanding of host/parasite
relationships in trypanosomiasis. Very few systems in the host act in isolation,
particularly the immune system, therefore future studies need to broaden their
baseline encompassing an integrated approach in evaluating the effects of




TECHNIQUE FOR THE DETECTION OF
ANTIGENIC COMPONENTS OF TRYPANOSOMA EVANSI
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INTRODUCTION
By virtue of their intracellular location and chemical structure, the
different subcellular components of the trypanosome engender a complex range
of host reactions to their presence. Some components may not evoke any
response while others stimulate a range of responses that may or may not be
protective against further challenge with the organism. Most studies conducted
on the role of the immune system in host/parasite relationships have used assay
systems such as ELISA (Voller et al., 1975, 1976, 1977; Luckins, 1977)
employing crude extracts of the parasite as antigen. Results from such assays
are incapable of providing information on the way in which the host responds
to individual trypanosome components. Apart from obtaining information on
host/parasite relationships serological assays are being used increasingly as
diagnostic aids. The use of crude parasite extracts as antigen also often
complicates the interpretation of results from such assays with the
multicomponent nature of the antigens often contributing to reduced
performance of potentially sensitive and specific assay techniques such as
ELISA. There is the need therefore, to identify the important components of
the parasite that could satisfy specific needs, such as reagents in immunoassays,
starting materials for the development of vaccines and also for a better overall
understanding of the host/parasite relationship.
Trypanosomal antigens can be divided into surface and non-surface or
internal components. The surface component consists of a 12-15 nm thick layer
of glycoprotein (Vickerman, 1969), the chemical composition of which
continually changes by a process known as antigenic variation throughout the
course of the infection (Soltys, 1963; Cross, 1975). The host generates a
specific immune response to each new antigenic type or variable antigen type
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VAT (Cross, 1975) which is only protective against a challenge with a
homologous VAT (Wellde et al., 1975, 1981; Emery et al., 1980; Morrison et
al., 1982a; Hall and Esser, 1984). The variable nature of the surface antigens
within the same stock of trypanosome reduces their value for use in
serodiagnostic tests as any one VAT will only detect antibodies produced
against itself unless a particular widespread VAT is used as antigen such as in
the card agglutination test CAT (Magnus et al., 1978). Surface antigens of
trypanosomes have attracted a lot of attention, however, for experimental
studies probably due to the practical ease with which such studies can be
conducted often with intact trypanosomes.
Internal antigens are components common not only to all VATs of a
trypanosome stock but also to other trypanosome stocks and species. These
antigens unlike the surface antigens, consist of a large number of components
and only become available to the immune system of the host after the intact
trypanosomes have been broken down by specific antibodies directed against
the surface antigen of the parasite (Roelants and Pinder, 1984). Antibody
responses to internal antigens characteristically, therefore, develop later than
those to the surface. The common nature of the internal antigens of
trypanosomes probably explains the high degree of cross reactions seen between
serum samples from animals infected with different species of trypanosomes
when tested using assays based on crude trypanosome extracts as antigen.
Cross reactions are important where more than one trypanosome species is
prevalent in an area each of which requires different control strategies. In
areas where there is only a single trypanosome species present the potentially
high level of redundancy of most of the trypanosome components in the crude
antigen extracts probably reduces the overall efficiency of assays such as
ELISA.
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The host response to trypanosome infection is considered to play a key
role in determining the outcome of infection. Many studies have been
conducted on the interaction between host immune system and the surface
antigen (Wellde et al., 1975, 1981; Emery et al., 1980; Morrison et al., 1982a;
Hall and Esser, 1984), while few studies have been undertaken with the
response to non-surface components (Le Ray, 1975). Surface antigen studies
are relatively easy to carry out as only a single component of the parasite is
involved and techniques for such assays are often not technically demanding.
The multicomponent nature of non-surface antigen and their location within
the body of the trypanosome make it difficult to assay the response to
individual components when employing commonly used methods such as
enzyme-linked immunosorbent assays (Voller et al., 1975; 1976; 1977; Luckins,
1977) with crude protein extracts as antigen.
The introduction of sodium dodecyl sulphate polyacrylamide gel
electrophoresis (SDS-PAGE) (Towbin et al., 1979), provided a powerful and
rapid method for the separation and identification of individual parasite
«
components based on their mobility in an electric field and molecular weight.
The identification of individual components as antigen, however, requires their
reaction with specific antibodies. Unfortunately, this cannot be undertaken
directly on the acrylamide gel, therefore the separated parasite components
have to be transferred onto a solid matrix such as nitrocellulose where they can
be probed for antigenicity. The process of transferring the component from
the SDS-PAGE gels onto the solid matrix is referred to as blotting; the
commonest variant used for antigenicity studies being referred to as "Western"
blotting (Burnette, 1981). Once transferred, the individual protein bands can
then be probed for antigenic activity with specific antibodies. The combination
of SDS-PAGE and "Western" blotting, therefore offers the possibility of
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dissecting the host's response to individual parasite antigens to evaluate their
association with particular stages of the infection.
The identification of individual parasite antigens using a combination of
SDS-PAGE and "Western" blotting, however, presents a number of practical
problems that have to be overcome to ensure that the results obtained are a
true reflection of the antigen-antibody reactions and not a procedural artifact.
Commonly encountered problems are mainly associated with the processing of
blots and the antibody preparation used to probe the blot. Some of these
problems include:
(1) The non-specific binding of reagents to areas of the solid matrix that
do not contain any parasite material. This arises from the high binding affinity
of the nitrocellulose membrane to any protein. This problem is usually
overcome by blocking off any such sites with excess proteins from other animal
species after transfer of the parasite components. The introduction of these
proteins could, however, interfere with subsequent reactions for the detection
of antigens, so the conditions for use of blocking reagents have to be well
established, usually for individual parasite system, to ensure reproducible
results.
(2) "Western" blotting also shares many of the problems encountered with
other immunoassays such as the non-specific binding of immunoglobulins or
normal serum components to the antigen. This problem is usually overcome
by the use of appropriate dilutions of the serum and other reagents.
The combination of SDS-PAGE and "Western" blotting has been used
extensively for the study of parasite systems (Almond and Parkhouse, 1986;
Cabrera et al., 1986; Cabrera and Parkhouse, 1986) including several
trypanosome species. Up to now the main applications of this technique has
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been in the study of the surface antigen of trypanosomes. Cardoso de Almeida
and Turner (1983) used the technique to investigate the properties of the
membrane form of the variant surface glycoprotein (VSG) of T. brucei, while
Ross et al. (1987) used it to evaluate the nature of attachment of the VSG to
the surface of T. congolense. Araujo and Tighe (1984) investigated the
expression of a surface coat component of T. cruzi in the bloodstream forms of
the parasite using SDS-PAGE/"Western" blotting, while Gardiner et al. (1987)
used the technique for the identification and isolation of a variant surface of
glycoproteins from T. vivax along with Cross (1978b) who used it for the
identification of the surface components of T. evansi.
The practical application of "Western" blotting for the analysis of immune
responses involve several procedure steps, each of which often has to be
optimized for the particular parasite systems. Such optimisation ensures that
the system itself does not influence the results of the antigen/antibody
interaction (R. Boid, personal communication) and also ensures reproducibility
of results: an overriding requirement in any comparative study.
The major steps that are involved in any "Western" blotting procedure
are:-
(a) The solubilisation of parasite proteins.
(b) The electrophoretic separation of crude parasite extract into individual
components.
(c) The transfer of separated parasite proteins onto a solid matrix such as
nitrocellulose membrane on which the antigen/antibody reactions take
place.
(d) The identification of the parasite antigens by probing of parasite proteins
with appropriate antibody.
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The experiments in this chapter were designed to develop a suitable





T. evansi TREU 2113 used for the study was obtained after a single
passage through mice of stabilated parasites from T. evansi TREU 1840. T.
evansi TREU 1840 was acquired by the Centre for Tropical Veterinary
Medicine (CTVM) from the University of Berlin in 1983 as a stabilated
material with a history of characterisation as T. evansi and isolation from a
buffalo in Java, Indonesia. The morphological appearance of the parasites on
Giemsa stained smears agreed with the characteristics of T. evansi listed by
Hoare (1972). The population of T. evansi (TREU 2113) used for the studies
is known to consist of trypanosomes of a single variant antigen type (VAT)
(T.W. Jones, personal communication).
Infections
Trypanosome infections were initiated from cryopreserved material
injected into mice. Once fulminating infections were established, the
trypanosomes were passaged into white albino rats. In turn, when the rats
developed fulminating infections they were exsanguinated by cardiac puncture
under general anaesthesia and about 10 ml of blood collected from each rat
into syringes containing 50 iu of heparin in 1 ml of phosphate buffered saline
(PBS) (Appendix 1). Infections in mice/rats were not continued beyond three
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days to minimise the possibility of antigenic change in the parasite population.
Preparation of T. evansi Soluble Antigens
Trypanosomes were separated from the host's blood cells by anion-
exchange chromatography on DEAE cellulose (DE52, Whatman Biochemicals)
by the method described by Lanham and Godfrey, (1970). The separated
trypanosomes were washed three times by centrifugation at 2,500 g for 10
minutes with phosphate saline glucose (PSG) pH 8.0 (Appendix 2). Parasite
washes were carried out in a 12 ml graduated centrifuge tube and after the
third centrifugation the pelleted trypanosomes were resuspended in twice their
volume of an enzyme protectant solution (Appendix 3) containing 0.25 mM
TLCK (N-p-tosyl-L-lysine chloromethyl ketone, Sigma Ltd.) as proteinase
inhibitor. Soluble antigens of the parasite were released by disrupting the
trypanosomes by freeze-thaw or sonication (Auffret and Turner, 1981). For
freeze-thaw disruption, trypanosomes suspended in enzyme protectant
(Appendix 3)/0.25 mM TLCK solution were subjected to three cycles of
freezing to -80°C for 10 minutes with solid carbon dioxide followed by thawing
to room temperature for 10 minutes. For sonication trypanosomes were
subjected to five cycles of ultrasound using an MSE ultrasonic disintegrator at
maximum amplitude (10 microns peak to peak) with a 2 mm titanium probe at
4°. Each sonication cycle lasted for 10 seconds with a 10-second interval
between cycles.
The resulting trypanosome lysate from both methods of disruption was
centrifuged at 10,000 g for 45 minutes at 4°C to separate the solubilise
components of the parasite from the non-solubilised components. The total
protein concentration of each supernate fraction was determined
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photometrically using BCA^ technique undertaken according to the
manufacturer's instruction (Pierce Chemical Company, USA). Sufficient
SDS-sample buffer was then added to the supernate to ensure that the final
solution contained three times as much SDS as there was trypanosomal protein.
The solution was then heated to 100°C for three minutes. The resulting,V
<—
solution was aliquoted into 100 p,l volumes and stored at -20°C until required.
Immediately before use, the samples were heated to 100°C again for one
minute to dissolve any SDS that might have crystallised out.
Electrophoretic Separation of T. evansi Proteins using Sodium Dodecyl
Sulphate Polyacrylamide Gel Electrophoresis (SDS-PAGE)
Vertical glass plates (160 mm x 180 mm) separated with 1.5 mm spacers
were filled with 7-20% continuous gradient polyacrylamide gel (see Appendix 4
for formulae). Each gel was cast using 20 ml of each polyacrylamide gel
component (7% and 20%) poured into one of the two units of a gradient
mixer. 26 |xl of 10% ammonium persulphate and 6 jxl of N^N^N^N-tetra-
methylene diamine (TEMED, BDH) were added to each unit of the gradient
mixer and the contents pumped into a glass mould at room temperature.
After polymerisation, a 4.5% stacking gel (Laemmli, 1970) containing 25 pd of
TEMED and 100 jjlI of 10% ammonium persulphate was layered on top of the
continuous gradient gel and 10 x 20 mm sample wells cast in the stacking gel
with a plastic comb.
For electrophoresis each gel was placed in a vertical gel tank apparatus
containing electrophoresis tank buffer (Appendix 5) in both top and bottom
reservoirs before the samples and proteins of known molecular weights
(Molecular weight markers, Pharmacia, Appendix 20) were loaded in the wells
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formed by the plastic comb in the polymerised stacking gel. Electrophoresis
was performed at room temperature, initially with a constant voltage of 150V
for one hour, to hasten the migration of the proteins through the stacking gel,
thereafter at a constant voltage of 80V until the bromophenol blue dye of the
SDS-sample buffer reached the bottom of the gel, a process that took between
16 and 20 hours.
Identification of Individual Trypanosome Proteins on SDS-PAGE Gels
After electrophoresis the gels were removed from the glass moulds and
stained either with Coomassie Brilliant Blue R-250 (Sigma Ltd., U.K.) or with
silver stain.
For Coomassie Blue staining, the gels were immersed in 0.1% (w/v)
Coomassie Brilliant Blue R-250 (Sigma Ltd., U.K.) in destain solution
(Appendix 6) at room temperature with continuous mild shaking for 2-4 hours.
Thereafter, the gels were destained with destain solution overnight. For silver
staining of trypanosome proteins in SDS-PAGE gels, the method described by
Morrissey (1981) was used. Briefly, the gels were incubated sequentially for
30 minutes in solutions 1, 2 and 3 (Appendix 7) to fix the proteins in the gels.
The gels were then washed with several changes of distilled water overnight.
Thereafter, the gels were incubated for 30 minutes in 0.1% (w/v) silver nitrate
(Sigma Ltd., U.K.), subsequently washed and then developed with an alkaline
solution of formaldehyde (Developer, Appendix 8) for about 20 minutes before
the reaction was stopped with 5 ml of 2.3M citric acid (BDH, U.K.) added
per 100 ml developer. After thorough rinsing of the stained gels in distilled
water for about 30 minutes the gels were photographed in order to have
permanent records of the results. The calibration curve from the molecular
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weight markers and calculation of molecular weight of individual trypanosome
proteins were based on measurements obtained from such photographs.
RESULTS
The overall protein profiles of the soluble antigens of T. evansi obtained
after freeze-thawing (Figure 2.1, No. 1) and sonication (Figure 2.1, No. 2)
were similar in that the same pattern of bands was seen when SDS-PAGE gels
were stained with both silver stain and Coomassie Blue. A greater number of
bands were, however, seen when the gels were stained with the silver stain
than with Coomassie Blue. Some differences were also seen between the range
of molecular weight of the components obtained by freeze-thaw and those by
sonication. The differences were confined to the lower molecular weight
regions in that the components identified from the freeze-thawed sample had a
molecular weight range of between 123800-11000 daltons (Figure 2.1, No. 1)
while those released by sonication were in the range of 123800 to 12500
daltons (Figure 2.1, No. 2). Certain protein bands such as those with
molecular weights of less than 20,000 were better resolved and more intensely
stained with both staining methods in the extracts obtained by freeze-thawing
rather than by sonication.
Furthermore, twice as much total protein obtained after sonication
(Figure 2.1, No. 2) had to be applied to the gel to produce results equivalent
to those obtained by the freeze-thaw method (Figure 2.1, No. 1).
FIGURE 2.1 (Nos. 1 and 2)
Supernate fraction of T. evansi lysate separated on SDS-PAGE and
stained with silver stain.
1. Sample prepared by freeze-thawing (39 |xg of protein
material/well).




Solubilisation releases the parasite antigens from intact organisms into a
state they can be easily used to investigate antigen/antibody reactions.
Furthermore, it is likely that the cell lysis resulting from treatments adopted in
the present study is closer to that occurring in the host when the parasite is
destroyed by the immune system (Murray and Urquhart, 1977), than if
parasite extracts had been obtained by other methods such as mixing the
parasites with sample buffer and boiling to release the proteins.
Disruption by freeze-thaw and sonication both released a broadly similar
range of proteins (Figure 2.1, Nos. 1 and 2). Differences were however, seen
in the intensity with which individual components were stained with the
intensity being greatest in samples obtained by freeze-thawing (Figure 2.1, No.
1). This was particularly noticeable with the lower molecular weight
components. Differences between the two techniques used for parasite
disruption were amplified by the staining method due to the sensitivity of the
silver staining method which is capable of detecting components present in 100
ng of protein amounts or less (Goding and Handman, 1984).
The differences seen in the amount and composition of proteins released
by freeze-thaw compared with sonication is probably related to the amount of
cell destruction taking place during each process. It would appear that the
extremes of temperature encountered by the trypanosome during freeze-thaw
were more effective in releasing soluble antigens from the trypanosomes than
the waves of ultrasound encountered during sonication.
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TRANSFER OF T. EVANSI PROTEINS ONTO
NITROCELLULOSE MEMBRANE
INTRODUCTION
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE)
provides a very rapid and refined way of separating the many parasite proteins
into individual components. The relatively small pore size of acrylamide in the
gel, however, presents practical problems in ensuring the penetration of
antibody into the gel when attempting to probe for antigenicity using specific
antibody.
A number of methods have been used to detect proteins directly after
fractionation on polyacrylamide gels such as using enzyme substrates (Dulaney
and Touster, 1970) or specific antibody (Showe et al., 1976) but the recent
innovation of transferring the gel-fractionated proteins onto some form of solid
phase (Bowen et al., 1980; Renart et al., 1979; Bittner et al., 1980) has greatly
assisted in the characterisation of the parasite components initially separated by
SDS-PAGE. Many of the techniques, however are time consuming,
complicated and technically demanding. The method described by Towbin et
al. (1979), however, overcomes many of these problems and involves the
electrophoretic transfer of gel-fractionated parasite proteins onto nitrocellulose
paper. Once transferred, the antigenicity of the individual parasite
components can be assessed with specific antisera. This process has been
found to be an elegant and straightforward method for antigenic analysis of
parasite proteins and has been used by many workers studying different
parasite systems (Burnette, 1981). The use of an electric current to effect the
protein transfer makes this process much faster than other techniques
employing passive diffusions or requiring the chemical activation of paper such
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as diazobenzyloxyl-methyl (DBM) paper before use. With the nitrocellulose
paper technique (Towbin et al., 1979) it is possible to routinely achieve what is
essentially a complete and quantitative elution of most proteins from SDS-
PAGE gels with no loss in electrophoretic resolution, which is not possible
with some of the other techniques (Burnette, 1981). Furthermore, it is also
possible to correlate specific immunological activity with individual protein
bands separated on the gel, since a perfect replica of the proteins on the gel is
produced after the electrophoretic transfer of proteins onto nitrocellulose
paper.
The principal factor influencing the transfer of proteins from SDS-PAGE
gels onto nitrocellulose paper is the length of time that the system is exposed to
electric field. Too short a time will result in too few proteins being eluted
while too long a time may result in the denaturation of the proteins and
possible damage of the gels due to excessive heat generated during the process
of electrophoresis. Recommended times for optimum transfer, however differ.
Burnette et al. (1981), for example, suggested a protein transfer (blotting) time
of between 16-22 hours at 6-8 V/cm of gel while Towbin et al. (1979)
suggested that a transfer time as short as one hour at the same field strength,
6 V/cm of gel,was sufficient.
Experiments in this part of Chapter Two were designed to determine the
appropriate time interval that would provide the maximum transfer of T.
evansi proteins from the gel to the nitrocellulose paper with respect to the
number of bands resolved and their intensity of staining.
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MATERIALS AND METHODS
Soluble antigens of T. evansi were prepared as described previously using
the freeze-thaw method and fractionated into individual components by SDS-
PAGE as described in the previous section.
Electrophoretic Transfer of T. evansi Proteins onto Nitrocellulose Paper
(Electroblotting Conditions)
After fractionation of T. evansi proteins by SDS-PAGE, the gel was
sectioned into four equal vertical pieces and each section laid, side by side, on
four strips of nitrocellulose paper previously cut to the size of the four gel
sections. A filter paper:nitrocellulose membrane:gel:filter paper "sandwich"
was then formed and the electrophoretic transfer of the proteins to the
nitrocellulose membrane undertaken following the instructions of the makers of
Ancos semi-dry electroblotter (Dako Ltd., U.K.) using the blotting buffer
(Appendix 19). Electroblotting was conducted for a maximum of 90 minutes
at room temperature with a voltage of 100V and a current of 200 mA. The
effect of transfer time on protein transfer was evaluated by removing one of
the four strips of gels with their corresponding underlying nitrocellulose
membranes, after 15, 45, 60 or 90 minutes elution. The residual proteins left
in the gel after a particular transfer time were detected by staining the gel with
Coomassie Blue as described previously. The amount of proteins transferred
onto nitrocellulose paper was determined by staining the nitrocellulose paper
with a 1% Amido black (Sigma Ltd., U.K.) in destain solution (Appendix 6)
for 15 minutes after which the nitrocellulose paper was destained with destain




Increasing amounts of T. evansi proteins were transferred from the gel
onto the nitrocellulose membrane with time. Maximum amounts of parasite
proteins were eluted by 90 minutes of blotting (Figure 2.2, No. 4) while the
least amount of proteins was transferred after 15 minutes of blotting (Figure
2.2, No. 5).
The intensity of staining of individual bands was also time dependent with
the lowest intensity of staining observed after 15 minutes and the highest after
90 minutes of blotting respectively. Protein bands with a lower molecular
weight, such as those below 43,000 daltons, were observed to elute faster from
the gels than those with higher molecular weights (Figure 2.2, Nos. 1-4). By
90 minutes of blotting however, small amounts of the lower molecular weight
bands were detected on the gel while slightly more of the higher molecular
weight components were left on the gel (Figure 2.2, No. 4).
FIGURE 2.2 (Nos. 1 to 8)
Transfer of Trypanosoma evansi proteins onto nitrocellulose mem¬
brane. (SDS-PAGE gel stained with Coomassie blue and nitrocellu¬
lose membrane with amido black.)
1. Polyacrylamide gel after 15 minutes of blotting.
2. Polyacrylamide gel after 45 minutes of blotting.
3. Polyacrylamide gel after 60 minutes of blotting.
4. Polyacrylamide gel after 90 minutes of blotting.
5. Nitrocellulose membrane after 15 minutes of blotting.
6. Nitrocellulose membrane after 45 minutes of blotting.
7. Nitrocellulose membrane after 60 minutes of blotting.




The principal results from this study clearly demonstrated that the elution
of T. evansi proteins from the gels to the nitrocellulose membrane was time
dependent, and that smaller molecular weight components appeared to be
eluted faster from the gel than those with higher molecular weights. These
observations are similar to the findings of Burnette (1981) who also
demonstrated that the rate of protein transfer was time dependent and that
smaller molecular weight components are eluted faster from the gel than the
higher molecular weight ones. The effect of component molecular size on
transfer time is probably associated with the sieving effect of the gel, in which
those components of large molecular weights are presented with more
resistance leaving the gel than those of small molecular weight.
Despite the fact that differences were seen in the transfer rates between
molecules of large and small molecular during the present study, the fact
that sufficient material had been transferred from the gel to the nitrocellulose
membrane by 90 minutes to provide an accurate representation of the proteins
in the gel was considered sufficient reason to adopt 90 minutes transfer time
for all future studies. The transfer time of 90 minutes using the present semi-
dry system is roughly in agreement with that recommended by Towbin et al.
(1979) for a wet system although markedly different from that of Burnette
(1981), who recommended a time of 20-22 hours for complete transfer of all
proteins up to 100,000 daltons using a wet system. The lack of adequate
cooling in the semi-dry system used in the present investigation would,
however, probably preclude blotting for unduly long periods of time.
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DETECTION OF ANTIGENIC COMPONENTS
OF T. EVANSI ON NITROCELLULOSE BLOTS
The principal requirement of any experimental system involving
antigen/antibody reactions is that the results obtained are a true reflection of
antigen/antibody interaction and not an artifact arising from factors such as
background or non-specific reactions (Tsang et al., 1985). The problem of
background staining is of particular importance in the case of nitrocellulose
membrane due to its high affinity for proteins which enhances the non-specific
staining problems which are common to all immunological assay systems.
Traditionally, the problem of background staining of the nitrocellulose
membrane has been overcome by a variety of methods including blocking
and/or inactivation of the binding sites of the nitrocellulose matrix after the
transfer of protein by blotting. Initially, inactivation and blocking with
substances such as tris (hydroxymethyl) aminoethane and ethanolamine proved
to be effective in reducing or eliminating non-specific reactions (Renart et al.,
1979). Lately, however, blocking procedures involving the use of excess
proteins such as bovine serum albumin (BSA) (Towbin et al., 1979; Aubertin
et al., 1983), foetal bovine serum (De Bias and Cherwinsk, 1983; Ramirez et
al., 1983), haemoglobin (Gershoni and Palade, 1982), gelatin (Lim and
Kasamatsu, 1983), milk (Johnson et al., 1984) and normal goat serum (Grogl
et al., 1985) have been used extensively for the control of background staining
(reviewed by Mohammad and Esen, 1989).
Clearly it is important to ensure that any blocking agent used to control
background staining does not influence the outcome of any antigen/antibody
reaction. In the present study the efficiency of two commonly used blocking
agents -lyophilised skimmed milk and goat serum have been evaluated under a
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number of conditions as part of an overall study designed to develop a suitable
protocol for the study of T. evansi antigens.
MATERIALS AND METHODS
Soluble antigens of T. evansi used were prepared as described previously
using the freeze-thaw method, fractionated into individual components by
SDS-PAGE and transferred onto nitrocellulose paper as described previously
using a 90 minute transfer time.
T. evansi-specific serum was prepared by infecting two rabbits with T.
evansi by injecting 4 x 10^ trypanosomes of TREU 2113 through an ear vein.
Seventeen days later the rabbits were bled for serum. Serum samples were also
collected from one uninfected rabbit.
Goat serum for blocking were obtained from a locally purchased goat.
Blood samples for serum were collected from both the goat and rabbits into
bottles without any anticoagulant. The blood samples were then held at 37°C
for 20 minutes and then at 4°C for two to three hours after which the
separated serum was carefully aspirated into 10 ml centrifuge tubes. The
serum samples were centrifuged at 2,500 g for 35 minutes at 4°C and
subsequently aliquoted into small volumes and stored at -20°C until required.
Lyophilised skim milk powder (Marvel) was dissolved in blocking buffer
(Appendix 9) to the appropriate w/v concentration and gently mixed until
completely solubilised.
Comparative studies on the efficiency of the two blocking agents were
initially undertaken by using both agents at a single concentration of 5% and a
range of anti-trypanosome serum dilutions of 1:200, 1:400 and 1:800. Later
studies were conducted using several concentrations of both blocking agents in
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conjunction with a single 1:200 dilution of the anti-trypanosome serum.
Processing of Blots
After the separation of the T. evansi soluble antigens with SDS-PAGE
and transfer onto nitrocellulose paper, the blot was blocked overnight with the
appropriate blocking agents made up in blocking buffer (Appendix 9). After
blocking, the blots were washed in PBS (Appendix 1) for 30 minutes with
three changes of the buffer (Grogl et al., 1985). Blots were then incubated
with the appropriate dilution of the T. evansi specific rabbit serum in blocking
buffer overnight. Unreacted serum protein was then removed by washing in
PBS as described above. The blots were finally incubated for three hours in a
1:4000 dilution of a peroxidase-labelled conjugate to goat anti-rabbit IgG heavy
and light chains (Nordic) made up in blocking buffer. The blots were washed
in PBS as previously described and any antigen/antibody complex was then
visualised by incubating the blots in 4-chloro-l-napthol substrate solution
(Sigma) (Appendix 10). Colour development was allowed to occur over the
next 15 to 20 minutes, blots finally rinsed in distilled water and permanent
records made by photography. Each test system was also tested with control
units in which the trypanosome-specific serum was replaced with serum
collected from an uninfected rabbit at the equivalent dilution.
RESULTS
(a) Effect of blocking agent and anti-trypanosome serum dilution
More antigen components were visualised when 5% goat serum (v/v) was
used as the blocking agent (Figure 2.3, Nos. 2, 4 and 6) than when 5%
lyophilised milk (v/v) was used (Figure 2.3, Nos. 1, 3 and 5) at all dilutions of
- 59 -
the trypanosome specific serum. With both blocking agents the total number
and intensity of staining of individual components visualised was dependent on
the dilution of the trypanosome specific serum. The greatest number of
components and the most intense staining were obtained with a serum dilution
of 1:200 (Figure 2.3, Nos. 1 and 2). The least number of components and the
lowest level of staining were obtained with a serum dilution of 1:800 (Figure
2.3, Nos. 5 and 6). In the absence of either blocking agents high background
staining of the nitrocellulose membrane was obtained which made it difficult to
identify the individual trypanosome components from the background (details
not shown).
FIGURE 2.3
Effect of anti-trypanosome serum dilution on antigen/antibody reac¬
tions.
1. Blots incubated with anti-trypanosome and normal rabbit sera
diluted 1:200 respectively and blocked with 5% milk.
2. Blots incubated with anti-trypanosome and normal rabbit sera
diluted 1:200 respectively and blocked with 5% goat serum.
3. Blots incubated with anti-trypanosome and normal rabbit sera
diluted 1:400 respectively and blocked with 5% milk.
4. Blots incubated with anti-trypanosome and normal rabbit sera
diluted 1:400 respectively and blocked with 5% goat serum.
5. Blots incubated with anti-trypanosome and normal rabbit serum
diluted 1:800 respectively and blocked with 5% milk.
6. Blots incubated with anti-trypanosome and normal rabbit serum
diluted 1:800 respectively and blocked with 5% goat serum.
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(b) Effect of blocking agent concentration on antigen/antibody reactions
At each blocking agent dilution more antigenic components were resolved
and were better stained when goat serum rather than milk was used as the
blocking agent (Figure 2.4, Nos. 5 to 7 and Nos. 1 to 4). Further, more
variation in results was obtained when milk rather than goat serum was used as
a blocking agent at each dilution. This variation appeared in the form that
more components were visualised when higher concentrations of milk were
used for blocking (Figure 2.4, No. 4) whilst on some occasions fewer
components were resolved at higher concentrations (Figure 2.4, Nos. 1 and 2).
Occasionally little difference was seen in the number of components seen and
in their degree of staining with widely varying milk concentrations (Figure 2.4,
Nos. 1, 2 and 3). On one occasion very intensely stained components were
seen when 20% (w/v) milk was used as the blocking agent (Figure 2.4, No. 4).
In general, results obtained using goat serum as the blocking agent were easily
reproduced with little variation between repeated runs, in terms of the number
of bands and their degree of staining. In the case of goat serum maximum
differentiation of bands was obtained when the system was blocked with either
4% or 8% (v/v) goat serum (Figure 2.4, Nos. 6 and 7).
FIGURE 2.4
Effect of blocking agent concentration on antigen/antibody reactions.
1. Blots incubated with anti-trypanosome and normal rabbit sera
diluted 1:200 respectively and blocked with 2.5% milk.
2. Blots incubated with anti-trypanosome and normal rabbit sera
diluted 1:200 respectively and blocked with 10% milk.
3. Blots incubated with anti-trypanosome and normal rabbit sera
diluted 1:200 respectively and blocked with 15% milk.
4. Blots incubated with anti-trypanosome and normal rabbit serum
diluted 1:200 respectively and blocked with 20% milk.
5. Blots incubated with anti-trypanosome and normal rabbit serum
diluted 1:200 respectively and blocked with 2% goat serum.
6. Blots incubated with anti-trypanosome and normal rabbit serum
diluted 1:200 respectively and blocked with 4% goat serum.
7. Blots incubated with anti-trypanosome and normal rabbit serum




The erratic nature of the results obtained in the present study when milk
was used as the blocking agent made milk unsuitable for further use in the T.
evansi system. Other workers have also reported difficulties with milk as a
blocking agent (Mohammad and Esen, 1989). These authors observed a
diminished antigen-antibody reaction when their system was blocked with milk
and they attributed this lowered sensitivity of their reactions to the possible
non-specific blocking of the antigen sites by milk proteins. They considered
that this was probably brought about by steric hinderance caused by proteins in
milk that bound to the sites not occupied by the antigens on the solid matrix
and physically preventing the antibodies from binding to specific antigen sites.
A similar observation was made in the present study where fewer T. evansi
components were observed when the system was blocked with milk (Figure
2.4, Nos. 1 to 4) than with goat serum (Figure 2.4, Nos. 5 to 7). This
observation coupled with an unexpected result of the boosting of both the
intensity and number of components visualised when a higher concentration of
milk was used for blocking, made the use of milk in the T. evansi system
unreliable. Consequently goat serum was chosen as a suitable blocking agent
for further studies on antigenic components of T. evansi and used at a dilution
of 4% as no differences were seen between the systems blocked with 4% or 8%
goat serum.
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OPTIMIZATION OF BLOCKING, SERUM AND
CONJUGATE REACTION TIMES
INTRODUCTION
In common with many chemical reactions, the rate at which the individual
components combine in an immunoassay is often time dependent. In most
immunoassays incubation times are designed to ensure saturation of
appropriate reaction sites which ensures that reagent specificity or its
concentration limits the assay and not the methodology. Too short an
incubation time could prevent maximum reactivity while too long an
incubation time could result in non-specific reactivity. Incubation times for the
individual steps in multistep immunoassay systems such as immunoblotting also
need to be realistically as short as possible to ensure that results can be
obtained in a reasonable period of time.
The previous sections of this chapter established most of the key factors
influencing the several stages involved in immunoblotting, but without regard
to the minimum time intervals required, for each stage. This final part of the
studyw«fc designed, therefore, to establish the practical incubation times for the
various stages of immunoblotting.
MATERIALS AND METHODS
Antigens and Antibodies
The combination of soluble antigen and anti-trypanosome serum at a
dilution of 1:200 shown to be optimum in previous studies were used in the
present experiment. After fractionation of T. evansi proteins using SDS-PAGE
and immunoblotting, the blot was blocked with 4% goat serum made up in
blocking buffer (v/v). The effect of different time intervals of 0.5, 1, 2 and 4
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hours, and overnight incubation at different stages in the antigen detection
protocol were studied to establish the appropriate combinations of incubation
times that gave the optimum immunoblotting results, as defined by the number
of bands visualised and their intensity of staining. The details of the procedure
followed for the analysis of the parameters are shown in Figure 2.5.
After the transfer of the T. evansi proteins onto the nitrocellulose
membrane, the blot was divided into three equal sections A, B and C (Figure
2.5), each section containing five columns of the transferred proteins. Strips
of the blot in Section A (Figure 2.5) were individually blocked (Strips 1-5) for
0.5, 1, 2 and 4 hours and overnight respectively. Each of these blots were
later incubated in the trypanosome-specific serum for four hours and in the
conjugate solution for two hours respectively. In between the different steps,
blots were washed in PBS.
The five strips from the blot in Section B (Figure 2.5) were blocked for
four hours. They were then incubated individually in the trypanosome-specific
serum (Strips 6-10) for 0.5, 1, 2 and 4 hours and overnight respectively.
Thereafter, all the strips were incubated in the conjugate solutions for two
hours. In between the different stages, the blots were washed in PBS.
The strips from the blot in Section C (Figure 2.5) were blocked and
incubated in the trypanosome specific rabbit serum for four hours. They were
then incubated individually in the conjugate solution starting from 0.5, 1, 1.5,
2 and 4 hours (Strips 11-15) respectively. In between the different stages, the
blots were washed in PBS.
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Iiaure_L5 Schematic representation of procedure used to
optimise blocking, serum and conjugate incubation
times.
Serum reaction .
times in hours 444 0.5 124 0/N* 4 4
Conjugate reaction-
time in hours 4222 22 222 0.5 1 1.5 2
A. Blots used to ascertain the effect of different blockina times
on antigen/antibody reactions. clocking times
B: Blots used to ascertain the effect of different serum reaction
times on antigen/antibody reactions.
C: ^-US£tt0 ascertain the e"ect of different conjugatereaction times on antigen/antibody reactions.
*: 0/N - Overnight incubation.
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RESULTS
(a) Effect of Blocking Time
Least background staining was observed in the strips of blots blocked for
between four hours and overnight (Figure 2.6, Strips 4 and 5).
(b) Effect of Serum Reaction Time
More components that were also more intensely stained were visualised in
the part of the blot that was incubated in the trypanosome specific rabbit
serum overnight (Figure 2.6, Strip 10).
(c) Effect of Conjugate Reaction Time
The optimum result, in terms of the degree of staining and number of the
components identified was achieved when the strips from the blot was
incubated in the conjugate solution for between two and four hours (Figure
2.6, Strips 14 and 15) respectively.
DISCUSSION
A combination of a blocking time of four hours, overnight incubation
with anti-trypanosome serum and a two-hour conjugate incubation time was
considered to provide optimum antigen detection; in that minimum amounts of
background staining and more numbers of individual T. evansi components
that were antigenic and also well stained were obtained using these time
combinations. Effectively, with this protocol the identification of trypanosome
antigenic proteins can be easily done within three days with the worker still
carrying on his routine laboratory activities and only returning to the "Western"
blotting procedure at stipulated intervals without interfering with the efficiency
of the experiment.
FIGURE 2.6
Optimization of blocking, serum and conjugate incubation times.
Numbers 1-5 Blots blocked for 0.5, 1, 2, 4 hours and overnight
respectively.
Numbers 6-10 Blots incubated with anti-trypanosome rabbit serum
for 0.5, 1, 2, 4 hours and overnight respectively.
Numbers 11-15 Blots incubated in conjugate solution for 0.5, 1, 1.5,




Based on the overall results from the studies reported in this chapter, a
final protocol was established for future studies on the antigenic composition of
T. evansi. The final combination of conditions that permitted the resolution of
the maximum possible number of antigenic components that could be discerned
easily and reliably were accepted for use. The following final protocol was
therefore adopted.
(a) The preparation of T. evansi soluble antigens by freeze-thawing.
(b) Protein transfer (blotting) time of 90 minutes onto nitrocellulose
membrane.
(c) The blocking of active sites on the solid matrix (nitrocellulose
membrane) with 4% goat serum in blocking buffer (Appendix 9) for a
minimum time of four hours.
(d) Overnight incubation of transferred trypanosome components with
1:200 dilution of trypanosome specific sera followed by a two-hour incubation
of the nitrocellulose strips with peroxidase-labelled conjugate solution.
This basic protocol was adopted in all the assays conducted in the later
stages of this study and any modifications included as appropriate.
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CHAPTER THREE
CHARACTERISATION OF THE SURFACE COAT
OF TRYPANOSOMA EVANSI AND THE
CLASS-SPECIFIC ANTIBODY RESPONSE TO IT




Each individual Salivarian trypanosomes is enveloped by a 12-15 nm thick
surface coat consisting of a matrix of identical glycoprotein molecules
(Vickerman, 1969). As in all parasite infections the surface of the organism
constitutes the first point of contact between the parasite and the host immune
system. Consequently the host's response to the surface of the parasite is often
of paramount importance in determining the outcome of the infection.
Trypanosomes differ from other parasites in their ability to change the
chemical composition of their surface glycoprotein coat (VSG) extensively
which leads to the appearance of successive waves of antigenically different
parasites throughout the course of infection. Due to the extreme specificity of
the host's response to each antigenically distinct population, the emergence of
new variants allows the parasite to escape the host's immune system. The
host's immune response to the VSG of trypanosomes has been extensively
studied (Wellde et al., 1975, 1981; Emery et al., 1980; Morrison et al., 1982a;
Hall and Esser, 1984) possibly to the detriment of other features of the
parasite, such as responses to the non-surface component of the parasite.
Mammals defend themselves against infection with parasites such as
trypanosomes by producing specific antibodies directed against particular
components or the organism (antigens) or in reality molecules that the host
recognises as not belonging to itself ("nonself" molecules). The usual outcome
of such a response is the elimination of the parasite from the host. Equally
important as parasite elimination is the role of the host's immune response in
protecting the host against reinfection with the same parasite. Protection to
reinfection stems from the fact that some antibody-secreting cells (B memory
cells) produced during the primary infection can persist for many years and
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provide lasting immunity to reinfection. A similar type of immunity can also
be elicited by vaccines which mimic the host's response to natural infections.
In the case of trypanosomes, however, neither the primary immune
response to infection nor vaccination can effectively eliminate or protect
against subsequent trypanosomal infections unless in cases of homologous
challenge due to the process of antigenic variations. The effect of antigenic
variation being that by the time the host's immune system has produced
antibodies to the antigen on the surface of a particular trypanosome
population, a proportion of the parasites will already be expressing a range of
different surface antigens. The parasites expressing these different surface
antigens then multiply and give rise to antigenically different parasite
populations which the existing antibodies produced by the host will not
recognise. This process continues throughout the infection with the host's
overworked immune system failing to eliminate the infection, and so the
parasites survive and proliferate (Donelson and Turner, 1985) in what appears
to be an immune host.
The total number of serologically different variant surface antigens that
can be expressed by any given trypanosome stock is unknown but studies with
T. b. equiperdum indicate that it is probably in excess of 100 (Capbern et al.,
1977) and could be as great as 1,000. Establishing serological relationships
between trypanosome isolates is a very complex process arising from the fact
that an infection initiated from a single trypanosome can give rise to a large
number of different antigenic types and that different stocks of trypanosomes
give rise to different sets of antigenic types. The serological identity of any
particular bloodstream trypanosome population, is determined by the antigens
on the surface of the organisms constituting that trypanosome population. The
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antigenic identity of any one trypanosome within a given population is termed
the Variant Antigen Type (VAT) of that trypanosome. At any one time
during the course of infection a trypanosome population can consist of one or
more VATs. All of the VATs potentially expressible by infection with a
trypanosome stock are referred to as the VAT repertoire of that particular
stock. Stocks of trypanosomes, which express the same VAT repertoire, are
considered to belong to the same serodeme (Gray and Luckins; 1976; Shapiro
and Pearson, 1986).
During the course of a trypanosome infection there is a tendency for
certain VATs of a serodeme to appear more frequently than others,
particularly during the early stages of infection. These VATs are termed
predominant VATs (pVATs) (Gray and Luckins, 1976) and are characteristic
of particular stocks of trypanosomes. In the case of tsetse-transmitted
trypanosomes there is also a tendency for a certain VAT to appear in the first
wave of parasitaemia after cyclical transmission by the tsetse fly (Gray, 1965)
irrespective of the VAT which infected the fly. This antigen type has been
termed the "basic" antigen, and it is likely different basic antigens could exist
for each trypanosome stock. ->
The VSG molecule of the trypanosome coat is highly immunogenic in that
it induces a strong antibody response from the host (Le Ray, 1975). The
action of this antibody probably represents the main mechanisms by which
trypanosomes are destroyed in the host (Wellde et al., 1975, 1981; Emery et
al., 1980; Morrison et al., 1982a; Hall and Esser, 1984). The antibody
response to the VSG of the individual trypanosome is considered to control
each wave of parasitaemia with at least 99.9% or more of the particular
trypanosome population being destroyed by specific antibodies. New parasite
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populations are then established from the surviving antigenically different
parasites (Doyle, 1977; Vickerman, 1978).
Antibodies produced by animals during the course of an infection have
been shown to be very effective in protecting animals against reinfection with
an antigenically homologous trypanosome population but confer no protection
against challenge by antigenically different trypanosomes. The net effect of
such specificity is that host antibodies developed against one particular VAT
do not react efficiently with other VATs in the repertoire, a phenomenon
which has intrigued workers since the turn of the century (Laveran and
Mesnil, 1902; Ehrlich et al., 1909; Browning and Gulbransen, 1936; Hornby,
1941; Fulton and Lourie, 1946; Weisenhutter, 1970; Wellde et al., 1975;
Nantulya et al., 1980; Wellde et al., 1981; Morrison et al., 1982a).
Despite the extreme immunogenicity of the VSG molecule the range of
VATs produced coupled with the specificity of the host antibody response
virtually eliminates the potential of using the VSG as an immunogen in the
development of a single VAT-component for a vaccine. The stabilising effect
of transmission on VAT expression that is linked to the appearance of basic
and predominant antigen types and the fact that metacyclic trypanosome
populations have a limited VAT repertoire has led some investigators to
suggest that some protection could be elicited with a multicomponent vaccine
containing a range of VATs (Hajduk and Vickerman, 1981; Esser et al., 1982;
Jenni, 1977; Nantulya et al., 1980). Outside of experimental systems,
however, this has not been achieved. Furthermore, the variable nature of the
VSG even within the same stock of trypanosome makes it of limited value as a
reagent in the serological assays for trypanosome infection. VSG specific tests
have however, a limited application in some diagnostic tests such as the card
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agglutination test (CAT) (Magnus et al., 1978) which depends on the use of
widespread predominant variable antigen types as antigen.
At present, most of the information on the properties of trypanosome
VSG and the equivalent host response has been obtained from studies
conducted using tsetse transmitted trypanosomes with T. brucei receiving most
attention (Cross, 1975; Johnson and Cross, 1979; Cardoso de Almeida and
Turner, 1983 etc.). Other authors have undertaken VSG-characterisation
studies with T. congolense (Rovis et al., 1978; Reinwald et al., 1978; Ondera et
al., 1982; Ross et al., 1987) and T. vivax (Gardiner et al., 1987). Studies on
non-tsetse-transmitted trypanosomes such as T. evansi are very limited. These
were often conducted as an adjunct to studies on tsetse transmitted
trypanosomes, consequently receiving cursory mention, and include those of
Cross (1978b) and Onodera (1984) with the latter making only a passing
reference to differences in the properties of the VSG molecules of relapsing T.
evansi populations.
Results from the biochemical characterisation of the VSG of a range of
Salivarian trypanosomes reported by Richards (1984) indicated that the VSG
of trypanosomes have a molecular weight range of 53,000-63,000. Results from
other studies, however, indicated that there are very wide variations in the
molecular weight of VSGs not only between different trypanosome species but
also between different stocks of the same species. Studies conducted on the
VSG of T. brucei by Cross (1975; 1977), Johnson and Cross (1977) and
Hoeijmakers et al. (1980) showed that the molecular weight of T. brucei VSG
ranged from 53,000-65,000 daltons as determined by sodium dodecyl sulphate
gel electrophoresis. Similar studies conducted on T. congolense also established
considerable difference between the molecular weight of VSG reported by
c
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several authors. Ross et al. (1987) reported that the VSG of a T. congolense
stock consists of a single component of molecular weight 54,000 while
Reinwald et al. (1978) identified two components of molecular weight 57,000
and 50,000 daltons with Rovis et al. (1978) reporting a single 56,000 dalton
component. Ondera et al. found a wider range of molecular weight of
53,000-63,000 for the surface component of different T. congolense stocks.
Only limited studies have been conducted on the VSG of other economically
important tsetse transmitted trypanosomes infecting livestock such as T. vivax.
The results from these studies showed that the VSG of T. vivax has a
molecular weight of 46,000 daltons (Gardiner et al., 1987), considerably lower
than that reported for other trypanosome species.
In the case of non-tsetse-transmitted trypanosomes such as T. evansi
information on the surface components is very limited, most of which is
so littl©
unfortunatelya vague and incomplete as to be of a use in furthering the
understanding of the nature of the VSG of this group of trypanosomes. Cross
(1978) applying the method used for characterising the VSG of T. brucei found
that the purified glycoprotein of T. evansi when examined by SDS-PAGE
under non-reducing conditions showed a single component of 96,000 molecular
weight. Under reducing conditions, however, two major components of
molecular weights of either 65,000 or 45,000 daltons were revealed which
differed from the single band he reported for T. brucei. The only other
information referring specifically to the VSG of T. evansi appears to be that
credited to Onodera (cited by Richards, 1984), who observed changes in the
molecular weight of the VSG of T. evansi from 53,000 to 63,000 daltons
between different relapsing T. evansi populations.
The first detailed studies on the biochemistry of the VSG of trypanosomes
were those reported by Cross (1975) who extracted, purified and labelled the
VSG of T. brucei and found that it consisted of a single polypeptide chain with
a molecular weight range of 53,000-65,000 daltons. Later, Johnson and Cross
(1979) using limited tryptic digestion, showed that each VSG molecule was
made up of two regions. A large N-terminal fragment with a molecular weight
range of 40,000-52,000 daltons and a smaller C-terminal fragment with a
molecular weight range of 13,000-17,000 daltons. Subsequent studies by
Holder and Cross (1981) established that the C-terminal domain contained an
immunogenic oligosaccharide common to VSG molecules from different stocks
and species which they referred to as the cross-reacting determinant (CRD).
Cardoso de Almeida and Turner (1983) were able to demonstrate that the
form of the VSG molecule of T. brucei that was bound to the membrane of the
intact trypanosome differed biochemically and immunochemically from the
released form of VSG that existed in soluble extracts normally used for in vitro
biochemical studies. By using an antibody raised to the CRD they showed that
after the rupture of the cell, membrane-bound form of VSG (mfVSG)
becomes enzymatically transformed into the soluble or released form of VSG
(sVSG), with important differences between their C-terminal domain. In the
membrane form VSG (mfVSG), the CRD is not exposed and is not, therefore,
recognised by the antibodies to the CRD while in the released or soluble
form VSG (sVSG) the CRD is exposed and can be recognised by the anti-
CRD serum. Many workers have used this difference between the two forms
of the VSG to carry out detailed studies of the VSG of many trypanosomes
(Gurnett et al., 1986; Bulow et al., 1989).
In view of the importance of the surface coat of the trypanosome in the
general immunobiology of the parasite coupled with the lack of information
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specific to the surface antigen of T. evansi (Cross, 1978), the studies in this
chapter were designed to identify and characterise the surface antigen
component of T. evansi and also to evaluate the host's antibody response to
this component over time. The results from such studies could provide
information of importance in better understanding of the relationship between
T. evansi and its mammalian host.
MATERIALS AND METHODS
History of Stocks of Trypanosomes Used
Trypanosoma evansi TREU 2113: The history of this stock of T. evansi
was presented earher in Chapter 2.
T. evansi TREU 2147: T. evansi TREU 2147 was obtained after a single
direct passage of TREU 2113 through mice.
T. evansi TREU 1944: T. evansi TREU 1944 was cloned from stabilated
trypanosomes, TREU 1839, which was acquired by CTVM from the
University of Berlin. The stock was originally isolated from a camel in Cairo,
Egypt in 1985.
T. evansi TREU 1773: T. evansi TREU 1733 was cloned from TREU
1445 which was a stock originally isolated from a camel from the Kassal
Province of the Sudan in 1978.
T. evansi TREU 1380: T. evansi TREU 1380 was obtained after TREU
381 was passaged through mice five times. The stock from which TREU 381
was derived was originally isolated from a horse from Arauca Province of
Columbia in 1967.
T. evansi TREU 1834: T. evansi TREU 1834 was obtained after TREU
1804 was passed through mice once. TREU 1804 was a stock isolated from a
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camel from Wadi Jauf in Yemen in 1983.
All the stocks in Giemsa stained smears conformed with the
morphological description of T. evansi listed in Hoare (1972).
SURFACE IODINATION OF TRYPANOSOMES
Trypanosome surface proteins of all the T. evansi stocks used in this study
125
were radioactively labelled with I (Amersham) by a modification of the
method used by Lanar and Manning (1984) as described by Ross et al. (1987).
Briefly, bloodstream forms of trypanosomes obtained from mice with
fulminating infections were separated from host blood cells by anion exchange
chromatography on DEAE cellulose (DE52, Whatman Biochemicals) as
described by Lanham and Godfrey (1970). After separation, trypanosomes
were washed three times in phosphate buffered saline pEl 8.0 containing 1%
(w/v) glucose (BDH Chemicals Ltd.) (PSG, Appendix 2) by centrifugation at
2,500 g for 10 minutes at 4°C to remove any remaining host component.
The final trypanosome pellet was then resuspended to a final
7 -1concentration of 5 x 10 ml in PSG. Six hundred |xl of the trypanosome
suspension were then placed into a glass bijou bottle containing 200 pg of
l,3,4,6-tetrachloro-3a, 6a-diphenylglycouril (IODO-GEN, Sigma Ltd.) which
had been previously dried down from a 2 pg/200 pi solution of the reagent in
■jpC
chloroform. Three hundred pCi of Nal (Amersham) were then added to




Non-detergent Lysis of I-Iabelled Trypanosomes
Following several washes with PSG containing 0.25 mM n-tosyl-l-lysyl-
chloromethyl ketone (Sigma Ltd., PSG/TLCK) to remove excess radiolabelling
reagents, the iodinated cells were lysed by freezing and thawing as described in
Chapter 2. The resulting trypanosome lysate was then separated into pellet
and supernatant fractions by centrifuging at 2,500 g for 10 minutes at 4°C.
125
Detergent-lysis of I-Iabelled Trypanosomes
125
The method used for the preparation of the I-labelled trypanosome
detergent lysate was that described by Cardoso de Almeida and Turner, 1983;
7
with modifications introduced by Ross et al., 1987). Briefly, about 3 x 10
125I-labelled trypanosomes were resuspended in 600 pd of PBS (Appendix 1)
containing 2% SDS and heated to 100°C. After cooling to room temperature
a sufficient amount of 2.5% Triton X-100 in PBS was added to give a final
concentration of 2% TX-100 and 0.4% SDS in the lysate.
125
Analysis of I-Iabelled Trypanosome Components
125
The supernatant and precipitate fractions obtained from I-labelled
125
trypanosome non-detergent lysate, and I-labelled trypanosome detergent
lysate were subjected to SDS-PAGE analysis on 7-20% polyacrylamide gels as
described in Chapter 2. Before applying the samples on the gels, 15 pd of each
125
I-labelled preparation containing 100,000 counts/min was mixed with 15 pd
of an equivalent unlabelled T. evansi homologous protein preparation
containing 90 p,g of protein. The mixture was then heated at 100°C for three
minutes. The unlabelled T. evansi material served as a source of extra proteins
which would enhance the visibility of the protein bands after staining the gels
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with Coomassie Blue.
Proteins of known molecular weight ranging from 94,000-14,000 daltons
(Pharmacia) were included in each electrophoresis run. Results from these
were used to construct a standard curve which was then used to calculate the
molecular weight of individual trypanosome protein components visualised
after the gels were stained with Coomassie Blue. After Coomassie Blue
staining the gels were placed in a gel drying apparatus before being exposed for
36 hours to Fuji RX-ray film (Fuji Photo Ltd., Japan) at -70°C in order to
visualise the radioactively labelled proteins. The molecular weight of
radiolabeled trypanosome components was determined by superimposition of
the autoradiograph onto the equivalent Coomassie Blue-stained gel.
T. evansi Specific Antibodies
Two female adult New Zealand White rabbits were used for the
production of T. evansi specific antibody. Each rabbit was infected through
the ear vein with 4 x 10^ trypanosomes of T. evansi TREU 2113. The
trypanosomes were initially grown in mice until fulminating infections
developed before the parasites were separated using anion-exchange
chromatography on DEAE cellulose (DE52, Whatman Biochemicals, UK) as
described in Chapter 2. After washing to remove host components, the
separated trypanosomes were resuspended in ice-cold PSG before they were
used to infect the rabbits.
Twenty-eight days after infection each rabbit was treated with 7 mg
j? p*y k-j .
(active principle) of diminazene aceturate (Berenil , Hoechst Lab, Germany)
Rabbits were bled for serum immediately before infection (day 0) and on days
7, 14 and 28 after infection. The rabbits were also bled on days 7, 28 and 39
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after drug treatment. Serum was prepared from the blood samples as
described in Chapter 2.
Anti-cross Reacting Determinant (CRD) Serum
The anti-CRD serum was a kind gift from Dr. C.A. Ross. The antisera
was prepared from the serum of a rabbit immunised with T. b. brucei as
described by Cardoso de Almeida and Turner (1983). The antiserum is known
to cross-react with the cross-reacting determinant of VSG from several other
trypanosome species (C.A. Ross, personal communication).
Identification of CRD in T. evansi VSG
After SDS-PAGE of unlabelled soluble antigen of the appropriate
trypanosome population prepared according to the protocol in Chapter 2, the
separated T. evansi proteins were transferred onto nitrocellulose membrane
(Anderman and Co., U.K.) using the semi-dry electroblotter (Ancos
Electroblotter, Dako Ltd., UK) according to the final protocol developed
during the study described in Chapter 2.
After blocking with excess proteins containing 4% goat serum (v/v) in XI
blocking buffer (Appendix 9), the presence of the CRD moiety on the blot was
probed by incubating the membrane with undiluted anti-CRD serum. Any
antibodies that bound to the trypanosome proteins were subsequently detected
125 • • •
by overnight incubation with I-labelled donkey anti-rabbit immunoglobulin
(Amersham, U.K.) (used at the rate of 50 jjlI of the radiolabeled antiserum
containing 3 x 10^ cpm (counts minute""^) added to 30 to 40 ml of the blocking
buffer). Subsequently any components of T. evansi that had reacted with the
anti-CRD serum were revealed by autoradiography at -70°C for 24 hours using
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Fuji X-ray film (Fuji Photo Ltd., Japan).
CLASS-SPECIFIC ANTIBODY COPRECIPITATION
ASSAY OF T. EVANSI PROTEINS
125
Class-specific antibody immunoprecipitation of T. evansi I-labelled
proteins was performed by a modification of the method described by Almond
and Parkhouse (1986). Serum samples that were examined in this way had
been collected from the rabbits before infection (day 0) and on days 7, 14 and
28 after infection and days 7, 28 and 39 after drug treatment. Each serum
sample was analysed for anti-trypanosome IgG, IgM and IgA activity using
appropriate heavy chain (Fc) specific antisera raised in goats against rabbit
IgG, IgM or IgA (Nordic^) to precipitate the equivalent class-specific fraction
of antigen/antibody complexes formed between radiolabelled trypanosome
proteins and serum from the trypanosome-infected rabbits.
Briefly, co-precipitation was undertaken by mixing 10 pi of the
appropriate serum from the rabbits exposed to infection with T. evansi with 20
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pi of the supernate fraction of I-labelled T. evansi TREU 2113, non-
detergent lysate adjusted with PBS to 10^ counts per minute at 4°C. The
mixture was then made up to a final volume of 400 pi for the IgG assay and
200 pi for the IgM and IgA assays with co-precipitation diluent (Appendix
11). These volumes had been found to give optimum results from an initial
study.
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After incubation of the I-labelled T. evansi antigen and rabbit serum
for four hours on ice, any trypanosome antibody complex formed was
precipitated from the mixture using an appropriate antiserum raised in goats to
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the heavy chain (Fc) portion of each class of rabbit immunoglobulin
(Nordic^). In the case of anti-trypanosome IgG precipitation 10 jjlI of the
antiserum was used and the mixture incubated for 24 hours. In the case of
anti-trypanosomes IgM and IgA 30 p.1 of the appropriate antisera was used and
the mixture incubated for 72 hours. The volumes of antisera and incubation
times had been found to be optimum from a preliminary assay.
Complexes formed with the class-specific antisera were precipitated by
centrifugation at 2,000 g for 10 minutes. Any unbound reactants were
removed by washing with coprecipitation diluent. Washing of the pellet was
continued until the radioactivity content of the pellet stabilised as monitored
with a gamma counter (Nuclear Enterprises NE1600). This happened by the
third wash.
Quantification of the Class-specific Antibody Response to the Iodinated
125
( I) components of T. evansi
After the third wash, the pellets produced after precipitation with class-
specific antisera were resuspended in 100 jjiI of co-precipitation diluent
(Appendix 11). The degree of radioactive incorporation in each of the pellets
was then estimated by measuring the amount of radioactivity in two 20 |xl
aliquots, of the suspension obtained from each sample with a gamma counter
(Nuclear Enterprises NE 1600).
Analysis of Co-precipitation Precipitates for Class-specific Antibody Activity
The composition of precipitates obtained after co-precipitation were
analysed by SDS-PAGE after mixing with an appropriate amount of cold
protein and SDS sample buffer as described above using the final protocol
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described in Chapter 2 with a 7-20% continuous gradient polyacrylamide gel
for 18 hours. The total protein profile of T. evansi TREU 2113 was examined
after staining the gel with Coomassie Blue as described previously. The gels
125
were then dried down and any I-labelled T. evansi antigen/class specific Ig
reactions visualised by autoradiography at -70°C for 36 hours using Fuji RX-
ray film (Fuji Photo Ltd., Japan).
Electron Microscopal Examination of Surface Coat of T. evansi
Trypanosomes derived from T. evansi TREU 1944, 2147 and 1834 were
fixed in suspension with 2.5% gluteraldehyde in 0.1M cacodylate buffer, pH
7.3 (Appendix 12) for periods up to two hours. The cells were then washed in
0.1M cacodylate buffer by centrifugation at 2,000 g over 20 minutes with the
buffer changed three times. The specimens were post-fixed in 1% osmium
tetraoxide (TAAB Lab. Equipment Ltd., UK) in 0.1M cacodylate buffer for
45 minutes and dehydrated in graded acetone (50%, 70%, 90% and 100%)
before being infiltrated with equal volumes of araldite mix (Agar Scientific,
UK) and Analar acetone (BDH) for 30 minutes at room temperature with
slight agitation and then overnight at 60°C. Further infiltration was carried
out with the araldite mix alone for one hour followed by three changes of
araldite mix and accelerator (Appendix 13) (19:1, v/v) for one hour per
infiltration. Embedding was undertaken with araldite mix and accelerator
(19:1, v/v) for another 48 hours at 60°C. Sixty nm thick sections were
produced from the blocks with Reichert OmU4 ultramicrotome fitted with a
diamond knife. Sections were then picked up on copper grids and examined
with a Phillips 400 TEM electron microscope operated at 100 KV.
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RESULTS
Non-detergent Lysis of T. evansi
More than 30 protein bands with a molecular weight range of 123,800 to
13600 daltons (d) were seen when both the supernate (Figure 3.1, No. 2)
and precipitate (Figure 3.1, No. 4) fractions of the T. evansi TREU 2113
non-detergent lysate were subjected to SDS-PAGE gels and then stained with
Coomassie Blue (Sigma). Two protein bands with molecular weights of 67,000
and 60,500 d were visualised after radioactive labelling, from both the
supernate and precipitate fractions of TREU 2113 (Figure 3.1, Nos. 1 and 3
respectively), 2147 and 1733 (data for the last two stocks not shown). A
single component with a molecular weight of 60,500 d was seen in
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autoradiographs from the supernate and precipitate fractions of I-labelled
TREU 1944 (Figure 3.2, Nos. 4a and 4b respectively) and TREU 1380 (data
not shown). No radiolabelled bands were seen on an autoradiograph from
both the supernate and precipitate fractions of lysates of radiolabelled proteins
of TREU 1834 (Figure 3.2, Nos. 3a and 3b respectively).
Detergent Lysis of T. evansi
A single band with a molecular weight of 60,500 d was seen on an
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autoradiograph from the detergent lysate of I-labelled TREU 1944 (Figure
3.2, No. 2) with no radioactivity detected from the lysate of TREU 1834
(Figure 3.2, No. 1). In each case, cells were observed to incorporate more
radioactivity at 4°C than at room temperature. The incorporation of
radioactivity into many bands was observed during some labelling procedures
carried out at room temperature. This was particularly evident in samples in
which many dead trypanosomes were observed at the end of the labelling
procedure.
FIGURE 3.1
Surface iodination of Trypanosoma evansi TREU 2113.
1. Supernate fraction of T. evansi TREU 2113 non-detergent lysate
after iodination.
2. Supernate fraction of T. evansi TREU 2113 non-detergent lysate,
non-iodinated stained with Coomassie Blue.
3. Precipitate fraction of T. evansi TREU 2113 non-detergent lysate
after iodination.
4. Precipitate fraction of T. evansi TREU 2113 non-detergent lysate,
non-iodinated stained with Coomassie Blue.
 
FIGURE 3.2
Proteins of T. evansi TREU 1834 and 1944 iodinated and lysed in the
presence and absence of detergents.
1. Blot onto which proteins of TREU 1834 were transferred after
iodination and lysis in the presence of a detergent.
2. Blot onto which proteins of TREU 1944 were transferred after
iodination and lysis in the presence of a detergent.
3a. Blot onto which the supernate fraction of T. evansi TREU 1834
was transferred after iodination and lysis in the absence of a
detergent.
3b. Blot onto which the precipitate fraction of T. evansi TREU 1834
was transferred after iodination and lysis in the absence of a
detergent.
4a. Blot onto which the supernate fraction of T. evansi TREU 1944
was transferred after iodination and lysis in the absence of a
detergent.
4b. Blot onto which the precipitate fraction of T. evansi TREU 1944




Components of T. evansi Recognised by the Anti-CRD Serum
Two radiolabeled components of molecular weights 67,000 and 60,500 d
were seen on an autoradiograph of the nitrocellulose membrane, onto which
the separated proteins of the supernate fractions of T. evansi TREU 1944 and
1380 produced by non-detergent lysis had been transferred and then probed
with anti-CRD serum (Figure 3.3, Nos. 2 and 10 respectively). One
component of molecular weight 60,500 d was recognised on a similarly
processed autoradiograph when the total proteins of TREU 2113 (Figure 3.3,
No. 4), 2147 (Figure 3.3, No. 6) and 1733 (Figure 3.3, No. 8) were probed
with the antiserum. No bands were seen when the supernate fraction of the
non-detergent lysate of TREU 1834 was probed with the anti-CRD serum
(Figure 3.3, No. 12). A 60,500 d band was, however, recognised by the anti-
CRD serum in the precipitate fraction from the non-detergent lysate of TREU
1834 (Figure 3.4, No. 2).
For clarity, the total protein profile of the supernate fraction from the
non-detergent lysate of each trypanosome stock after separation on SDS-PAGE
and Coomassie Blue staining is shown as odd numbers in Figure 3.3, adjacent
to each autoradiograph from the equivalent blots probed for reactivity with
anti-CRD serum.
FIGURE 3.3
Components of different stocks of T. evcinsi recognised by the anti-
CRD serum.
(a) Odd number figures represent the protein profiles of the super-
nate fraction of the lysate of the different stocks of T. evansi pro¬
duced by non-detergent lysis, separated with SDS-PAGE and
stained with Coomassie Blue.
(b) Even number figures represent the proteins as in (a) above of the
different stocks of T. evansi probed with anti-CRD serum on
"Western" blotting.
Numbers 1 and 2: TREU 1944
Numbers 3 and 4: TREU 2113
Numbers 5 and 6: TREU 2147
Numbers 7 and 8: TREU 1733
Numbers 9 and 10: TREU 1380
Numbers 11 and 12: TREU 1834
946743302014
FIGURE 3.4
Proteins of T. evansi TREU 1834 recognised by anti-CRD serum.
1. Protein profile of the precipitate fraction of the lysate of TREU
1834 produced by non-detergent lysis, separated with SDS-PAGE
and stained with Coomassie Blue.
2. Proteins of TREU 1834 as in 1. above probed with anti-CRD
serum on "Western" blotting.
3. Protein profile of the supernate fraction of the lysate of TREU
1834 produced by non-detergent lysis, separated with SDS-PAGE
and stained with Coomassie Blue.
4. Proteins of TREU 1834 as in 3. above probed with anti-CRD




Each T. evansi stock (TREU 1944, 2147 and 1834) examined by electron
microscopy was seen to have a thick, compact and dense surface coat overlying
the plasma membrane (Figure 3.5, Nos. 1 to 3).
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Class-specific Antibodies to the I-labelled Components of T. evansi
Assayed by Coprecipitation
1 25
IgG antibodies: A single I-labelled component with a molecular weight
of 60,500 d was recognised by serum collected from both rabbits seven days
after infection with TREU 2113 (Figure 3.6, Nos. 2 and 9). From 14 days
125
after infection, a further I-labelled component (67,000 d) was recognised.
Thereafter both components were recognised throughout the post-infection and
post-drug treatment periods (Figure 3.6, Nos. 3 to 14). Preinfection sera
125
collected from both rabbits failed to react with any I-labelled trypanosome
components (Figure 3.6, Nos. 1 and 8).
IgM antibodies: A single radiolabelled component of 60,500 d, was
recognised by the serum sample collected seven days after infection from one
rabbit (Figure 3.7, No. 2) while the equivalent serum from the second rabbit
recognised an additional component of 67,000 d (Figure 3.7, No. 9).
Thereafter both bands were recognised by serum samples collected from both
rabbits throughout the post-infection and post-drug treatment periods (Figure
3.7, Nos. 3 to 14).
125
IgA antibodies: There was considerable variation in the pattern of
labelled antigens of T. evansi recognised by IgA antibodies produced by the
two rabbits. In one of the rabbits the bands, 67,000 and 60,500 d were faintly
recognised by IgA in serum collected 14 days post-infection (Figure 3.8,
FIGURE 3.5
Transmission electron micrograph of section through the surface of the
body of different stocks of T. evansi.
(Magnification x 165,000).
Number (1) TREU 1944
Number (2) TREU 2147




IgG antibodies produced by rabbits to the I-labelled components of
T. evansi during the course of infection and after drug treatment.
(Numbers 1-7 and 8-14 are reactions with serum samples collected
from the first and second rabbits respectively.)
1. Components identified by the normal rabbit serum.
2. Components identified by serum collected 7 days after infection.
3. Components identified by serum collected 14 days after infec¬
tions.
4. Components identified by serum collected 28 days after infection.
5. Components identified by serum collected 7 days after drug treat¬
ment.
6. Components identified by serum collected 28 days after drug
treatment.
7. Components identified by serum collected 39 days after drug
treatment.
8. Components identified by the normal rabbit serum.
9. Components identified by serum collected 7 days after infection.
10. Components identified by serum collected 14 days after infection.
11. Components identified by serum collected 28 days after infec¬
tions.
12. Components identified by serum collected 7 days after drug treat¬
ment.
13. Components identified by serum collected 28 days after drug
treatment.
14. Components identified by serum collected 39 days after drug
treatment.
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IgM antibodies produced by rabbits to the I-labelled components of
T. evansi during the course of infection and after drug treatment.
(Numbers 1-7 and 8-14 are reactions with serum samples collected
from the first and second rabbits respectively.)
1. Components identified by the normal rabbit serum.
2. Components identified by serum collected 7 days after infection.
3. Components identified by serum collected 14 days after infection.
4. Components identified by serum collected 28 days after infection.
5. Components identified by serum collected 7 days after drug treat¬
ment.
6. Components identified by serum collected 28 days after drug
treatment.
7. Components identified by serum collected 39 days after drug
treatment.
8. Components identified by the normal rabbit serum.
9. Components identified by serum collected 7 days after infection.
10. Components identified by serum collected 14 days after infection.
11. Components identified by serum collected 28 days after infection.
12. Components identified by serum collected 7 days after drug treat¬
ment.
13. Components identified by serum collected 28 days after drug
treatment.
14. Components identified by serum collected 39 days after drug
treatment.
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IgA antibodies produced by rabbits to the I-labelled components of
T. evansi during the course of infection and after drug treatment.
(Numbers 1-7 and 8-14 are reactions with serum samples collected
from the first and second rabbits respectively.)
1. Components identified by the normal rabbit serum.
2. Components identified by serum collected 7 days after infection.
3. Components identified by serum collected 14 days after infection.
4. Components identified by serum collected 28 days after infection.
5. Components identified by serum collected 7 days after drug treat¬
ment.
6. Components identified by serum collected 28 days after drug
treatment.
7. Components identified by serum collected 39 days after drug
treatment.
8. Components identified by the normal rabbit serum.
9. Components identified by serum collected 7 days after infection.
10. Components identified by serum collected 14 days after infection.
11. Components identified by serum collected 28 days after infection.
12. Components identified by serum collected 7 days after drug treat¬
ment.
13. Components identified by serum collected 28 days after drug
treatment.
14. Components identified by serum collected 39 days after drug
treatment.




No. 3). Thereafter, both bands continued to be recognised by all serum
samples collected from the rabbit throughout the post-infection and post-drug
treatment periods (Figure 3.8, Nos. 4 to 7). IgA in serum from the second
rabbit however, recognised the 60,500 d component faintly at seven days after
infection (Figure 3.8, No. 9). Thereafter, both 67,000 and 60,500 d
components were recognised by all the serum samples collected from the rabbit
throughout both the post-infection and post-drug treatment periods (Figure
3.8, Nos. 10 to 14). The 67,000 dalton band appeared to be better recognised
by the IgA antibodies than the 60,500 d band based on the intensity of staining
on the blot (Figure 3.8).
Quantification of the Class-specific Antibody Response to the Iodinated
125
( I) Components of T. evansi
The amount of radioactivity incorporated into the complexes formed
125
between the I-labelled trypanosome proteins and the class-specific
antibodies to rabbit IgG, IgM and IgA with the serum samples collected from
the two rabbits differed at different times during the post-infection and post-
drug treatment periods (Figure 3.9A and B). Least radioactive incorporation
was observed in complexes formed with the serum samples collected seven days
after infection, whilst the greatest amounts were recorded with serum samples
collected during late infections or after drug treatment.
Greatest average radioactive incorporation was observed in complexes
formed by reaction with IgG specification (6,500-20,000). Next in magnitude
were those of IgM antiserum with 4,000-12,000 cpm and least IgA with 2,800-
7,250 counts per minute per 20 pd (cpmp 20 jjlI). Minimal amounts of
radioactivity were incorporated in the products of incubation with the normal
FIGURE 3.9
Radioactivity in the complexes precipitated by the different immuno¬
globulin isotypes in the serum of rabbits during the course of infection
with T. evansi and after drug treatment. (A and B are counts from
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rabbit serum - with 705, 450 and 317 cpmp 20 |xl for IgG, IgM and IgA
respectively. The amount of radioactive incorporation into the complexes
formed by the three Ig isotypes, IgG, IgM and IgA is represented in Figure
3.9.
The differences between the different T. evansi stocks used in the present
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Radiolabelling of intact T. evansi organism with I in this study resulted
in the incorporation of radioactivity into two or one or no components, with
radiolabelled components having a molecular weight of either 67,000 and/or
60,500 dalton bands (Figure 3.1 and Figure 3.2, No. 4a). It is likely that
these labelled components represent surface components of the trypanosomes
because intact organisms do not incorporate the label into other than their
surface elements (Zingales, 1984). Furthermore, the radiolabelling technique
employed in this study has been used extensively for surface labelling of a
range of parasites (Gardiner and Dwyer, 1981; Howard et al., 1982) including
several trypanosome species (Gardiner et al., 1983; Ross et al., 1987; Camargo
et al., 1982a,b). The association of radiolabelling of more components with
preparations containing many dead or dying trypanosomes, is a further
indication that the labelling of intact trypanosomes is confined to the surface of
the organism as these additional components labelled are thought to be exposed
after the breakdown of the intact trypanosome.
The differences seen between the different stocks of T. evansi with respect
to the total number and molecular weight of the individual components
radiolabelled during the present study was not considered a peculiarity
restricted to T. evansi. In T. congolense, Ross et al. (1987) iodinated a single
component while Rovis et al. (1978) labelled more than one surface component
of the same parasite. The failure to label any trypanosome component as in
the case of TREU 1834 in the present study does not appear to have been
reported previously. It is likely that the differences in the results of
radiolabelling seen between different stocks reflect variations in the
biochemical composition of the surface coat of the individual trypanosome
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populations although the significance of such differences in the host/parasite
relationship is unknown.
The results from electron microscopal studies (Figure 3.5, Nos. 1 to 3)
clearly demonstrated no physical difference between the surface coats of the
individual trypanosome populations. The failure to radiolabel any component
of TREU 1834 was not, therefore, due to the lack of a surface coat and
provides further evidence that failure to label TREU 1834 was probably due to
the absence of specific amino-acid residues on the surface of the parasites
which react with the iodination reagents or that any component bearing the
appropriate amino acids is not exposed on the surface of the parasite.
Furthermore, results from the Coomassie Blue staining of the total proteins of
each stock of T. evansi evaluated in this study, indicate that both the 67,000
and 60,500 d are present in all the stocks (Figure 3.3, odd numbers). It is
likely therefore that the other two factors - amino acid sequencing on the
surface of the parasite or the absence of the component from the surface of the
parasite could have influenced the results of radiolabelling.
Successful iodogen-mediated cell iodination (Fraker and Speck, 1978)
depends on the availability of tyrosyl residues on the surface of parasites
(Zingales, 1983). It is likely that in the case of some stocks such as TREU
1944 in which only the 60,500 component was identified on surface iodination
(Figure 3.2, Nos. 4a and 4b) that this component was the only component
exposed on the surface of the parasite having both sufficient tyrosyl residues
and accessible to labelling. In other stocks such as TREU 2113 in which both
components (67,000 and 60,500) were radiolabelled (Figure 3.1, Nos. 1 and
3), it is likely that both components were exposed on the surface of the
parasites and with sufficient tyrosyl residues for successful labelling. In the
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stock where none of the components were labelled (Figure 3.2, 3a and b), it is
possible that neither component was exposed on the surface of the parasite or
more likely that neither of them had sufficient exposed tyrosyl residues. The
use of other iodinating techniques such as the Bolton and Hunter technique
(Bolton and Hunter, 1985) that react with different amino acid residues might
produce different results after surface-labelling these parasite populations.
The use of the anti-CRD serum as a means of characterising surface
component of the T. evansi was based on the premise that the antiserum only
recognises the CRD-epitope in the soluble form of VSG (sVSG) and not in the
membrane bound VSG (mfVSG) where the recognition of the determinant by
anti-CRD serum is impaired (Cardoso de Almeida and Turner, 1983). The
CRD antibodies were found to bind to the 60,500 daltons component in all six
stocks of T. evansi studied as a single component in the case of four stocks
(Figure 3.3, Nos. 4, 6 and 8 and Figure 3.4, No. 2) and in combination with
the 67,000 dalton component in two stocks (Figure 3.3, Nos. 2 and 10).
The association of the CRD with the 60,500 d component suggests that
this component could represent the non-variable portion of the VSG molecule
of T. evansi while the other surface-associated 67,000 d component might
represent the variable portion. In two stocks, however the CRD epitope
appeared to be distributed equally between both 60,500 and 67,000
components. This result suggests that the oligosaccharide molecule which
comprises the CRD may not necessarily be restricted to the C-terminal domain
of the VSG of T. evansi alone as has been suggested for other trypanosome
species (Holder and Cross, 1981).
The surface components of trypanosomes derived from T. evansi TREU
1834 behaved very differently from the other stocks examined in the present
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study. Of the six stocks of T. evansi examined, it was not possible to
radiolabel any surface components of TREU 1834. Furthermore, results from
the studies with the anti-CRD serum identified a single component of
molecular weight 60,500 in the pellet fraction after non-detergent lysis (Figure
3.4, No. 2) that was lacking in the supernate fractions (Figure 3.4, No. 4)
unlike other stocks in which the component was identified in the supernatant-
fraction of the lysate preparation. In the case of TREU 1834 it is possible that
the glycoprotein surface coat of this stock is very tightly bound to the plasma
membrane and not, therefore, released during non-detergent lysis of the cell, a
process that normally releases the VSG in a water-soluble state (Auffret and
Turner, 1981; Cardoso de Almeida and Turner, 1983). Although both the
67,000 and 60,500 dalton components that are associated with the surface of
the other trypanosome stocks are faintly present in the total proteins of this
stock, (Figure 3.3, No. 11) it is possible that they may not represent the actual
surface components of TREU 1834. The two components with the molecular
weight of 56,000 and 43,000 in the supernate fraction of the lysates may
represent the surface components (Figure 3.3, No. 11), based on the fact that
they are clearly distinct from all other components in the total protein profile
of the trypanosome stock which is recognised as a common feature of VSGs on
Coomassie Blue-stained gels (C.A. Ross, 1989, personal communication).
These differences in the molecular weight range of the postulated surface
components of TREU 1834 compared to those of the other five stocks could
be a reflection of radical differences in amino acid sequences in the VSG
molecules of TREU 1834 which would in turn affect the efficiency of the
iodination method used for surface labelling.
The recognition of the 60,500 and 67,000 d components of T. evansi 2113
by serum collected early after infection provides further evidence that these
two components are surface associated, as early host antibody responses are
usually directed at surface components of invading organisms. The recognition
of T. evansi surface antigen components by the three main immunoglobulin
isotypes, IgG, IgM and IgA whose production was maintained throughout the
period of observation (Figures 3.6 to 3.8) confirms the importance of VSG-
specific antibody response, not only, for the elimination of a particular parasite
population but also for the protection of animals against reinfections with
homologous trypanosomes (Emery, et al., 1980; Mitchell and Pearson, 1983;
Hall and Esser, 1984) as it would be difficult for parasites expressing
homologous surface antigens to establish in animals having VSG-specific
antibodies to the surface antigens. It is likely that the VSG-specific IgM
antibodies which appeared early in animals to the surface components served to
destroy the trypanosomes through lysis which could then have induced the
production of IgG antibodies largely to the non-surface components
(Vickerman and Barry, 1982) to remove the products of lysis or ameliorate
any possible toxic consequencies of large amounts of biologically active
substances produced by either dead or dying trypanosomes (Seed, 1969; Tizard
and Ringleberg, 1973; Huan et al., 1975) possibly by detoxification (Roitt et
al., 1985).
The appearance of IgA antibody to the surface antigen components of
TREU 2113 is not clearly understood. IgA antibody is commonly associated
with seromucous surfaces. IgA antibodies secreted during infection may be
playing a supportive role in the control of parasitaemia via the activation of the
alternative complement pathway or the agglutination of parasites before they
are eliminated by phagocytic effector cells of the body such as neutrophils and
macrophages (Roitt et al., 1985; Bowry, 1984). Few studies have been
undertaken to study the importance of IgA antibody response in trypanosome
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infection. One such study by Herbert et al. (1980) reported that the total IgA
level in man was unaffected while in another study Nielsen et al. (1978)
described a reduction in total IgA level in calves infected with T. congolense.
Although these authors were unable to explain the relevance of the findings,
Nielsen et al. (1978) however, suggested extending the studies to IgA levels in
external mucosal surfaces where IgA is at least partly responsible for protection
against invading pathogens.
The identification of the two surface-associated components 67,000 and
60,500 by all classes of antibody in the serum samples collected throughout the
period of observation from the rabbits indicates the continual presence of
antibodies against the components throughout the period of infection and after
drug treatment. The persistence of antibody to these components during the
period of infection may be due to consistent re-expression of particular
antigenic types such as the predominant antigen type (pVAT) particularly as
TREU 2113 is known to be a predominant antigen type (T.W. Jones, personal
communication). Such consistent re-expressions of a particular antigen type
could act as a source of continuous antigenic stimulation leading to a build-up
of specific antibodies in the serum of infected animals. The antibodies against
the trypanosome surface antigens persisting in the serum after drug treatment
could be those that had been produced before the institution of chemotherapy
that persisted in circulation. Alternatively, it is possible that the persistence of
the antibodies during the post treatment period could be associated with the
elimination of the effects of the factors known to be released by living
trypanosomes that block the terminal stages of differentiation of parasite-
activated B lymphocytes to immunoglobulin-secreting cells or inhibits secretion
of immunoglobulin by these cells (Black et al., 1985). The elimination of the
parasites by chemotherapy and consequently the elimination of the effects of
- 107 -
these factors on parasite-activated B cells are thought to contribute to the rapid
production of antigen-specific antibodies after drug cure as suggested by
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The immune system of the hosts plays a crucial role in the outcome of any
parasite challenge, the success of which is influenced by the balance between
the range of different immune defence mechanisms available to the host
(Cabrera et al., 1986). The mammalian immune system consists of two
functional divisions; the innate immune system which acts as a non-specific
first line of defence against infectious agents and the adaptive immune system
which provides a specific reaction tailored to each infectious agent and usually
results in the elimination of the agent (Roitt et al., 1985). The adaptive
immune system consists of two interrelated divisions, the cellular and humoral
which are only mobilised when the first defences of the innate system are
breached.
At the humoral level the pattern of the five main classes of
immunoglobulins - IgG, IgM, IgA, IgD and IgE, elicited during the antibody
response to infection is of great importance in determining the outcome of the
parasite challenge (Shakib and Stanworth, 1980; Turner, 1977), as each
immunoglobulin isotype can mediate a different range of biological functions
such as adherence to specific defence cells or activation of the complement
system (Almond and Parkhouse, 1986).
Structurally each immunoglobulin molecule consists of one or more basic
units each containing four polypeptide chains - two identical high molecular
weight or heavy (H) chains and two identical low molecular weight or light (L)
chains. The light and heavy chains are joined by three interchain disulphide
bonds into a Y-shaped molecule (Figure 4.1).
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FIGURE 4.1














Both light and heavy chains are further divided into a series of 12 similar
subunits or domains, each domain consisting of approximately 110 amino
acids. The N-terminal domain of the immunoglobulin molecule shows a
marked degree of variation in its amino acid residue composition and is termed
variable in contrast to the other more stable domains termed constant. Each
light chain contains a single variable domain (VL) and a single constant
domain (CL) while each heavy chain contains one variable region (VH) and
three or four constant domains (CH^, CHb,, CH^ and CH^) (Reeves, 1987).
The different domains of the immunoglobulin molecule affect the biological
functions of the various immunoglobulin classes and subclasses, with sites for
complement system activation, and attachment of cells such as phagocytes and
mast cells etc. present in the different domains (Bowry, 1984). The
classification of the immunoglobulins being based on the antigenic differences
between their heavy chains or Fc portion (Weir, 1983).
The ability of any antibody molecule to combine with a particular antigen
is dependent on a region of the immunoglobulin molecule called the antigen
binding site (Fab portion) which is formed from the variable portions of both
of the heavy and light chains. The part of the immunoglobulin molecule made
up of constant regions of the heavy chain (often referred to as the Fc portion
from early crystallisation studies) determines the effect of such binding on the
antigen. The Fc fragment of the different immunoglobulin classes differ
antigenically and in their molecular weight and primary structure. After
binding to an antigen has taken place via the Fab portion, the Fc fragment of
the molecule binds to special Fc receptor sites present on many effector cells
such as neutrophils, mononuclear phagocytes, eosinophils and B lymphocytes to
activate the process that will bring about the elimination of the parasite. The
exact nature of the effector process is dependent on the cell type that the
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antigen-antibody complex has bound to via the Fc portion of the antibody
molecule.
The most abundant immunoglobulin in the serum is IgG and it is evenly
distributed between both the intra- and extravascular pools of the body. It is a
monomeric protein with a molecular weight of 146,000 (Roitt et al., 1985),
which ensures that it can diffuse readily through the different membranes of
the body, making it particularly suitable for dealing with fast-diffusing toxins
and microbes localised in tissues. The affinity of the antigen-binding sites on
any one IgG molecule is far greater for a particular antigen than that of other
classes of immunoglobulins. Furthermore, the affinity of IgG produced in
response to infection increases progressively during an immune response; in a
later response it can be 10,000 times higher than in early responses (Bowry,
1984). IgG is also the main immunoglobulin class associated with secondary
immune response. This probably arises from the fact that the effector cells
responsible for the antibody response arising from a secondary immune
response (B memory cells) are primed for producing mainly IgG (Roitt et al.,
1989). IgG, can be further divided into four subclasses - based on structural
and antigenic differences in their heavy chains, IgGp IgG2» IgG^ and IgG^.
The differences in the heavy chains of the different subclasses are reflected in
differences between their functional activities such as their ability to activate
complement (Klaus et al., 1979).
The other major serum immunoglobulin class is IgM. IgM is localised
largely within the intravascular pool, and has a pentameric structure with a
molecular weight of 970,000 (Roitt et al., 1985). The pentameric structure of
IgM improves upon its avidity, over that of other immunoglobulin classes.
This arises from the fact that each IgM molecule has 10 antigen binding sites
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in comparison with the two of each IgG molecule. The pentameric structure
makes IgM especially effective in activating complement, handling of
antigenically complex infectious agents and an efficient agglutinating and
cytolytic agent (Steward, 1976; Roitt et al., 1985).
Antibodies belonging to the other three main immunoglobulin classes are
not as widespread as IgG or IgM and have a more limited and often local
reactivity. The predominant immunoglobulin in seromucous secretion is IgA,
although limited amounts of IgA is detectable in serum. IgA is secreted locally
by plasma cells in the intestinal mucosa, the lacrimal gland, respiratory
passages, salivary glands, sweat and mammary glands where it acts locally on
infectious agents. IgA in external secretions is called secretory IgA (slgA) and
is a dimer joined by a J chain and contains an additional component, a protein
called the secretory component - SC. This component is synthesized in the
epithelial mucous membrane cells and is believed to protect dimeric IgA from
proteolysis. Secretory IgA may be of either subclass of IgA (IgAl and IgA2)
and has a molecular weight of 385,000 (Roitt et al., 1985). Most serum IgA
in man occurs as the basic four chain monomer with a molecular weight of
150,000 daltons, while in most other mammals serum IgA is mainly polymeric,
occurring mostly as a dimer.
IgA is efficient in the neutralisation of local toxins and activation of the
complement system through the alternative pathway (Bowry, 1984). The Fc
portion of IgA has a lower affinity than that of IgG for receptors in phagocytic
cells, therefore, much of IgA's protective value may be due to its ability to
combine directly with and neutralise pathogenic micro-organisms without
necessarily involving any other effector system (Reeves, 1987).
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Antibodies belonging to the IgD class of immunoglobulin are usually
present in a low concentration constituting only about 1% of the total plasma
immunoglobulin pool. They are however, present in large quantities on the
membrane of circulating B lymphocytes, particularly early B cells in
conjunction with IgM. Although the exact biological activity of IgD is
unknown, it is believed to play an important role in antigen-triggered
lymphocyte differentiation (Roitt et al., 1985). IgD is not thought to mediate
any of the usual effector functions attributed to immunoglobulins.
IgE, also known as 'reaginic' antibody because of its ability to fix to tissue
cells so that, on reaction with antigen, histamine and other vasoactive agents
are released. IgE is the least abundant of the immunoglobulins and it is
usually found firmly fixed on the surfaces of mast cells and basophils via its Fc
receptors. Although IgE is the least plentiful of all serum immunoglobulins, its
presence is often dramatically felt when their consequential binding to specific
antigens causes mast cells and basophils to release powerful inflammatory
mediators such as histamines (Reeves, 1987). IgE is particularly important in
the development of active immunity against helminthic parasites and the
implementation of immediate hypersensitivity reaction seen in conditions such
as asthma and hay-fever.
Antibodies belonging to any of the five main immunoglobulin classes
could be produced by the host during the course of any infection. Antibody
belonging to particular classes lacking the necessary properties to destroy
parasites such as trypanosomes via complement or cell-mediated mechanisms
may act as blocking antibodies which saturate antibody binding sites on the
parasite thus preventing the action of protective immunoglobulins (Cabrera et
al., 1986). The effective control of parasite infection therefore depends on a
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delicate balance between the different immunoglobulin classes during the
course of infection.
There is increasing evidence that the immunoglobulin isotype produced in
response to certain parasite components greatly influences the way in which the
host deals with an infection (Almond and Parkhouse, 1986). This arises from
a combination of the fact that some parasite components may be more
antigenic than others and induce a better protective immune response from the
host than other components and also that certain immunoglobulin classes
perform some effector functions better than others, e.g. IgM is a more
efficient complement activating antibody than IgG.
In the case of trypanosomes, the antibody response to the surface is far
greater than that to the less immunogenic internal components (Le Ray, 1975).
Furthermore, animals that generate an IgM antibodies response against the
surface coat of the parasite would probably be better protected against the
effect of the infection than those that generated a predominantly IgG response
because IgM is classically considered to be more effective than IgG in the
activation of complement, which is one of the principal ways by which
trypanosomes are considered to be eliminated by the host (Wellde et al., 1975,
1981; Murray and Urquhart, 1977; Emery et al., 1980; Morrison et al., 1982).
Studies on antibody response to trypanosome infection have established
that infected animals produce antibodies against both the surface antigens and
also the non-surface or common antigens of the parasite (Raadt, 1974; Le
Ray, 1975). Antibody responses to the surface antigens play a vital role in the
elimination of parasites and protection against rechallenges with homologous
trypanosomes (Wellde et al., 1975, 1981; Emery et al., 1980; Morrison et al.,
1982). Differences have been reported between the immunoglobulin isotype
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response in animals infected with trypanosomes by several workers, which are
possibly linked to the assay systems used. Investigations based on agglutination
testing reported that the primary response of rabbits to T. b. gambiense and
rats or cattle to T. b. brucei infection was predominantly IgM (Seed et al.,
1969; Zahalsky and Weinberg, 1976). Conversely, other researchers reported
that the primary response of mice and cattle to 7. b. brucei or mice to T. b.
rhodesiense was predominantly IgG. In these latter studies, Nantulya et al.
(1979) used a radioimmunoassay with a purified VSG preparation as antigen
and reported predominant IgG production, similar results to those of Campbell
et al. (1978), Sacks and Askonas (1980) and Mansfield et al. (1981) who used
VSG specific fluorescent antibody staining method. These apparently
conflicting results on immunoglobulin class involvement could be due to the
techniques used for the assay of antibodies. IgM is a more efficient
agglutinating antibody than IgG, therefore it is likely that the agglutination test
would preferentially detect IgM at the expense of IgG.
Other studies on the effect of trypanosome infection on the immune
system have shown that in addition to the production of specific antibodies
against parasite antigens, host B lymphocytes can be activated in a non-specific
manner which results in the production of large amounts of non-specific
immunoglobulins (Houba, 1969; Hudson et al., 1976; Terry et al., 1980)
probably due to the action of trypanosome mitogens (Urquhart et al., 1973;
Esuruso, 1976; Assoku and Tizard, 1978). Much of these non-specific
immunoglobulins produced by polyclonal activation of B cells are considered to
belong to the IgM class of immunoglobulins (Hudson et al., 1976; Terry et al.,
1980). The presence of these non-specific immunoglobulins often complicate
the interpretation of results of host/parasite interaction observed in
- 117 -
immunological assays and can affect the overall understanding of the specific
response to the parasite.
The variant surface glycoproteins of the trypanosome have attracted most
attention in studies on the immunobiology of trypanosomes probably due to its
high degree of immunogenicity (Le Ray, 1975) and also its role in protecting
animals against reinfections (Wellde et al., 1975, 1981; Emery et al., 1980;
Morrison et al., 1982; Hall and Esser, 1984). This preoccupation of
researchers with the host's response to the surface antigens of trypanosome
could have been to the detriment of responses to the non-surface components
of the parasites. It is likely that the technical problems of differentiating
between responses to both surface and non-surface components of
trypanosomes has also contributed to the fact that most studies have been
restricted to the surface component. The VSG specific response by the host
probably serves only to bring about the lysis of each antigenically different
population of trypanosome. The way in which the host deals with the
consequential release of internal antigen is largely unknown which could form
an equally important part of the response to infection.
Although some studies on the range of immunoglobulin isotypes produced
in response to trypanosome infection have been conducted by several workers,
all of the studies have considered the parasite as a single antigenic entity, not
as a collection of different antigenic components which in reality it is. Such a
single antigen concept is probably only valid during the first encounter between
host and parasite, particularly in the case of trypanosomes with their limited
surface antigen composition. Once the host has initiated immune-mediated
parasite destruction, a range of individual parasite components will become
available to the host. It is possible that the type of host response to such
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individual components might be important in influencing the final outcome of
an infection.
Few limited studies have been undertaken on the class-specific antibody
response in animals infected with T. evansi (Luckins et al., 1978; Luckins et
al., 1979). These have employed techniques such as the single radial diffusion
test to measure total IgM/IgG or ELISA and IFAT neither of which can
associate changes in immunoglobulin levels with response to specific parasite
antigens. Results obtained from these studies which evaluated only IgG and
IgM levels in the infected animals showed that IgM levels were higher than
IgG during the period of primary infection.
The current study is therefore designed to evaluate the nature of class-
specific antibody responses in animals infected with T. evansi. The individual
components of the parasite which have been separated by electrophoresis have
been probed for their antigenicity using serum samples collected from animals
at different times after infection.
MATERIALS AND METHODS
Trypanosomas
T. evansi TREU 2113 described in Chapter 2 was used for infection of all
the rabbits and for the preparation of the soluble antigens used throughout this
study.
Rabbit Infection
Trypanosome populations obtained from stabilate material were injected
into mice. When fulminating levels of parasites were obtained, animals were
exsanguinated under ether anaesthesia and about 1 ml of blood collected into
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disposable syringes containing 50 units of heparin via a cardiac puncture. The
parasites were then separated from the host's blood cells with anion-exchange
chromatography using DEAE cellulose (DE52 Whatman Biochemicals) as
described by Lanham and Godfrey (1970) and used to infect the rabbits.
Eight adult New Zealand White rabbits were each infected through the ear
vein with about 4 x 10^ motile trypanosomes, suspended in ice-cold phosphate
saline glucose (PSG) pH 8.0 (Appendix 2). Twenty-eight days after infection
each rabbit was injected with 7 mg (active principle) of diaminazene aceturate
(Berenil^, Hoechst) intramuscularly (i/m)pev !>oJ-y u-t.
Collection of Serum Samples from T. evansi Infected Rabbits
Blood for the preparation of serum was collected from each rabbit before
infection and on days 7, 10, 14, 17, 21, 24 and 28 after infection. Blood was
also collected from each rabbit on days 7, 14, 18, 21, 28, 33 and 39 after drug
treatment. Serum was prepared from these blood samples as described in
Chapter 2. On each occasion that blood was collected for serum, blood
samples were also collected into tubes containing EDTA (Sigma Ltd.) for the
determination of packed cell volume (PCV) by the microhaematocrit method
(Schalm, 1975) and for the estimation of parasitaemia initially by wet mount
and subsequently by the dark ground/phase contrast buffy coat scoring system
described by Paris et al. (1982).
Clinical Signs in Rabbits Infected with T. evansi
The body weight in kg and rectal temperature in °C of each rabbit was
recorded immediately before each blood collection.
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Separation of Soluble T. evansi Antigens by SDS-PAGE
A soluble antigen preparation of T. evansi TREU 2113 was prepared by
freeze-thaw according to the protocol described in Chapter 2. The resulting
extract was then subjected to SDS-PAGE on a 7 to 20% gradient
polyacrylamide gel as described in Chapter 2. Ninety jxg of the trypanosome
soluble protein were loaded into each well cast in the stacking gel with one well
of each gel receiving a mixture of proteins of known molecular weight
(molecular weight markers, Pharmacia).
After electrophoresis, the separated trypanosome components were
electrophoretically transferred to nitrocellulose membrane (Anderman and Co.,
U.K.) as described in the final protocol described in Chapter 2.
DETECTION OF ANTIGENIC COMPONENTS OF T. EVANSI
After the transfer, a section of the nitrocellulose membrane containing the
molecular weight markers and at least one lane of the T. evansi soluble
antigens was cut off and stained with 1% amido black (Sigma Ltd.) as
described in Chapter 2. This stained portion of the blot was subsequently used
for the construction of a standard curve based on the migration of the
individual proteins making up the molecular weight markers. The molecular
weight of individual components of T. evansi were calculated by interpolation
from this curve.
Antigenic components in the remaining part of the nitrocellulose paper
were detected using serum collected from rabbits at different times after
infection and drug treatment using the final protocol described in Chapter 2
but modified to detect class-specific antibody. This modification involved the
addition of an extra processing step in which a second antiserum preparation
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raised in goats to an appropriate rabbit immunoglobulin isotype (Nordic^) was
used to probe any T. evansi antigen/antibody complex arising from the
incubation of the blot with post-infection/post-treatment rabbit serum (Ag/Ab).
A third antiserum raised in rabbits against goat IgG and conjugated to
peroxidase (Nordic^") followed by incubation with substrate solution was used
to visualise the Ag/Ab/anti-Ig isotype complex.
In order to produce optimum antigen detection it was necessary to tailor
reaction conditions according to the immunoglobulin isotype under study.
Consequently a range of different serum concentrations was used. The details
of the particular dilutions of the serum and antisera used in the assay are
summarised in Table 4.1.
Table4.1Serandantiseradilutionssefothdetectionf.evansiantig s. Immunoglobulin (Ig)classRabbitserum dilution (Firstantibody)Goatanti-r bbit antiseradilu on (Secondantibo y) Anti-IgG(Fc), IgM(Fc)and IgA(Fc)

















The following controls were incorporated into every "Western" blotting
procedure used for the detection of antigens of T. evansi in this study.
(a) Any non-specific binding of the second and third antibodies to T.
evansi antigens was monitored by incubating of the separated T. evansi proteins
after transfer onto nitrocellulose paper directly with the affinity purified
antigen (2nd and 3rd antibodies) and substrate in the absence of any test or
normal rabbit serum.
(b) Any non-specific binding of the substrate solution to the product of T.
evansi soluble extract/rabbit serum reactions was monitored by the incubation
of the separated T. evansi proteins bound onto nitrocellulose with a pooled
post-infection rabbit serum sample and the substrate solution in the absence of
the second and third antibodies respectively.
(c) Any non-specific binding of the serum protein in rabbit serum to T.
evansi components was monitored by the incubation of the separated T. evansi
proteins after transfer onto nitrocellulose with normal rabbit serum collected
from uninfected animals, and then sequentially with the second, third
antibodies and the substrate solution.
RESULTS
Total Protein Profile of T. evansi soluble Extract
At least 30 individual protein components with molecular weights ranging
from 123,800 to about 13,600 daltons were identified in the supernate fraction
of the trypanosome lysate used as soluble antigens after separation on SDS-
PAGE and staining with Coomassie Brilliant Blue (Sigma Ltd.) (Figure 4.2).
FIGURE 4.2
Total protein profile of T. evansi soluble extract (supernate fraction of




Skin sections prepared from tissue collected 2 hours after ANTIGEN 4
was injected intradermally into T. evansi infected and Berenil treated
rabbit.
(A: shows clusters of polymorphonuclear leucocytes, H&Exl50;B:
shows blood vessel clogged with polymorphonuclear leucocytes and
erythrocytes predominantly with one to two mononuclear cells, H & E
x 1,500.
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T. evansi Antigens Identified by IgG Antibodies using Anti-IgG (Fc) as the
Second Antibody
IgG antibodies to T. evansi components were first detected in the serum
of rabbits seven days after infection. Although the number of antigen
components labelled differed between individual rabbits, IgG antibody to two
components with the molecular weight, 67,000 and 60,500 were usually
labelled first either individually or together by serum collected from most of
the rabbits. The 60,500 dalton component was usually labelled by serum
collected early in infection (Figure 4.3, Lane 2).
Serum collected during the course of infection recognised progressively
more trypanosome components, with the staining of individual bands becoming
more intense as the infection progressed. Between 7 and 10 days after
infection between 2 and 7 components were labelled, with serum from most
rabbits recognising components with the molecular weights of 67,000, 42,000
and 32,400. By 28 days after infection the number of trypanosome
components recognised increased to between 16 and 25 (Figure 4.3, Lane 8).
The molecular weights of the T. evansi components recognised by IgG
antibodies in the serum of rabbits during the period of primary infection
ranged from about 94,000 to 16,500 daltons. Of these components, eight
major polypeptides with molecular weights of 94,000, 85,000, 75,500, 67,000,
60,500, 43,000, 32,400 and 28,600 daltons respectively were identified by
serum collected from seven of the eight rabbits up to 28 days after infection
(Figure 4.3, Lanes 2 to 8). Of these eight major components, three
components with molecular weights of 94,000, 67,000 and 60,500 were
recognised by all eight rabbits at some time during the first 28 days of
infection.
FIGURE 4.3
T. evansi antigens identified by IgG antibodies using anti-IgG (Fc) as
the second antibody.
Number 1 T. evansi proteins probed with normal rabbit serum.
Numbers 2-8 T. evansi proteins probed with days 7, 10, 14, 17, 21,
24 and 28 post infection serum respectively.
Numbers 9-15 T. evansi protein probed with days 7, 14, 18, 21, 28,




The number of trypanosome components recognised by serum collected
after the rabbits were treated with Berenil differed between individual animals.
In general, more antigen components were identified by the IgG antibodies
after drug treatment (Figure 4.3, Lanes 9 to 15) than during the post-infection
period (Figure 4.3, Lanes 2 to 8).
Seven to 14 days after drug treatment there was an initial reduction in the
number of antigen components recognised by the IgG antibodies (Figure 4.3,
Lanes 9 and 10) when compared with the number of components recognised
I
by serum collected 28 days after infection (Figure 4.3, Lanes 4 to 8). Serum
collected seven days after drug treatment only recognised 10-12 components
(Figure 4.3, Lane 9), while that collected 28 days post-infection recognised
about 20 components (Figure 4.3, Lane 8) Thereafter, progressively more
antigen components were labelled by serum collected after drug treatment. By
18 days after drug treatment, most of the antigen components identified during
primary infection were again detected on the blot after drug treatment.
Antibodies to the 32,400 dalton component disappeared while antibodies to
three components of low molecular weights (25,400, 19,500 and 12,500) were
detected in large amounts (Figure 4.3, Lanes 11 to 15), antibodies to which
were not detected during the period of primary infection.
T. evansi Antigens Identified by IgM Antibodies using Anti-IgM (Fc) as the
Second Antibody
Fewer trypanosome components were identified as antigenic by IgM
antibodies in serum collected from all the animals during the post-infection
period than were identified by IgG antibodies during the equivalent period.
Differences, however, were seen between individual rabbits in the time taken
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for trypanosome-specific IgM antibodies to appear. Five out of the eight
rabbits recognised a single protein band 10 days after infection of either 60,500
or 67,000 daltons, while serum from three rabbits recognised the 67,000 dalton
band as early as seven days after infection. By 14 days after infection
however, all eight rabbits had produced IgM antibodies that recognised three
major trypanosome components of molecular weight 94,000, 67,000 and 60,500
(Figure 4.4, Lanes 4 and 5). At 21 days after infection there was a reduction
in both the number of antigenic components identified by the IgM antibodies
and in the intensity of labelling of individual components by serum from all the
rabbits (Figure 4.4, Lane 6).
Only one trypanosome components out of the three, recognised during the
period of primary infection (Figure 4.4, Lanes 2 to 8) was identified by serum
collected 7 days after treatment (Figure 4.4, Lanes 9 and 10) in all the rabbits.
Two of the three antigen components (94,000 and 67,000) recognised by IgM
antibodies during the primary infection period (Figure 4.4, Lanes 2 to 8) were
labelled by the serum collected during the post-treatment period (Figure 4.4,
Lanes 9 to 15). Serum from one rabbit, however recognised all the three
antigen components (94,000, 67,000 and 60,500) that had been detected
during the primary infection after drug treatment. Antigen components with
molecular weights of 30,000, 28,600 and 12,500 were recognised by post-
treatment IgM antibodies in addition to those recognised by serum collected
during the post-infection period in all the rabbits.
FIGURE 4.4
T. evansi antigens identified by IgM antibodies using anti-IgM (Fc) as
the second antibody.
Number 1 T. evansi proteins probed with normal rabbit serum.
Numbers 2-8 T. evansi proteins probed with days 7, 10, 14, 17, 21,
24 and 28 post infection serum respectively.
Numbers 9-15 T. evansi proteins probed with days 7, 14, 18, 21, 28,
33 and 39 post treatment serum respectively.
129
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T. evansi Antigens Identified by IgA Antibodies using Anti-IgA (Fc) as the
Second Antibody
The pattern of T. evansi antigens identified by the IgA antibodies in the
serum collected from the rabbits during the period of primary infection was
similar to that recognised by the IgM antibodies with respect to the molecular
weight range. Differences in the pattern of antigen recognition were however
seen between individual rabbits. IgA antibodies in serum collected from some
rabbits detected a single 67,000 dalton trypanosome component seven days
after infection while others did not recognise any component until 14 days
after infection. IgA from the majority of the eight rabbits however, recognised
one or more trypanosome component by 10 days after infection (Figure 4.5,
Lane 2). Unlike the IgM antibodies, the antigen components once identified
by IgA, remained so all throughout the period of primary infection.
The major difference between the IgA antibody profile of serum collected
post-infection and that collected post-treatment was the loss of antibodies to
60,500 trypanosome component in all the rabbits. Serum from all the rabbits
continued to recognise the 94,000 dalton antigen component while the 67,000
component tended to be faintly and inconsistently recognised during the
period. Two lower molecular weight components - 28,600 and 12,500 daltons
which were not recognised by the animals during the primary infection were
recognised by the IgA antibodies produced by the animals after drug treatment
(Figure 4.5, Lanes 9 to 15).
The pattern of the different immunoglobulin isotypes produced by the
animals and the extent of their recognition of selected T. evansi components
during the period of primary infection and after drug treatment are
summarised in Table 4.2.
FIGURE 4.5
T. evansi antigens identified by IgA antibodies using anti-IgA (Fc) as
the second antibody.
Number 1 T. evansi proteins probed with normal rabbit serum.
Numbers 2-8 T. evansi proteins probed with days 7, 10, 14, 17, 21,
24 and 28 post infection serum respectively.
Numbers 9-15 T. evansi proteins probed with days 7, 14, 18, 21, 28,
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Variations between Individual Rabbits with Respect to Antibody Production
to T. evansi Antigens
The eight rabbits included in the present study were divided into two
groups based on the number of antigenic components labelled by the three
immunoglobulin isotypes present in their serum during the course of infection,
and the time antibodies to the antigens first appeared.
One group of three rabbits recognised many trypanosome components as
antigens in particular the 67,000 and 60,500 components along with more than
20 other components ranging in molecular weight from 94,000 to about 19,500
daltons for antibodies of the IgG class. Antibodies belonging to IgM and IgA
classes also recognised the 67,000 and 60,500 components along with the
94,000 and 30,000 dalton components in addition to one or two other smaller
components with a molecular weight of less than 30,000 which were faintly
labelled. Furthermore, this group of rabbits recognised the antigen
components early, at 7 and 10 days after infection and antibody to these
components was maintained throughout the period of observation until the
infection was terminated by chemotherapy. Figure 4.6 represents a typical
series of blots from one of the rabbits in this group illustrating these points.
A second group of five rabbits recognised fewer trypanosome components
as antigens than the animals in the first group. Furthermore, they did not
always develop antibodies belonging to all three immunoglobulin classes
recognising the two components with a molecular weight of 67,000 and 60,500
daltons. Limited recognition of these two components was most pronounced in
the case of the IgM and IgA classes. IgG from the serum of the rabbits in this
group did not recognise more than eight antigen components in total at any
time during the period of observation. Fewer of the components also were
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recognised by the IgM and IgA antibodies produced by these animals than
were recognised by the animals in the first group. As well as failing to
recognise many antigen components early in infection, serum from this second
group lost the ability to recognise many of ithe trypanosome components as the
infection progressed. This loss of antigen recognition was common to the three
classes, IgG, IgM and IgA, of antibodies. Figure 4.7 represents a typical series
of blots from one of the rabbits in this group illustrating these points.
Clinical Signs in Animals Infected with T. evansi
Mean packed cell volume readings of 40.33%± 3 with a range of 37 to
42% were recorded before all the animals were infected. After infection, PCV
readings decreased progressively with increasing duration of infection with
readings from individual animals reaching a minimum value of 22% before
drug treatment. In three rabbits an increase in the PCV reading was observed
seven days after infection. Thereafter, the PCV value dropped and continued
to decrease until a mean pre-infection value was recorded just before and after
the infection was terminated by chemotherapy.
Parasites were first detected in the blood of these rabbits 10-14 days after
infection. Thereafter, parasite counts reduced until the infection was
eliminated with chemotherapy (Figure 4.8A, C and E). Although there was a
reduction in the body weight of all the animals between 7-10 days after
infection and thereafter, fluctuations in body weight in these three rabbits were
within a narrow range (Figure 4.8C). An increase in rectal temperature that
coincided with the appearance of parasites in blood observed in all the animals
was followed by fluctuations of rectal temperature readings within a
narrow range in each of these three rabbits (Figure 4.8E).
FIGURE 4.6
T. evansi antigens identified by IgG, IgM and IgA antibodies produced
by a resistant rabbit during the period of primary infection.
0 T. evansi proteins probed with normal rabbits serum.
1-7 T. evansi proteins probed with days 7, 10, 14, 17, 21, 24 and 28




T. evansi antigens identified by IgG, IgM and IgA antibodies produced
by a susceptible rabbit during the period of primary infections.
0 T. evansi proteins probed with normal rabbit serum.
1-7 T. evansi proteins probed with days 7, 10, 14, 17, 21, 24 and 28




Clinical signs in animals infected with T. evansi.
A Variations of packed cell volume (PCV) with parasitaemia in a
resistant rabbit.





Clinical signs in animals infected with T. evansi.
C Variations in change in body weight gain with parasitaemia in a
resistant rabbit.




Clinical signs in animals infected with T. evansi.
E Variations in rectal temperature reading with parasitaemia in a
resistant rabbit.






Five rabbits suffered severely from the effects of the infection showing
signs of difficult breathing, marked weight loss, clogging of the eyes and
nostrils by discharges and anorexia. These animals had a different PCV
pattern from those in the above group of three rabbits in that, there was a
progressive decrease in the PCV readings from day 7 after infection until about
day 24 post-infection when marked increases in PCV values, reaching up to
47% in some rabbits, were recorded (Figure 4.8B). Haematological
examination of Giemsa stained blood smears revealed the presence of few red
blood cells, many of which were macrocytic and hypochromatic in the blood
samples collected from these rabbits (Figure 4.9B) during the period the high
PCV values were recorded. This observation contrasted markedly with the
haematological picture of blood samples collected from these animals prior to
infection (Figure 4.9A) in which the red blood cells appeared normal and were
smaller in size with no immature cells present. During the same period, the
haematological examination of blood samples collected from the other three
rabbits not showing late high PCV values, did not reveal the presence of
immature red blood cells. They only showed the presence of fewer red blood
cells than were observed in the animals prior to infection. The erythrocytes in
the blood of these rabbits were also macrocytic and hypochromatic. Parasites
were detected in the blood of the five rabbits seven days after infection.
Thereafter, fulminating levels of parasitaemia were observed as the infection
progressed (Figure 4.8B, D and F).
After the initial reduction in body weight observed in all the rabbits after
infection, fluctuations in the body weight reading within a wider range (Figure
4.8D) than the other three rabbits were observed in this group of five rabbits.
Similarly the initial increase in the rectal temperature reading that coincided
with the appearance of parasites in the blood observed in all the animals was
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followed by fluctuations of the rectal temperature reading within a wider range
in these five rabbits (Figure 4.8F) than were observed for the other three
rabbits (Figure 4.8E).
FIGURE 4.9
Giemsa's stained thin blood smears from a susceptible rabbit.
A Blood smear prepared from a blood sample collected before the
rabbit was infected with T. evansi.
B Blood smear prepared from a blood sample collected during late
period of infection when haematological examination revealed





A high proportion of the protein components in the trypanosome were
shown to be antigenic with up to 24 of the 30 protein components being
recognised by host antibodies at some point during the infection. Previous
studies had clearly demonstrated that only two of the components - the 67,000
and 60,500 dalton components were associated with the surface of the
trypanosome (see Chapter 3 for details of surface component characterisation).
The other components are therefore, likely to be of non-surface origin and
represent the internal antigens of the trypanosome.
In all the rabbits the predominant antibody response, as defined by the
number of parasite components recognised and the intensity of staining of the
components was IgG in nature (Figure 4.3, Lanes 1 to 8). Next in magnitude
appeared to be IgM (Figure 4.4, Lanes 1 to 8) with the least response
attributable to IgA (Figure 4.5, Lanes 1 to 8). The predominance of the IgG
response is similar to that reported by Campbell et al. (1978), Nantulya et al.
(1979), Sacks and Askonas (1980) and Mansfield et al. (1981) for mice and
cattle infected with T. b. brucei or mice infected with T. b. rhodesiense using
radioimmunoassay (RIA) or fluorescent antibody staining method (IFA).
Results from the present studies differ however, from the findings of Seed et
al. (1969), Zahalsky and Weinberg (1976) who reported a predominantly IgM
response during the period of primary infection in rabbits infected with T. b.
gambiense and rats or cattle infected with T. b. brucei using an agglutination
assay.
It is possible that the conflicting results arise from the nature of the
antigen used and type of assay employed. Assays using the agglutination test
would be more likely to detect IgM principally rather than IgG due to the
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efficient agglutinating property of IgM in vitro (Seed, 1972; 1977; Takayangi
and Eriquez, 1973; Luckins, 1976; Musoke et al., 1981). The agglutinating
property of IgM is further enhanced with particulate antigens (Bowry, 1984) as
in the case of the whole trypanosomcs used as antigens in agglutination assays
in which predominant IgM levels were reported. In the case of RIA, IFA and
SDS-PAGE/WB equal opportunity should have been given for IgG and IgM to
bind, following detection using appropriate class specific serum. The
predominant IgM response recorded by the workers that used the agglutination
test may therefore, be a consequence of the assay system. Workers that
reported a predominantly IgG response, tended to use the antigens in a less
particulate form. It is possible that these techniques were relatively less
sensitive in detecting IgM (Osier, 1971) than the agglutination test or that the
higher affinity of IgG over that of IgM (Bowry, 1984) enhanced the efficiency
of its binding to the soluble agntigens used in these assays.
The increasing IgG activity observed with the increasing duration of
infection which heightened after drug treatment may be associated with the
release of the internal or common antigens of the parasites which are known to
elicit IgG production (De Raadt, 1974). More parasites would be destroyed by
VSG-specific antibodies as the infection progresses while chemotherapy would
bring about the destruction of many parasites.
Since the technique used for this assay highlights only antigen-antibody
specific responses, the results obtained in this study may indicate that more
trypanosome specific antibodies belong to the IgG class than IgM. This would
therefore be in agreement with the views of other workers who demonstrated
that most IgM produced in trypanosomiasis is probably non-trypanosome
specific (Hudson et al., 1976; Terry et al., 1980). Alternatively, the higher
- 143 -
concentration of IgG in the serum in addition to its higher affinity than those
of IgM may have favoured the binding of more IgG than IgM to the soluble
antigens of T. evansi such as were used in the present study because IgM
antibodies are known to bind better to particulate than soluble antigens (Bowry
1984).
The limited IgA responses observed in the rabbits in this study is in
keeping with the fact that IgA antibodies are classically considered to act
mainly outside the blood and are secreted at the external mucosal surfaces and
therefore, are unlikely to be involved extensively in the vascular phase of an
infection. IgA may, however, have a role to play in the response to
trypanosomiasis infection should the parasite intrude into extravascular
seromucous sites where IgA would have a role to play in the control of the
parasite (Nielsen et al., 1978). The ability of the brucei group of
trypanosomes to localise in a range of extravascular sites such as testis, ear and
under the skin etc. is well established (Losos and Ikede, 1970; Nagle et al.,
1980). Although no direct evidence for such localisation has been
demonstrated for T. evansi, it may likely have a role to play in the increased
IgA levels observed in rabbits in this study in late infections.
The greater number of antigen components detected after drug treatment
compared to the number identified before treatment is probably due to the
rapid destruction of the parasites by the drugs with consequential massive
release of parasite components, most of which would probably be of non-
surface in origin. The fact that IgM and IgA responses are largely restricted to
the surface components with most of the responses to the non-surface
components being predominantly IgG, probably indicates that different effector
mechanisms are involved in the handling of these individual components. The
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association of antibody to several low molecular weight components, 25,400,
19,500 and 12,500, (Table 4.2) with the post-drug treatment period suggests
that different antigens are released following parasite destruction by the drug
compared to the immune system probably suggesting different mechanisms of
parasite destruction. The loss of antibodies to the 32,400 dalton component
after drug treatment (Table 4.2) which happened in all the animals suggests
that this component could be used as an antigen in immunoassays such as
ELISA (Voller, 1977) for the diagnosis of active T. evansi infections, thereby
overcoming the problem of distinguishing between persistent antibodies due to
an ongoing infection particularly in cases of very low parasitaemia, and
antibodies persisting after the infection had been eliminated by chemotherapy.
The presence of antibodies to the two surface components of T. evansi
throughout the period of observation probably has important implications for
both host and parasite as specific VSG- antibody production is considered to be
important for the elimination of trypanosomes and protection against
reinfections by homologous trypanosome populations (Wellde et al., 1975,
1981; Emery et al., 1980; Hall and Esser, 1984). Such antibody persistence
might be due to the fact that the antibodies remained in circulation for the
length of time of observation after they had been produced or that there was a
continuous source of antigenic stimulus that maintained their production. The
possible elimination of the effect of immunoglobulin-secreting prohibitive
factor on antigen primed B cells due to the effect of some trypanosomes factors
by chemotherapy (Black et al.K) may have contributed in part to the
maintenance of antibody levels after the elimination of the parasites by
chemotherapy in this study as was suggested by Shapiro (1986).
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Evaluation of the range of clinical signs shown by the animals infected
with T. evansi during this study divided the animals into two groups. One
group showed little change in PCV, low parasitaemia and no marked loss of
body weight (Figure 4.8A, C and E) and were considered to be resistant to the
T. evansi infection. The other group showed marked changes in PCV, high
parasitaemia and a marked loss of body weight (Figure 4.8B, D and F) and
were classed as susceptible. Similar criteria have been used by other authors to
distinguish between cattle that were resistant from those that were susceptible
to trypanosome infection (Roelants et al., 1983).
A comparison of the nature and magnitude of the immune response of the
animals classed as either resistant or susceptible on the basis of clinical signs
revealed that those classed as resistant tended to produce antibodies to many
trypanosome components, antibodies appeared early in infection and persisted
throughout the course of the infection (Figure 4.6). Animals classed as
susceptible produced antibodies to fewer trypanosome components, the
antibodies were detected later in infection and were not maintained throughout
the course of infection (Figure 4.7). This association, between antibody
production and outcome of infection suggests that the immune system may
therefore, have a role to play in determining the way in which individual
animals respond to a T. evansi infection. The fact that the response of the
immune system is under genetic control and that differences were observed
between the immune response of individual animals to T. evansi in this study,
suggests that the response of animals to T. evansi may be dependent on their
genetic make-up. Such observation having been reported in the cases of
trypanotolerance in cattle which is influenced by inheritance (Roclants, 1986).
This suggests that it might be possible to produce T. evansi-resistant breeds of
animals as has been suggested for other trypanosomes species (Roelants, 1936)
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whether some factors operate for T. evansi as in tsetse transmitted
trypanosomes is not known.
Results from the present study have indicated that an early and sustained
antibody response to T. evansi infection is probably more capable of controlling
the parasitaemia than a delayed and limited antibody response. This
observation is similar to that made by Pinder et al. (1987) who recorded a
high degree of correlation between the resistance of mice to infection with T.
congolense and early antibody response to the epitopes exposed on live
trypanosomes. These authors suggested that an early antibody response
appeared to be the most important criterion for trypanosome population
control and that when the antibody response is delayed trypanosome growth
overwhelms the defence mechanisms of the host bringing about the death of
the animal. Black et al. (1986) in their study with T. brucei also found that
the resistant mice produced more antibodies than the susceptible mice. A
similar association between the magnitude of the immune response and
resistance to infection has also been reported with other parasites, such as
helminths. Almond and Parkhouse (1986) found that the sera from mice
resistant to Trichinella spiralis infection recognised far more parasite antigens
than the susceptible ones. There is therefore mounting evidence that the
ability of the resistant animals to secrete effective antibodies early in infection
was an important factor to their resistance.
The association seen between resistance and response in the present study
was not just limited to the surface components. The greatest differences
between the resistant and susceptible animals were seen in their response to the
non-surface components. The number of the non-surface components
recognised by all three Ig classes, IgG, IgM and IgA in the sera of the
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resistant animals (Figure 4.6) were greater in number and more intensely
stained than those identified by the sera of the susceptible animals (Figure
4.7). This result suggests that the involvement of the immune response of the
host to the non-surface components may be important in deciding the outcome
of a trypanosome infection. This observation clearly shows that the destruction
of the live trypanosomes via VSG-specific antibody might not be the only
factor important in the survival of the animal. Of equal importance might be
the way that the immune system deals with the products that arise from the








An outstanding property of trypanosomes is their ability to produce a
large range of antigenically distinct parasite populations during the course of an
infection, a process referred to as antigenic variation (Soltys, 1963). The
effect of this is that at any one time during an infection, the trypanosome in
the blood can consist of several different antigenic types. In nature therefore,
it is likely that animals will be exposed to challenge with a range of
antigenically distinct trypanosomes populations. Furthermore, in areas of
Africa, where several species of trypanosomes are endemic, the picture would
be complicated by the fact that at any one time an animal could be infected by
more than one species of trypanosome.
The surface component of trypanosomes is highly immunogenic and it is
well established that immunity to reinfection can easily be produced in a
number of ways, such as by short-term infection followed by cure using T.
congolense (Browning and Calver, 1943; Fulton and Lourie, 1946;
Wiesenhutter, 1970) or T. brucei (Browning and Gulbransen, 1936). Other
methods of inducing immunity include the injection of irradiated parasites, as
in the case of T. rhodesiense, T. equiperdum and T. equinum into animals
(Fulton and Lourie, 1946). In all cases, however, immunity was found to be
strictly confined to reinoculations with homologous trypanosomes. This
homologous type of protection was attributed to the specificity of the host
antibodies to the particular infecting trypanosome population (Wellde et al.,
1975; Herbert and Wilkinson, 1977; Emery et al., 1980; Nantulya et al.,
1980b; Wellde et al., 1981; Morrison et al., 1982; Hall and Esser, 1984).
Attempts to induce protective immunity experimentally in animals against
an heterologous variable antigen type (VAT) challenge has been achieved by
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exposing animals to infection with T. evansi and eliminating the infection after
an extended period of time by chemotherapy. This type of immunisation
process relies on maintaining the infection in the animals long enough to
produce antibodies to most of the predominant VATs (pVATs) that the
animal might be expected to be exposed to (T.W. Jones, personal
communication). Such protective immunity is, however, limited to challenge
with the pVATs that the animals had been exposed to. Animals exposed to
other VAT populations succumb to the infection in the same way as animals
immunized against a single VAT and then challenged with heterologous
antigens (extensively reviewed in Roelants and Williams, 1982; Morrison et al.,
1982a).
Despite the range of antigenic types of trypanosomes circulating in nature
and the extreme specificity of the host response, animals continue to survive in
trypanosome endemic areas in the absence of external control measures such as
chemotherapy. One factor that could account for the ability of the animals to
thrive in the presence of high trypanosome challenge in the absence of
chemotherapy is the tendency for stocks of trypanosomes to produce
predominant VATs early in infection. In the case of tsetse transmitted
trypanosomes this is further reinforced by the fact that the antigenic repertoire
of metacyclic trypanosomes is limited and the existence of stock specific basic
antigen types. In the case of non-tsetse-transmitted trypanosomes, although
there is no basic antigen because of the lack of metacyclics, the method of
pVAT development is as in tsetse-transmitted trypanosomes early in infection.
Continuous exposure to basic and predominant VATs probably continues in an
endemic area until most animals have produced antibodies against the range of
pVATs circulating in the area. This host antibody spectrum could place a
restriction on the range of VATs that can be expressed by a trypanosome
- 151 -
stock, making it possible for an animal to develop immunity to all the pVATs
in the VAT repertoire. However, if the animal is exposed to a pVAT that is
outside the range of VATs it had experienced previously then infection would
result.
Should the ability of animals to control infections with trypanosomes be
based solely on the production of VAT-specific antibodies (Herbert and
Wilkinson, 1977; Hall and Esser, 1984) then it would be difficult to reconcile
this with the absence of massive trypanosome epidemics resulting in high
mortalities in many endemic areas where animals are probably exposed to a
multiplicity of variant antigenic types at any one time. This paradox probably
suggests that other factors could play a role in protecting animals against
disease in the field, particularly in the endemic areas with high Glossina
challenge in the absence of chemotherapy (Roelants, 1986).
Results presented in Chapter 4 on the immune response of rabbits to
primary T. evansi infections demonstrated clearly that animals produce
antibodies against both the surface and non-surface components of the parasite,
with up to 20 non-surface components identified by antibody in the serum
collected from animals during the first four weeks of infection. Furthermore,
there appeared to be an association between such antigen recognition and
susceptibility to infection, with resistant animals recognising more of the
surface and non-surface antigenic components than did susceptible animals.
This result implies that the response to non-surface protein components could
play a role in influencing the course of infection and development of disease.
The fact that some of these non-surface components are probably common not
only to different stocks but also to different species of trypanosomes (Roelants
and Finder, 1984), suggests that the response to these components could play a
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role in protecting animals from infection with different stocks or species of
trypanosomes.
Several workers have considered the possibility that responses to the non-
surface components could play a role in the protection of animals exposed to
trypanosomes. This was mentioned in the review by Roelants and Pinder
(1984) who concluded that past emphasis on the studies of VSG-specific
antibodies produced in trypanosomiasis might have been to the detriment of
identifying a possible role for the non-surface components in the protection of
animals against infection. These authors however, did express some
uncertainty as to the way in which such components could be involved in the
development of immunity. They concluded, however, that the response
probably arises following the destruction of the intact organism by VSG-
specific antibodies.
The aim of the studies reported in this Chapter is to evaluate the role of
antibodies produced against the individual antigen components of a stock of T.




T. evansi: T. evansi TREU 2113 described in Chapter 2 was the
trypanosome stock used for all the primary infections and reinfection in the
homologous T. evansi system.
T brucei: The stock of T. brucei (TREU 2049) was obtained after the
initial stock EATRO 1595 acquired from Kenya was passaged once through
mice. The morphology of the parasites was identical to the morphological
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details of T. brucei listed by Hoare (1972).
T. vivax TREU: A stabilate population, TREU E08, of a rat adapted
Wellcome strain of T. vivax was used for the production of a further stabilate,
TREU 2130, after the original parasites were passaged four times through rats.
The morphology of the parasites was similar to the morphological details of T.
vivax listed in Hoare (1972).
T. congolense: The original stock, a stabilate population - ILRAD 1180,
acquired from ILRAD, Kenya from Glossina morsitans was passaged once
through mice to produce a further stabilate - TREU 1880 which was then
grown in mice before being used to infect rabbits. The parasites showed all
the morphological characteristics of T. congolense (Hoare, 1972).
T. evansi: The stock of T. evansi (TREU 1834) used for the heterologous
challenges in this work has been described previously in Chapter 3.
Experimental Animals
Ten adult female New Zealand White rabbits were infected with 4 x 10~*
motile trypanosomes of TREU 2113, from mice with fulminating infections.
Trypanosomes were resuspended in 0.5 ml aliquots of ice-cold PSG (Appendix
2) and injected into the rabbits through the ear vein. Twenty-one days after
infection rabbits were treated with a single intramuscular (i/m) injection of 7
mg/kg" body weight (active principle) of diaminazene aceturate, Berenil^
(Hoechst, West Germany). Thirty days after Berenil^ treatment pairs of
rabbits were challenged with 4 x 10^ motile trypanosomes of each trypanosome
population, T. evansi TREU 2113, 1834, T. brucei TREU 2049, T. vivax
TREU 2130 or T. congolense TREU 1880 grown in mice.
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All animals were bled before the primary infection with T. evansi TREU
2113 (day 0) and on days 7, 10, 14, 17 and 21 after infection. Blood samples
were also collected from the animals 7 and 14 days post-drug treatment and
again on days 7, 10, 14, 17, 21 28 and 30 after challenge.
Two types of blood samples were collected on each occasion.
(a) Blood samples collected in bottles with EDTA (Sigma Ltd.) used for
the estimation of parasitaemia by darkground/phase contrast buffy coat scoring
system (Paris et al., 1982), and packed cell volume (PCV %) estimation by the
microhaematocrit technique (Schalm, 1975). Blood samples negative for
trypanosomes by the darkground/phase contrast buffy coat scoring system
(Paris et al., 1982) were subsequently inoculated into mice. These mice were
subsequently examined daily for trypanosomes for at least 30 days by
examination of wet film prepared from the tail blood.
(b) Blood samples collected in bottles without anticoagulant were used for
the preparation of serum, according to the method described previously in
Chapter 2.
Soluble Antigens of Trypanosome Populations
Soluble antigens of each trypanosome population were prepared by
freezing and thawing using the final protocol described in Chapter 2.
Antibody Responses to Infection and Challenge
The immunoglobulin isotype response of the animals to the particular
trypanosome population were assessed using SDS-PAGE with 90 |xg
sample/well of the appropriate soluble trypanosome antigen followed by
blotting of the separated components onto nitrocellulose membrane. After the
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reacting of the transferred proteins with appropriate rabbit sera, the activity of
the individual immunoglobulin isotypes, IgG, IgM and IgA were probed for
with the appropriate immunoglobulin heavy chain (Fc) specific antisera
(Nordic^") as described in Chapter 4.
Soluble antigen preparation of T. evansi TREU 2113 was tested against
serum samples collected from all the 10 rabbits, 0, 7, 14, 17 and 21 days after
infection, 7 and 14 days after drug treatment and 7, 14, 17 and 30 days after
challenge.
Soluble antigen preparation from the other trypanosome populations were
tested against serum samples collected from each of the 10 rabbits 14 days after
infection with T. evansi TREU 2113, 14 days after drug treatment and 21 days
after rechallenge with the respective trypanosome population used as antigen.
Ten adult female New Zealand White rabbits were infected in pairs with 4
x 10^ motile parasites of each of the trypanosome populations used in the study
in order to establish the normal prepatent periods of these parasites in the
absence of any priming with T. evansi stock (TREU 2113) used for all the
primary infections.
RESULTS
Parasitaemia Profiles during Primary Infection with T. evansi TREU 2113
Trypanosomes were first detected in the blood of nine of the 10 rabbits
seven days after infection with T. evansi TREU 2113. In the remaining rabbit,
parasites were not detected until 10 days after infection (Figure 5.IE).
Thereafter, fluctuations in levels of parasitaemia were observed in all the
rabbits until day 21 post-infection when they were treated with Berenil^
(Hoechst, West Germany) (Figure 5.1A to E). Up to 30 days after treatment
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no parasites were seen in the blood of 10 of the rabbits used. Two of the
original rabbits included in the study relapsed during this time and were not
used for the challenge studies.
Parasitaemia during challenge period: Differences were seen in both the
prepatent period and pattern of parasitaemia in the animals after the challenge
period when compared to the control animals and were linked to the
trypanosome population used for challenge. The only rabbits in which
trypanosomes were not detected after challenge were those reinfected with the
homologous stock, TREU 2113. Trypanosomes were not detected in the blood
of the infected rabbits after drug treatment and up to 30 days after challenge
(Figure 5.1A), while trypanosomes appeared in the blood of naive animals
infected with TREU 2113, 7 days after infection. In the case of heterologous
T. evansi challenge (TREU 1834) parasites were first seen on day 21 after
rechallenge in both rabbits compared to 7 days after infection in the naive
animals. A slight increase over the initial level of parasitaemia recorded 21
days after reinfection was seen in both rabbits by the last parasitaemia
estimation at 30 days after reinfection (Figure 5.IB).
Trypanosomes were detected in the blood samples collected from both
rabbits challenged with T. brucei TREU 2049 for the first time 17 days after
rechallenge compared to 7 days after infection with the same population in
naive rabbits. Blood parasite counts remained stable in one infection/cure
rabbit up to day 21 post-challenge after which parasites were not detected
again by buffy coat microscopal examination or mouse inoculation for the
remainder of the observation period (Figure 5.1C). In the case of the second
infection/cure rabbit, after the initial appearance of trypanosomes on day 17
after challenge, parasites were not detected in the blood of the rabbit up to the
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point when the last blood examination was conducted at 30 days after
challenge (Figure 5.1C).
Parasites were detected for the first time in the blood of one of the rabbits
challenged with T. vivax seven days after challenge. Thereafter, increases in
the level of parasitaemia with a slight fluctuation were observed throughout the
rest of the period of observation (Figure 5.ID). Parasites appeared in the
blood of the second rabbit for the first time 10 days after reinfection. This
was followed by a fall in the level of parasitaemia starting from 14 days after
reinfection. From 28 days after reinfection, an increase was seen in the level
of parasitaemia which was maintained for the rest of the period (Figure 5.ID).
Parasites appeared in the blood of naive rabbits infected with this stock of T.
vivax 10 to 11 days after infection.
Trypanosomes were detected in the blood samples of the two rabbits
challenged with T. congolense for the first time on day 10 after reinfection
compared to 11 to 12 days in naive rabbits. After this period fluctuations in
parasitaemia were recorded with higher parasite counts obtained from one
rabbit until day 30 post-infection (Figure 5.IE).
Antibody Responses to TREU 2113 during the Primary Infection Period
Reaction with TREU 2113 as soluble antigen: All the rabbits produced
antibodies belonging to each of the three classes of immunoglobulins, IgG, IgM
and IgA, to a range of components of 71 evansi TREU 2113 during the period
of primary infection. IgG activity was predominant in that antibody belonging
to this class recognised more components (Figure 5.2A, 3A, 4A, 5A and 6A,
Nos. 2 to 5) than did those belonging to the IgM class (Figure 5.2B, 3B, 4B,
5B and 6B, Nos. 2 to 5). Antibodies belonging to IgA class recognised the
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least number of components (Figure 5.2C, 3C, 4C, 5C and 6C, Nos. 2 to 5).
Reactions with TREU 1834, TREU 2049, TREU 2130 and TREU 1880
as soluble antigens: Differences were seen in the number of components of
each trypanosome population recognised as antigen by the serum collected 14
days after infection with T. evansi TREU 2113.
In the case of the heterologous T. evansi population (TREU 1834) two
antigenic components with molecular weights of 67,000 and 41,800 daltons
were recognised by the IgG antibodies in the 14 day serum (Figure 5.3A, No.
12). None of the proteins of TREU 1834 were, however, recognised as
antigens by antibodies belonging to either the IgM (Figure 5.3B, No. 12) or
IgA class (Figure 5.3C, No. 12) of immunoglobulin. The soluble antigen
preparation of T. brucei (TREU 2049) contained at least 30 clearly
recognisable antigenic components with molecular weights between 125,000
and 20,000 daltons which reacted with the IgG antibodies in the 14 day serum
(Figure 5.4A, No. 13). Between four and five of the T. brucei components
were recognised as antigens by antibodies belonging to the IgM and IgA class
of immunoglobulins (Figure 5.4B and 4C, No. 13). The IgG from the 14 day
serum recognised two T. vivax components but only faintly (Figure 5.5A, No.
13). IgM from the same serum recognised one of these components (Figure
5.5B, No. 13) while IgA in addition to recognising the two components
identified by IgG, recognised three other components, bringing the number of
T. vivax components recognised by IgA antibodies to five in total (Figure 5.5C,
No. 13). None of the T. congolense components were recognised as antigens
by either the IgG (Figure 5.6A, No. 13), IgM (Figure 5.6B, No. 12) or IgA
(Figure 5.6C, No. 13) antibodies in the serum collected 14 days after infection
with TREU 2113.
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Antibody Response during the Post-drug Treatment Period
Reactions with T. evansi TREU 2113 soluble antigens: Antibodies
belonging to the three immunoglobulin classes in the serum collected from
animals after drug treatment reacted with soluble antigens of T. evansi TREU
2113. More antigenic components of T. evansi were recognised during the
post-treatment period than were recognised during the post-infection period.
IgG antibody activity predominated in that this class of antibody identified
more T. evansi components (Figure 5.2A, 3A, 4A, 5A and 6A, Nos. 6 and 7)
than IgM (Figure 5.2B, 3B, 4B, 5B and 6B, Nos. 6 and 7) or IgA which
recognised the least number of components (Figure 5.2C, 3C, 4C, 5C and 6C,
Nos. 6 and 7).
Reactions with soluble antigens of TREU 1834: Four antigenic
components of T. evansi TREU 1834, which were additional to the two 67,000d
and 4l,800dcomponents, recognised by serum collected from the animals
during the post-infection period with T. evansi TREU 2113, were recognised
by serum collected from the two animals 14 days after drug treatment. One of
the new components had a molecular weight of 78,000 daltons, while the
remaining three components had molecular weights ranging from 36,000 to
48,000 daltons (Figure 5.3A, No. 13). None of the components of T. evansi
TREU 1834 were recognised by the IgM (Figure 5.3B, No. 13) or IgA (Figure
5.3C, No. 13) antibodies in the serum collected from the animals 14 days after
drug treatment.
The T. brucei components recognised as antigens by IgG antibodies in
serum collected from the rabbits 14 days after drug treatment (Figure 5.4A,
No. 14) were similar in molecular weight range with those recognised by IgG
antibodies in serum collected 14 days after infection with TREU 2113 (Figure
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5.4A, No. 13), apart from the fact that components with molecular weight less
than 31,000 daltons were more faintly stained by serum collected after drug
treatment than that collected during the post-infection period. Fewer T. brucei
components were recognised as antigens by IgM antibodies in serum collected
from the rabbits after drug treatment (Figure 5.4B, No. 14) than were
recognised by IgM in serum collected after infection with T. evansi TREU
2113 (Figure 5.4B, No. 13). More T. brucei components were recognised as
antigens by IgA in 14 day post-treatment serum (Figure 5.4C, No. 14) than
were identified by IgA antibodies in serum collected 14 days after infection
with T. evansi TREU 2113 (Figure 5.4C, No. 14). More T. vivax components
were recognised as antigenic by IgG (Figure 5.5A, No. 14), IgM (Figure 5.5B,
No. 14) and IgA (Figure 5.5C, No. 14) antibodies respectively in the sera
collected from the rabbits 14 days after drug treatment in comparison with the
number of T. vivax components identified as antigenic by the three antibody
classes in the serum collected from the rabbits 14 days after infection with T.
evansi TREU 2113 (Figures 5.5A, B and C, No. 13). A group of two to three
T. congolense components with molecular weights above 94,000 daltons were
recognised by IgG (Figure 5.6A, No. 14) and none by IgM (Figure 5.6B, No.
14) and IgA (Figure 5.6C, No. 14) antibodies present in the serum collected
14 days after drug treatment.
Antibody Response during the Challenge Period
Response to challenge with T. evansi TREU 2113: Serum samples
collected from rabbits after challenge with T. evansi TREU 2113 recognised
more components of T. evansi TREU 2113 than any of the serum samples
collected after primary infection with TREU 2113 or after Berenil treatment.
IgG antibody activity (Figure 5.2A, No. 8 to 11) was highest during challenge
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as judged by the number of T. evansi antigen components recognised and their
intensity of labelling. Next to this was the number of components recognised
by IgM (Figure 5.2B, Nos. 8 to 11) and lastly IgA (Figure 5.2C, Nos. 8 to 11)
antibodies in serum samples collected 21 days after challenge with T. evansi
TREU 2113. The IgG antibodies, apart from recognising two T. evansi
TREU 2113 components, with molecular weights - 67,000 and 60,500 daltons,
more intensely during the challenge period than after primary infection and
drug treatment, also recognised several additional components within the
molecular weight range of 43,000 and 12,500 daltons (Figure 5.2A, Nos. 8 to
11) that were not recognised by any serum sample collected before challenge
(Figure 5.2A, Nos. 1 to 7). IgM antibodies in the serum samples collected
from animals after challenge with T.. evansi TREU 2113 recognised two
components with molecular weight of 85,000 and 75,500 daltons and some
other components with molecular weights around 30,000 daltons (Figure 5.2B,
Nos. 8 to 11) that were not recognised before the challenge (Figure 5.2B, Nos.
1 to 7). No new components were recognised by IgA antibodies in the serum
collected after challenge while antibodies to the 60,500 dalton component
identified during primary infection (Figure 5.2C, Nos. 1 to 4) were absent in
the serum samples collected after challenge (Figure 5.2C, Nos. 8 to 11).
Response to heterologous challenge: Serum collected from animals 21
days after challenge with T. evansi 1834 were tested against separated proteins
of TREU 1834 to find out the antibodies whose production was induced by the
reinfections. The IgG in the serum recognised about seven components of the
trypanosome (Figure 5.3A, No. 14). One component with a molecular weight
of 67,000, and a group of low molecular weight components with a molecular
weight of around 30,000 daltons were common to both T. evansi TREU 2113
and 1834. None of the components of TREU 1834 were recognised by IgM
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(Figure 5.3B, No. 14) or IgA (Figure 5.3C, No. 14) antibodies in the scrum
collected 21 days after challenge.
The pattern of antigen recognition in rabbits challenged with T. brucei
(Figure 5.4A, 4B and 4C, No. 15) and T. vivax (Figure 5.5A, 5B and 5C, No.
15) was similar to those observed in animals reinfected with TREU 1834 in
that increasing numbers of the components of the challenge trypanosome stock
were identified by serum samples collected from animals 21 days after
rechallenge. In all cases, the 67,000 dalton component and a group of lower
molecular weight components around 30,000 and 43,000 daltons were common
to the T. evansi TREU 2113 stock used for the initial infection and the
rechallenge trypanosome species. IgG activity expressed in terms of the
number of components identified and the degree of labelling was, however,
greater than that of IgM with IgA activity least during the rechallenge period.
Of the five components of TREU 1834 faintly recognised by the IgG
antibodies collected from the rabbits 21 days after reinfection with TREU 1834
only a few components with molecular weights from 94,000 daltons and above
appeared to be common between TREU 2113 and T. congolense. No
components of T. congolense were recognised by IgM (Figure 5.6B, No. 14) or
IgA (Figure 5.6C, No. 14) in sera collected from the rabbits during the post-
challenge period.
FIGURE 5.1
Parasitaemia in rabbits during primary infection with T. evansi and
challenge with different stocks and species of trypanosomes.
A Rabbits infected with T. evansi TREU 2113 and challenged with
the same stock.
B Rabbits infected with T. evansi TREU 2113 and challenged with
T. evansi TREU 1834.
C Rabbits infected with T. evansi TREU 2113 and challenged with
T. brucei.
D Rabbits infected with T. evansi TREU 2113 and challenged with
T. viva:c.







T. evansi TREU 2113 antigens identified by IgG antibodies produced
by a rabbit during the period of primary infection, after drug treat¬
ment and rechallenge with the same stock.
Number 1 Proteins of T. evansi TREU 2113 probed with normal
rabbit serum.
Numbers 2-5 Proteins of T. evansi TREU 2113 probed with days 7,
14, 17 and 21 post infection serum respectively.
Numbers 6-7 Proteins of T. evansi TREU 2113 probed with serum
samples collected on days 7 and 14 post drug treat¬
ment respectively.
Numbers 8-11 Proteins of T. evansi TREU 2113 probed with serum
samples collected on days 7, 14, 17 and 30 after
rechallenge with the same stock.
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FIGURE 5.2B
T. evansi TREU 2113 antigens identified by IgM antibodies produced
by a rabbit during the period of primary infection, after drug treat¬
ment and rechallenge with the same stock.
Number 1 Proteins of T. evansi TREU 2113 probed with normal
rabbit serum.
Numbers 2-5 Proteins of T. evansi TREU 2113 probed with days 7,
14, 17 and 21 post infection serum respectively.
Numbers 6-7 Proteins of T. evansi TREU 2113 probed with serum
samples collected on days 7 and 14 post drug treat¬
ment respectively.
Numbers 8-11 Proteins of T. evansi TREU 2113 probed with serum
samples collected on days 7, 14, 17 and 30 after








T. evansi TREU 2113 antigens identified by IgA antibodies produced
by a rabbit during the period of primary infection, after drug treat¬
ment and rechallenge with the same stock.
Number 1 Proteins of T. evansi TREU 2113 probed with normal
rabbit serum.
Numbers 2-5 Proteins of T. evansi TREU 2113 probed with days 7,
14, 17 and 21 post infection serum respectively.
Numbers 6-7 Proteins of T. evansi TREU 2113 probed with serum
samples collected on days 7 and 14 post-drug treat¬
ment respectively.
Numbers 8-11 Proteins of T. evansi TREU 2113 probed with serum
samples collected on days 7, 14, 17 and 30 after









Antigens of T. evansi TREU 2113 and 1834 identified by IgG antibo¬
dies produced by a rabbit during the periods of primary infection with
TREU 2113, after drug treatment and challenge with TREU 1834.
Number 1 Proteins of T. evansi TREU 2113 probed with normal
rabbit serum.
Numbers 2-5 Proteins of T. evansi TREU 2113 probed with days 7,
14, 17 and 21 post infection serum respectively.
Numbers 6-7 Proteins of T. evansi TREU 2113 probed with serum
samples collected on days 7 and 14 post drug treat¬
ment respectively.
Numbers 8-11 Proteins of T. evansi TREU 2113 probed with serum
samples collected on days 7, 14, 17 and 30 after chal¬
lenge with T. evansi TREU 1834.
Number 12 Proteins of T. evansi TREU 1834 probed with serum




Proteins of T. evansi TREU 1834 probed with serum
collected 14 days after drug treatment.
Proteins of T. evansi TREU 1834 probed with serum
collected 21 days after challenge with the same stock.
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FIGURE 5.3B
Antigens of T. evansi TREU 2113 and 1834 identified by IgM antibo¬
dies produced by a rabbit during the periods of primary infection with
TREU 2113, after drug treatment and challenge with TREU 1834.
Number 1 Proteins of T. evansi TREU 2113 probed with normal
rabbit serum.
Numbers 2-5 Proteins of T. evansi TREU 2113 probed with days 7,
14, 17 and 21 post infection serum respectively.
Numbers 6-7 Proteins of T. evansi TREU 2113 probed with serum
samples collected on days 7 and 14 post drug treat¬
ment respectively.
Numbers 8-11 Proteins of T. evansi TREU 2113 probed with serum
samples collected on days 7, 14, 17 and 30 after chal¬
lenge with T. evansi TREU 1834.
Number 12 Proteins of T. evansi TREU 1834 probed with serum




Proteins of T. evansi TREU 1834 probed with serum
collected 14 days after drug treatment.
Proteins of T. evansi TREU 1834 probed with serum
collected 21 days after challenge with the same stock.
168
FIGURE 5.3C
Antigens of T. evansi TREU 2113 and TREU 1834 identified by IgA
antibodies produced by a rabbit during the periods of primary infec¬
tion with TREU 2113, after drug treatment and challenge with TREU
1834.
Number 1 Proteins of T. evansi TREU 2113 probed with normal
rabbit serum.
Numbers 2-5 Proteins of T. evansi TREU 2113 probed with days 7,
14, 17 and 21 post infection serum respectively.
Numbers 6-7 Proteins of T. evansi TREU 2113 probed with serum
samples collected on days 7 and 14 post drug treat¬
ment respectively.
Numbers 8-11 Proteins of T. evansi TREU 2113 probed with serum
samples collected on days 7, 14, 17 and 30 after chal¬
lenge with T. evansi TREU 1834.
Number 12 Proteins of T. evansi TREU 1834 probed with serum




Proteins of T. evansi TREU 1834 probed with serum
collected 14 days after drug treatment.
Proteins of T. evansi TREU 1834 probed with serum







Antigens of T. evansi TREU 2113 and T. brucei identified by IgG
antibodies produced by a rabbit during the periods of primary infec¬
tion with TREU 2113, after drug treatment and challenge with T. bru¬
cei.
Number 1 Proteins of T. evansi TREU 2113 probed with normal
rabbit serum.
Numbers 2-5 Proteins of T. evansi TREU 2113 probed with days 7,
14, 17 and 21 post infection serum respectively.
Numbers 6-7 Proteins of T. evansi TREU 2113 probed with serum
samples collected on days 7 and 14 post drug treat¬
ment respectively.
Numbers 8-12 Proteins of T. evansi TREU 2113 probed with serum
samples collected on days 7, 14, 17, 21 and 30 after
challenge with T. brucei.
Number 13 Proteins of T. brucei probed with serum collected 14
days after infection with T. evansi TREU 2113.
Number 14 Proteins of T. brucei probed with serum collected 14
days after drug treatment.
Number 15 Proteins of T. brucei probed with serum collected 21
days after challenge with the same stock.
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FIGURE 5.4B
Antigens of T. evansi TREU 2113 and T. brucei identified by IgM
antibodies produced by a rabbit during the periods of primary infec¬
tion with TREU 2113, after drug treatment and challenge with T. bru¬
cei.
Number 1 Proteins of T. evansi TREU 2113 probed with normal
rabbit serum.
Numbers 2-5 Proteins of T. evansi TREU 2113 probed with days 7,
14, 17 and 21 post infection serum respectively.
Numbers 6-7 Proteins of T. evansi TREU 2113 probed with serum
samples collected on days 7 and 14 post drug treat¬
ment respectively.
Numbers 8-12 Proteins of T. evansi TREU 2113 probed with serum
samples collected on days 7, 14, 17, 21 and 30 after
challenge with T. brucei.
Number 13 Proteins of T. brucei probed with serum collected 14
days after infection with T. evansi TREU 2113.
Number 14 Proteins of T. brucei probed with serum collected 14
days after drug treatment.
Number 15 Proteins of T. brucei probed with serum collected 21
days after challenge with the same stock.
 
FIGURE 5.4C
Antigens of T. evansi TREU 2113 and T. brucei identified by IgA
antibodies produced by a rabbit during the period of primary infection
with TREU 2113, after drug treatment and challenge with T. brucei.
Number 1 Proteins of T. evansi TREU 2113 probed with normal
rabbit serum.
Numbers 2-5 Proteins of T. evansi TREU 2113 probed with days 7,
14, 17 and 21 post-infection serum respectively.
Numbers 6-7 Proteins of T. evansi TREU 2113 probed with serum
samples collected on days 7 and 14 post drug treat¬
ment respectively.
Numbers 8-12 Proteins of T. evansi TREU 2113 probed with serum
samples collected on days 7, 14, 17, 21 and 30 after
challenge with T. brucei.
Number 13 Proteins of T. brucei probed with serum collected 14
days after infection with T. evansi TREU 2113.
Number 14 Proteins of T. brucei probed with serum collected 14
days after drug treatment.
Number 15 Proteins of T. brucei probed with serum collected 21
days after challenge with the same stock.
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FIGURE 5.5A
Antigens of T. evansi TREU 2113 and T. vivax identified by IgG anti¬
bodies produced by a rabbit during the periods of primary infection
with TREU 2113, after drug treatment and challenge with T. vivax.
Number 1 Proteins of T. evansi TREU 2113 probed with normal
rabbit serum.
Numbers 2-5 Proteins of T. evansi TREU 2113 probed with days 7,
14, 17 and 21 post infection serum respectively.
Numbers 6-7 Proteins of T. evansi TREU 2113 probed with serum
samples collected on days 7 and 14 post drug treat¬
ment respectively.
Numbers 8-12 Proteins of T. evansi TREU 2113 probed with serum
samples collected on days 7, 14, 17, 21 and 30 after
challenge with T. vivax.
Number 13 Proteins of T. vivax probed with serum collected 14
days after infection with T. evansi TREU 2113.
Number 14 Proteins of T. vivax probed with serum collected 14
days after drug treatment.
Number 15 Proteins of T. vivax probed with serum collected 21
days after challenge with the same stock.
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FIGURE 5.5B
Antigens of T. evansi TREU 2113 and T. vivax identified by IgM anti¬
bodies produced by a rabbit during the periods of primary infection
with TREU 2113, after drug treatment and challenge with T. vivax.
Number 1 Proteins of T. evansi TREU 2113 probed with normal
rabbit serum.
Numbers 2-5 Proteins of T. evansi TREU 2113 probed with days 7,
14, 17 and 21 post infection serum respectively.
Numbers 6-7 Proteins of T. evansi TREU 2113 probed with serum
samples collected on days 7 and 14 post drug treat¬
ment respectively.
Numbers 8-12 Proteins of T. evansi TREU 2113 probed with serum
samples collected on days 7, 14, 17, 21 and 30 after
challenge with T. vivax.
Number 13 Proteins of T. vivax probed with serum collected 14
days after infection with T. evansi TREU 2113.
Number 14 Proteins of T. vivax probed with serum collected 14
days after drug treatment.
Number 15 Proteins of T. vivax probed with serum collected 21
days after challenge with the same stock.
 
FIGURE 5.5C
Antigens of T. evansi TREU 2113 and T. vivax identified by IgA anti¬
bodies produced by a rabbit during the periods of primary infection
with TREU 2113, after drug treatment and challenge with T. vivax.
Number 1 Proteins of T. evansi TREU 2113 probed with normal
rabbit serum.
Numbers 2-5 Proteins of T. evansi TREU 2113 probed with days 7,
14, 17 and 21 post infection serum respectively.
Numbers 6-7 Proteins of T. evansi TREU 2113 probed with serum
samples collected on days 7 and 14 post drug treat¬
ment respectively.
Numbers 8-12 Proteins of T. evansi TREU 2113 probed with serum
samples collected on days 7, 14, 17, 21 and 30 after
challenge with T. vivax.
Number 13 Proteins of T. vivax probed with serum collected 14
days after infection with T. evansi TREU 2113.
Number 14 Proteins of T. vivax probed with serum collected 14
days after drug treatment.
Number 15 Proteins of T. vivax probed with serum collected 21
days after challenge with the same stock.
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FIGURE 5.6A
Antigens of T. evansi TREU 2113 and T. congolense identified by IgG
antibodies produced by a rabbit during the periods of primary infec¬
tion with TREU 2113, after drug treatment and challenge with T.
congolense.
Number 1 Proteins of T. evansi TREU 2113 probed with normal
rabbit serum.
Numbers 2-5 Proteins of T. evansi TREU 2113 probed with days 7,
14, 17 and 21 post infection serum respectively.
Numbers 6-7 Proteins of T. evansi TREU 2113 probed with serum
samples collected on days 7 and 14 post drug treat¬
ment respectively.
Numbers 8-12 Proteins of T. evansi TREU 2113 probed with serum
samples collected on days 7, 14, 17, 21 and 30 after
challenge with T. congolense.
Number 13 Proteins of T. congolense probed with serum collected
14 days after infection with T. evansi TREU 2113.
Number 14 Proteins of T. congolense probed with serum collected
14 days after drug treatment.
Number 15 Proteins of T. congolense probed with serum collected
21 days after challenge with the same stock.
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FIGURE 5.6B
Antigens of T. evansi TREU 2113 and T. congolense identified by IgM
antibodies produced by a rabbit during the periods of primary infec¬
tion with TREU 2113, after drug treatment and challenge with T.
congolense.
Number 1 Proteins of T. evansi TREU 2113 probed with normal
rabbit serum.
Numbers 2-5 Proteins of T. evansi TREU 2113 probed with days 7,
14, 17 and 21 post infection serum respectively.
Numbers 6-7 Proteins of T. evansi TREU 2113 probed with serum
samples collected on days 7 and 14 post drug treat¬
ment respectively.
Numbers 8-11 Proteins of T. evansi TREU 2112 probed with serum
samples collected on days 7, 14, 17 and 30 after chal¬
lenge with T. congolense.
Number 12 Proteins of T. congolense probed with serum collected
14 days after infection with T. evansi TREU 2113.
Number 13 Proteins of T. congolense probed with serum collected
14 days after drug treatment.
Number 14 Proteins of T. congolense probed with serum collected
21 days after challenge with the same stock.
177
FIGURE 5.6C
Antigens of T. evansi TREU 2113 and T. congolense identified by IgA
antibodies produced by a rabbit during the periods of primary infec¬
tion with TREU 2113, after drug treatment and challenge with T.
congolense.
Number 1 Proteins of T. evansi TREU 2113 probed with normal
rabbit serum.
Numbers 2-5 Proteins of T. evansi TREU 2113 probed with days 7,
14, 17 and 21 post infection serum respectively.
Numbers 6-7 Proteins of T. evansi TREU 2113 probed with serum
samples collected on days 7 and 14 post drug treat¬
ment respectively.
Numbers 8-12 Proteins of T. evansi TREU 2113 probed with serum
samples collected on days 7, 14, 17 and 30 after chal¬
lenge with T. congolense.
Number 13 Proteins of T. congolense probed with serum collected
14 days after infection with T. evansi TREU 2113.
Number 14 Proteins of T. congolense probed with serum collected
14 days after drug treatment.
Number 15 Proteins of T. congolense probed with serum collected




In a study concerned with immunization of animals, the protocol used will
influence the results obtained. In the current study the protocol adopted was
designed to ensure that the animal had produced antibodies to the maximum
number of T. evansi antigens before challenge. Previous studies in Chapter 4
had established that these conditions could be met by infection followed by
cure from 21 days after infection. In the present study challenges after the
primary infection were carried out 30 days after drug treatment to minimise
the possible residual prophylactic effect of Berenil^ which has been recorded
to remain for up to three weeks in cattle (Van Hoeve and Cunningham,
1964). Trypanosomal activity of Berenil in rabbits treated at the dose rate
used in the present study has been shown to be absent by 30 days after
treatment (T.W. Jones, personal communication). The previously reported
phenomenon of parasite relapse following late drug treatment was only
observed in two rabbits after drug treatment possibly due to the high dose rate
of Berenil used.
The only absolute measure of assessing protection in the case of
trypanosomiasis is the absence of parasites from the blood after challenge.
This was only achieved in the case of homologous challenge with TREU 2113
(Figure 5.1A). This observation is in agreement with the findings of many
workers who clearly demonstrated that both domestic animals and laboratory
rodents are rendered resistant to the homologous trypanosome population after
infections are followed by drug cure (Lavern and Mesnil, 1902; Ehrlich et al.,
1902; Hornby, 1941; Wiesenhutter, 1970; Nantulya et al., 1980b).
The absolute protection seen in animals infected with homologus
trypanosomes is likely to be due to the presence of specific antibody production
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in particular against the parasite surface antigens because these components
were better recognised in these rabbits during the challenge period (Figure
5.2A, Nos. 8-11) than were recognised by the animals challenged with the rest
of the trypanosome populations used in the present study in which absolute
protection was not recorded. Responses to the internal components of the
trypanosomes may have also contributed to the absolute protection observed in
the animals challenged with the homologous trypanosome stock as more of the
internal components of the parasite were identified by sera collected from these
animals than were recognised by sera collected from the other rabbits
challenged with the heterologous trypanosome populations. This specific
response to the homologous parasite antigens is considered to be anamnestic in
nature as would be seen from the increased intensity of labelling and the
increased number of parasite components recognised by the antibodies
particularly belonging to the IgG class, produced by the animals during the
reinfection period (Figure 5.2A, Nos. 8-11). Similar anamnestic responses to
antigens of a particular parasite population have been reported for some IgG
subclasses by Musoke et al. (1981) in cattle infected with T. brucei. The role
of such an IgG response to protection against T. evansi infection, in relation to
the activities of IgM and IgA was however, not investigated in the present
study but there is ample evidence that it may be playing an important role.
In the case of heterologous challenge, with a different stock of the same
parasite species (T. evansi TREU 1834; Figure 5.IB) and T. brucei (Figure
5.1C) partial protection of animals as indicated by extended prepatent periods
and lower parasite numbers during reinfection compared with the respective
challenge populations in naive animals was observed. It was considered
possible that the partial protection observed in animals challenged with T.
brucei could be associated with the fact that many antigens of T. brucei, one of
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which corresponded in molecular weight (67,000 daltons) to one of the surface
components of T. evansi TREU 2113, were recognised particularly by IgG
antibodies (Figure 5.4A, No. 13) some by IgM (Figure 5.4B, No. 13) and IgA
(Figure 5.4C, No. 13) in the serum collected from animals after the primary
infection with T. evansi TREU 2113. Responses in animals challenged with T.
evansi TREU 1834 were peculiar, however, in that only two components of
TREU 1834, one of them again corresponding to the surface component of T.
evansi TREU 2113 with the molecular weight of 67,000 daltons, were
recognised by the IgG antibodies (Figure 5.3A, No. 12) and none by IgM
(Figure 5.3B, No. 12) and IgA (Figure 5.3C, No. 12) in the serum collected
from animals after infection with T. evansi TREU 2113. It is possible that the
recognition of the 67,000 dalton component may have contributed to the
partial protection observed in these animals in the absence of specific
antibodies against other components of TREU 1834 because the 67,000 dalton
component was always recognised in all cases of absolute protection in the
present study. It is also possible that non-antibody dependent factors in the
absence of specific antibodies to the antigens of T. evansi TREU 1834 could be
involved in the inhibition of the early establishment of the challenge parasite
populations and low levels of parasitaemia observed in animals challenged with
TREU 1834 during the post-reinfection period (Figure 5.IB). Such a
possibility has been advanced by Lloyd et al. (1979) to explain the suppressed
response they observed in the absence of any evidence of cross-immunity to an
antigenically distinct stock of T. congolense used in their reinfection studies.
These authors considered that this factor might have interfered at some point
with parasite replication. The role of non-antibody dependent factors on the
development of other species of trypanosomes such as T. lewisi and T. musculi
have been observed by some workers (Targettand Veins, 1979) and it may be
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possible that these factors affecting other Stercorarian species of trypanosomes
may also be important in the development of some salivarian species of
trypanosomes.
Animals reinfected with T. congolense and T. vivax were not protected
against the reinfecting parasite populations in that the prepatent period of the
parasites in these test animals were similar to those observed in naive rabbits
and also the other fact that the animals had fulminating parasitaemias all
through the challenge period (Figure 5.ID and E). The lack of protection
observed in these animals is thought to be due to the very limited recognition
of T. vivax antigens (Figure 5.5A,B and C, No. 13) and none of the T.
congolense antigens (Figure 5.6A, B and C, No. 13) by the three classes of
antibodies under study, present in the serum collected from the rabbits after
infection with T. evansi TREU 2113.
The most important aspect of the host response in this study appears to be
the pattern of antibody response to the different components of the parasite.
Results from this study show that when specific antibody response against the
surface component is pronounced, as was observed with the rechallenge with
homologous species (TREU 2113), where the 67,000 and 60,500 d components
(parasite surface-associated components - See Chapter 3 for details) were very
prominently identified by antibodies in serum collected when the animals were
infected with T. evansi TREU 2113, absolute protection occurred. Partial
protection was observed in cases such as in the animals challenged with T.
brucei, where mostly the components corresponding to the non-surface and
only one, of molecular weight 67,000, of the surface components of T. evansi
TREU 2113, used for the primary infection, were identified by antibodies
collected from the serum of rabbits after infection with T. evansi TREU 2113
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(Figure 5.4A, B and C, No. 13). In cases where the antibodies recognised
very limited numbers or none at all of both the components corresponding to
the surface and non-surface components of T. evansi TREU 2113 as was
observed in animals challenged with T. vivax (Figure 5.5A, B and C, No. 13)
and T. congolense (Figure 5.6A, and C, No. 13 and 5.6B, No. 12) no
protection against the challenge parasite population was observed. These
observations are in agreement with the findings of several workers (Wellde et
al., 1975; Emery et al., 1980; Morrison et al., 1982; Hall and Esser, 1984)
who associated absolute protection to homologous parasite challenge with the
production of VSG-specific antibodies.
The close antigenic relationship observed between the stock of T. evansi
used for all the primary infections, TREU 2113, and T. brucei (TREU 1880)
is thought to be due to the fact that they belong to the same subgenus -
Trypanozoon. It is also interesting to observe that most of the cross- reactions
between these two species were with the components that correspond to the
non-surface component of TREU 2113 which should be expected (Roelants
and Pinder, 1984), as the non-surface components are known to be common
not only to different stocks but species of trypanosomes. It is difficult to
explain why no such relationship was observed between the two stocks of T.
evansi used in this study. This may indicate that TREU 1834 is not a typical T.
evansi population in that the same stock of parasites showed peculiar reactions
in studies involving several other species of T. evansi used in Chapter 3 for
studies involving the surface coat in which using the same technique the
surface coat of TREU 1834 could not be labelled. The closer antigenic
relationship observed between T. evansi and T. vivax but not with T.
congolense in this study is interesting. These relationships, if found to apply
generally and not just to a few stocks of the different trypanosome species,
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could be useful in selecting animals for rearing in areas with a different history
of endemicity for the different species of trypanosomes, as results from this
study indicate that animals previously exposed to T. evansi are likely to suffer a
less severe form of T. brucei infection than T. congolense infection.
Results from the studies in this chapter have therefore, confirmed the
importance of antibodies produced against the surface components of a
particular trypanosome population in protecting animals from reinfection with
the homologous parasites. The observations concerning the possible role of
antibody responses to the non-surface component of the parasite and the
possibility of other non-antibody dependent factors influencing the outcome of
infections in primed animals are some of the important findings of the present
study which may be important for the development of alternative control
strategies that should be further investigated.
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CHAPTER SIX
EARLY EVENTS FOLLOWING CHALLENGE OF
RABBITS WITH TRYPANOSOMA EVANSI
AND T. EVANSI COMPONENTS
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INTRODUCTION
Trypanosomes have to be introduced through the skin of the animal or
human host by an arthropod vector before the trypanosome infection can
establish. The first reaction to the parasite at the skin barrier, can therefore
be important in influencing the outcome of the infection. The most obvious
and well documented host's reaction to the introduction of trypanosomes into
the skin is the development of the chancre (Burtt and Fairbairn; 1945; De
Raadt et al., 1966) a localised skin reaction at the bite site within 7-11 days
after infection which then gradually subsides up to one month after infection.
Chancres have been observed in a range of hosts such as man and rabbits
subjected to infection with T. rhodesiense (Fairbairn and Godfrey, 1957; Willet
and Gordon, 1957; Emery and Moloo, 1980), and cattle and goats infected
through tsetse bites with T. brucei, T. vivax and T. congolense (Luckins and
Gray, 1978; Gray and Luckins, 1980; Emery et al., 1980a; Emery and Moloo,
1981; Luckins, 1981; Dwinger et al., 1987; Dwinger, 1988).
While chancres can be induced by all three species of tsetse- transmitted
trypanosomes that infect domestic livestock, the size of the reaction differs
between trypanosome species. For any unit parasite inoculation the lesions
caused by T. brucei are larger and the reaction more intense than those
produced by T. congolense or T. vivax (Emery et al., 1980; Akol and Murray,
1983). Furthermore, certain stocks of T. congolense and T. vivax do not
appear to induce any detectable skin reactions (Luckins and Gray, 1979;
Dwinger, 1985).
Results from detailed studies on the properties of the initial host response
at the skin level to tsetse-transmitted infections suggest that these reactions are
mostly specific immune reactions directed against the parasites. Such reactions
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are antibody-mediated and are effected by trypanolysis as has been
experimentally demonstrated by several authors (reviewed in Vickerman and
Barry, 1982) who clearly linked the development of chancres only with
trypanosomes and not with uninfected fly bites or trypanosome extracts.
At the early stages the cell types in the chancre are predominantly
neutrophils. This characteristically rapid increase in the number of neutrophils
in the early stages of chancre development (Emery et al., 1980) suggests that
the development of chancre is not a classical cell-mediated immune (delayed
type hypersensitivity) response (Vickerman and Barry, 1982). Furthermore,
the chancre does not exhibit the clinical and histological characteristics of the
four types of classical delayed type hypersensitivity reaction (Roitt et al.,
1989). The fact that the chancre develops in naive animals also rules out the
reaction as a hypersensitivity type of reaction. These features along with
infiltration by lymphocytes, lymphoblasts, plasma cells, macrophages and
eosinophils usually observed in chancre reactions (Emery and Moloo, 1980)
suggest that the chancre represents a complex and dynamic combination of an
acute inflammatory response coupled with some kind of an immunological
reaction evoked by the presence of the trypanosome.
Functionally, the chancre probably plays a dual role in host/parasite
relations. The first role which is of advantage to the parasite, is that the
chancre could provide focus for the generation of a range of antigenically
different parasites prior to the appearance of initial parasitaemia in the host.
The second role being the provision of antigens which serve to prime the
draining lymph nodes (Emery and Moloo, 1980). This action would be of
advantage to the host, as such a priming would set into motion some
immunological defence reactions to infection. Results from studies on T.
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congolense conducted by Luckins and Gray (1979) indicated that the initial
antigenic diversification of trypanosomes occurs within the chancre.
No reports of chancre development studies have been made in the case of
T. evansi infection, possibly as chancres have always been associated with the
bites of tsetse flies infected with trypanosomes. Furthermore, the intradermal
route is very rarely used for infecting animals experimentally with T. evansi,
unlike infection induced with the tsetse-transmitted trypanosome species via
tsetse flies.
Results from earlier studies on host antibody response to T. evansi
infections presented in Chapters 3 and 5 have clearly demonstrated the
involvement of the surface and non-surface components of the trypanosome in
the immune response generated by the host when the trypanosomes were
introduced intravenously into the hosts. More importantly, an association was
made between the number of the components of the parasites identified by the
antibodies produced by the host and the degree of resistance or susceptibility of
infected animals. Animals that recognised both the surface and a large
number of the non-surface components were found to be more resistant than
those that failed to recognise either components well. However, it is unknown
whether such responses have any relevance in the very early stages of natural
infections introduced through the skin.
The present study was therefore designed to study the nature of reactions
developing at the site of intradermal inoculation of T. evansi using intact
parasites and extracts of trypanosomes in an attempt to understand the
host/parasite relation in T. evansi infections at the point of first contact




T. evansi TREU 2147, an immediate derivative of TREU 2113 used in
previous studies was used for the infections, superinfections and the
preparation of the antigens used for the studies undertaken in this chapter.
ANTIGENS
(a) Whole Trypanosomes
Response to infection with intact trypanosomes was undertaken by
inoculation of whole trypanosomes resuspended in 0.1 ml ice-cold PSG
(Appendix 2) intradermally into the rabbits at two different doses - 4 x 10^
(ANTIGEN 1) and 1 x 10^ (ANTIGEN 2). The trypanosomes were obtained
from mice with fulminating infections and separated from the host's blood cells
using DEAE cellulose (DE52, Whatman Biochemicals) as described previously
before being inoculated into rabbits.
(b) T. evansi Soluble Extract
Host response to the injection of whole trypanosome extract, and isolated
surface and non- surface components were based on reactions to appropriate
parasite materials obtained from soluble antigen preparations prepared by
freeze-thawing as described in Chapter 2. The supernate fraction of such
parasite lysate after centrifugation at 10,000 g for 45 minutes at 4°C was made
up to 0.1 ml with distilled water and used as ANTIGEN 3.
Fractionation of T. evansi soluble antigens into surface and non-surface
components: A soluble extract of T. evansi TREU 2147 as prepared above
were separated into individual protein components by SDS-PAGE as described
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in the final protocol in Chapter 2. The separated protein components were
isolated from two sections of the gel by the method described by Gill et al.
(1986). One section contained components with molecular weights of 67,000
and 60,500 daltons known to be the surface components of the parasite, while
the other section contained components known to be non-surface in origin
from the studies conducted on the identification of the surface components of
the parasite in Chapter 3.
Briefly, 1350 p,g total proteins of the soluble extract of T. evansi
contained in 0.5 ml of SDS sample buffer (Appendix 14) was distributed
amongst 13 sample wells and subjected to SDS-PAGE on 7-20% acrylamide gel
slabs. After electrophoresis a longitudinal section of the gel containing one
track of the T. evansi separated proteins and another track containing the
standard molecular weight proteins (Pharmacia) was cut out from the gel and
stained with Coomassie Blue (Sigma) to visualise the proteins. Using this
stained part of the gel as a template, a horizontal strip of the unstained portion
of the gel corresponding to the two surface associated components of molecular
weights 67,000 and 60,500 on the stained gel section was carefully cut out from
the unstained portion of the gel. The gel section containing the two protein
components was then transferred into a 10 ml centrifuge tube containing 1 ml
ice-cold PBS, macerated with a glass rod and the proteins contained in the gel
left to elute for 90 minutes at 4°C. After centrifuging at 10,000 g for 45
minutes at 4°C, the supernatant was aspirated, dialysed against distilled water
for 24 hours and freeze-dried. Before use the freeze-dried sample was
resuspended in 0.1 ml of distilled water and used as ANTIGEN 4. The
remaining portion of the unstained gel containing the non-surface components
of TREU 2147 was treated in a similar fashion to the portion as for
ANTIGEN 4 except that an extraction volume of 2 ml was used. After
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freeze-drying the sample was reconstituted in 0.1 ml distilled water and used as
ANTIGEN 5.
Control (non-trypanosome) solution: A section of a polymerised gel that
had SDS sample buffer and no trypanosome proteins in the wells of the
stacking gel during electrophoresis, was cut out and put into a 10 ml centrifuge
tube containing 2 ml ice-cold PBS. The gel was treated as in ANTIGEN 5.
After dialysis and freeze-drying the sample, the resulting material was
reconstituted in 1 ml of distilled water. 0.1 ml of this preparation was used as
SDS-PAGE control solution.
The protein concentration of all the trypanosome fractions were
determined photometrically using BCA^ (Pierce Chemical Company, USA).
EXPERIMENTAL ANIMALS
(1) Infected Animals
Two adult female New Zealand White rabbits were infected with 4 x 10^
motile trypanosomes through the ear veins. Each animal was allowed to carry
the infection for 21 days before they were each injected intradermally with 0.1
ml PSG containing 4 x 10^ motile trypanosomes (ANTIGEN 1), 1 x 10^
motile trypanosomes (ANTIGEN 2), 33 jxg protein of ANTIGENS 3, 4 and 5
and the control solution respectively. Each antigen administration was
duplicated on each side of the back giving rise to four tracks of antigens,
running longitudinally from the shoulders to the hindquarters as shown in
Figure 6.1. The preparation of the animals prior to the inoculation of the
antigens and control solution involved the shaving of both sides of the back 24
hours before the samples were injected. One hour before the samples were
inoculated the shaved portions of the back were sterilised with 70% alcohol.
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(2) Infected and Drug Treated Animals
Two adult female New Zealand White rabbits were infected through the
ear vein with 4 x 10^ motile trypanosomes as above. The animals were
allowed to carry the infection for 21 days before they were treated with 7 mg
R
(active principle) of diaminazene aceturate (Berenil , Hoechst, W. Germany)
ptr
injected intramuscularly (i/m) deep into the thigh muscles. Twenty five days
after drug treatment the animals were each inoculated intradermally with
ANTIGENS 1 to 5 and the control solution as in the case of the infected
animals.
Infected animals were examined for the presence of trypanosomes in the
blood 7, 14 and 21 days after infection and on days 7, 14 and 25 days post
drug treatment in the animals that were drug treated, by the buffy coat
microhaematocrit method (Woo, 1970).
(3) Uninfected Control Animals
Two adult female New Zealand White rabbits, without previous exposure
to T. evansi or T. evansi extracts were used as control animals in this study.
One rabbit served as a control for the infected rabbits and the other for the
drug treated rabbits. The animals were injected with ANTIGENS 1 to 5 and
the control solution on equivalent days as the infected and the infected and
drug treated rabbits.
RESPONSE TO ANTIGEN ADMINISTRATION
Skin Thickness
A double skin thickness was formed by pinching up the skin at the site of
the antigen inoculation with the fingers before measurements were taken from
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each site with vernier callipers in mm. These measurements were taken before
the antigens were inoculated and subsequently at 2, 24 and 48 hours after the
administration of the antigens. The 2, 24 and 48 hour skin measurements
were taken from all the sites of antigen inoculation along three longitudinal
tracks, one (Lane B) and two (Lanes C and D) tracks on each side of the back
respectively (Figure 6.1).
Cellular Infiltration
Biopsies were taken after the animals had been sedated by infiltrating
Xylocaine-HCl locally through the subcutaneous (s/c) route in such a way that
the parts of the body from which samples were obtained were completely
anaethetised in that animals did not react to pin pricks on those parts.
Two hour post antigen inoculation skin biopsies were collected from each
antigen inoculation site along one track (Lane A) on one side of the body,
with the 3 mm biopsy punch (Baker Laboratories Ltd.). The 48 hour skin
biopsies were collected from each site of antigen inoculation from two (Lanes
B and C) of the three remaining tracks, one track from each side of the back.
Each skin biopsy was divided into two equal parts, one for light and the
other for electron microscopic studies. Tissues for light microscopic studies
were fixed in 10% buffered formal saline. Skin sections 5 (xm thick were cut
from paraffin-embedded blocks prepared by conventional methods and stained
with Giemsa or Mayers haematoxylin and eosin (Cook, 1974). Tissue samples
destined for electron microscopy were fixed in 2.5% glutaraldehyde in
cacodylate buffer pH 7.2 (Appendix 12) and processed for electron
microscopic studies using the methods described in Chapter 3 with the only




Results of microscopal examination of the buffy coat of blood samples,
revealed parasites in the blood of the infected rabbits on day 21 post infection
in all the infected rabbits before the antigens were administered. Parasites
were not seen in the blood of the drug treated animals on 7, 14 and 25 days
after drug treatment.
LOCAL SKIN REACTIONS IN RABBITS AFTER INTRADERMAL
INOCULATION OF T. EVANSI AND T. EVANSI COMPONENTS
(a) Changes in skin thickness
Each of the five antigens (ANTIGENS 1-5) and the control solution
caused some changes in skin thickness at the sites of inoculation in all animals.
The greatest increases being observed in the infected and drug treated rabbits
and the least in the uninfected naive rabbits used as control animals.
Inoculation of live trypanosomes (ANTIGENS 1 and 2) into naive rabbits
resulted in a mean increase in skin thickness in the two rabbits of 0.9 mm
(ANTIGEN 1) and 0.57 mm (ANTIGEN 2) at 48 hours post-antigen
inoculation skin compared to pre-antigen inoculation measurements.
Inoculation of live trypanosomes resulted in a continuous increase in skin
thickness that took place from 2 to 48 hours post antigen inoculation (Figure
6.2A). The greatest increase in the skin thickness in naive rabbits, with both
antigens, was seen 48 hours post inoculation (Table 6.1).
Inoculation of trypanosome extracts (ANTIGENS 3 to 5) into naive
rabbits resulted in a mean increase in the skin thickness of the two rabbits of
0.17 mm with ANTIGEN 3, 1.00 mm with ANTIGEN 4 and 0.13 mm with
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ANTIGEN 5 by 48 hours after inoculation. Skin thickness was observed to
decrease by 48 hours after the administration of each of these antigen (Figure
6.2A). The greatest increase in skin thickness, for this group of antigens, was
obtained 24 hours after antigen inoculation (Table 6.1).
Inoculation of live trypanosomes (ANTIGENS 1 and 2) into the infected
rabbits resulted in a mean increase in the skin thickness of the two rabbits of
1.3 mm (ANTIGEN 1) and 1.02 mm (ANTIGEN 2) at 48 hours post-antigen
inoculation compared to the pre-antigen inoculation skin measurements. The
skin thickness decreased in these rabbits 48 hours after the administration of
the antigen (Figure 6.2B), with the greatest increase in the skin thickness seen
24 hours post inoculation (Table 6.1).
Inoculation of trypanosome extracts (ANTIGENS 3 to 5) resulted in a
mean increase in the skin thickness of 0.85 mm with ANTIGEN 3, 1.98 mm
with ANTIGEN 4 and 0.96 mm with ANTIGEN 5 48 hours post-antigen
inoculation. By 48 hours after antigen inoculation decreases in skin
measurements were observed (Figure 6.2B). The greatest increase in skin
measurements were obtained 24 hours after inoculation (Table 6.1).
Inoculation of live trypanosomes (ANTIGENS 1 and 2) into rabbits
infected with T. evansi and treated with Berenil resulted in a mean increase in
the skin thickness of 1.50 mm (ANTIGEN 1) and 1.25 (ANTIGEN 2) by 48
hours post-antigen inoculation. The skin thickness decreased in both these
rabbits at 48 hours after the administration of the antigen (Figure 6.2C) with
greatest mean increase in skin thickness obtained 24 hours after antigen
inoculation (Table 6.1). Inoculation of trypanosome extracts (ANTIGENS 3
to 5) resulted in a mean increase in the skin thickness of the two rabbits of
1.05 mm (ANTIGEN 3), 3.00 mm (ANTIGEN 4) and 1.25 mm (ANTIGEN
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5) at 48 hours post-antigen inoculation. The skin thickness measurements were
observed to decrease at 48 hours after antigen inoculation (Figure 6.1C) with
greatest increases in skin measurements obtained 24 hours after antigen
inoculation (Table 6.1).
Inoculation of the control solution resulted in a slight increase in the skin
thickness in all the three groups of rabbits. This ranged from an average value
of 0.02 in naive rabbits, 0.42 mm in the infected animals to 0.46 mm in the
infected and drug treated animals. The skin thickness measurements were
observed to decrease in all the animals 48 hours after sample administration
(Figure 6.1C) with the greatest increase obtained 24 hours post sample
inoculation (Table 6.1).
FIGURE 6.1
Numbers 1-5 indicate ANTIGENS and sites of inoculation. No.
6 = control solution.
Skin measurements for the 2, 24 and 48 hour post antigen inocu¬
lations repsectively were obtained from all the antigen inoculation
sites along LANES B, C and D.
Tissues for 2 hour post antigen inoculation biopsies were obtained
from all antigen inoculation sites in LANE A while samples were
obtained from LANES B and C for the 48 hour post antigen ino¬
culation biopsies.
!• 19 10 19
29 29 29 29






Increase in skin thickness of rabbits challenged with T. evansi and T.
evansi components.
A Uninfected rabbits.
B Rabbits infected with T. evansi before challenge.
C Rabbits infected with T. evansi and treated with Berenil before
challenge.
FIGURE 8.1
Class-specific antibody production in primed rabbits challenged with T.
evansi soluble antigens of immune complexes.
A and B Rabbits challenged with T. evansi soluble antigens.
C and D Rabbits challenged with immune complexes formed with T.
evansi soluble antigens and post infection serum.
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Table 6.1 Average increase in skin thickness (mm) in the three
groups of rabbits between skin measurements at 0 hours
and at any time of maximum skin thickness
Antigens 1 2 3 4 5 6
Infected











0.57 0.09 1.02 0.17 0.06
(1) +: Highest mean skin measurement obtained after 48 hours
and the rest after 24 hours post antigen inoculation.
(2) Mean measurement of normal skin thickness (mm): 1.45
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HISTOLOGICAL EXAMINATION OF SKIN BIOPSIES
Microscopal examination of sections prepared from tissue samples
collected from the sites of antigen inoculation, in the three groups of animals,
revealed similar types of cellular infiltration with differences restricted to the
cell types seen at the different sampling times of 2 and 48 hours post-antigen
inoculation. The differences seen were in the magnitude of cellular infiltration
at the site of antigen inoculation with the highest level of infiltration in each
case occurring in the infected and drug treated animals. Minimal cellular
infiltration was observed in sections prepared from tissues obtained from sites
where the control solution was inoculated.
Cellular Reactions in Skin Biopsies Collected Two Hours after Antigen
Inoculation
Animals showed severe signs of inflammation at the sites of inoculation t
two hours after ANTIGENS 1-5 were injected into the skin of animals. The
inflammation
intensity of A appeared greatest at sites where ANTIGEN 4 was injected in
all groups of rabbits. Microscopal examination of biopsy sections prepared
from tissues collected from the animals two hours after the injection of the
antigens revealed marked cellular infiltration, congestion and oedema. The
cell types present were predominantly neutrophils and eosinophils with one or
two mononuclear cells in each microscopic field. These mononuclear cells
were mainly lymphocytes. Blood vessels were often clogged by these cells and
large numbers of red blood cells. Cellular aggregation was greatest in the
dermis with cellular infiltration most pronounced at sites where ANTIGEN 4
was injected in all the groups of animals (Figure 6.3A and B) In general, fewer
numbers of polymorphonuclear leucocytes, neutrophils and eosinophils, were
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seen at sites where live trypanosomes were injected (ANTIGENS 1 and 2) than
where the trypanosome extracts (ANTIGENS 3, 4 and 5) were inoculated.
Very few cells were seen in the sections prepared from tissues obtained from
the normal skin of rabbits where no antigens were injected (Figure 6.5B) and
from sites where the control solution was injected (Figure 6.6A).
Trypanosomes were not observed in sections prepared from tissues collected
two hours after antigen inoculation even in the sites where the highest numbers
of trypanosomes (ANTIGEN 1) were inoculated.
Cellular Reactions in Skin Biopsies Collected 48 Hours after Antigen
Inoculation
Signs ofacute inflammation were reduced in all animals 48 hours after the
inoculation of all the antigens. Animals were however, still sensitive to touch
inflammation
at the sites of antigen inoculation because of ^ particularly when the teeth
of the vernier callipers were closed up on the skin.
Cellular infiltration seen in sections prepared from all tissues 48 hours
after antigen inoculation were dominated by mononuclear cells with
perivascular cuffs formed around blood vessels (Figure 6.5A). The cell hypes
identified were predominantly lymphocytes, some monocytes and plasma cells
and a few macrophages. Most of the cellular changes were observed in the
dermis. Few trypanosomes were seen in the section appearing as single
organisms in some of the tissue sections (Figure 6.5 b). Neutrophils and
eosinophils were observed in sections from sites where the trypanosome
components (ANTIGENS 3 to 5) were inoculated, unlike those sites where live
trypanosomes (ANTIGENS 1 and 2) were injected in which mostly
mononuclear cells were seen.
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Control Biopsies
Minimal reaction to the control solution was seen in all cases with a few
neutrophils and eosinophils seen scattered throughout sections obtained two
hours after inoculation. A few mononuclear cells were seen in sections
prepared from tissues collected 48 hours after the inoculation of the control
solution (Figure 6.6A).
Microscopal examination of sections obtained from tissue collected from
sites where no antigens were injected revealed the presence of few
mononuclear cells. The expected structural components of the normal skin,
such as fibroblasts and reticulum cells were present (Figure 6.6B).
Electronmicroscopal Examination
Electron microscopal examination of biopsy sections revealed that the
neutrophils were activated at sites where ANTIGEN 4 was injected as they
were seen engulfing many particulate materials, some of which appeared to be
collagen fibres (Figure 6.4A to C). No such activation was seen in sections
prepared from tissues where the other antigens and the control solution were
injected (Figure 6.3D).
FIGURE 6.3
Skin sections prepared from tissue collected 2 hours after ANTIGEN 4
was injected intradermally into T. evansi infected and Berenil treated
rabbit.
(A: shows clusters of polymorphonuclear leucocytes, H & E x 150; B:
shows blood vessel clogged with polymorphonuclear leucocytes and






Cellular activity in sections from tissues obtained from sites of
ANTIGEN inoculation 2 hours post-antigen administration.
(A: x 4,600; B: x 7,700; C: x 10,000 show activated neutrophils at dif¬
ferent stages of phagocytosis; D: x 2,500 shows activities at a site
where the control solution was injected.
All tissues were obtained from infected and Berenil treated animals.)
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FIGURE 6.5
Giemsa'a stained section prepared from tissue collected 48 hours after
live trypanosomes (ANTIGEN 1) were intradermally injected into T.
evansi infected and Berenil treated rabbits.
A shows clusters of mononuclear cells with many of them forming
distinct cuffs around blood vessels, x 500.
B shows a single trypanosome (T) and some mononuclear cells iden¬





Section from tissue collected 48 hours after the control solution was
injected intradermally into T. evansi infected and Berenil treated rab¬
bit, showing a few mononuclear cells, x 500.
FIGURE 6.6B
Giemsa's stained section from tissue collected from the skin of an
uninfected rabbit that did not receive any intradermal ANTIGEN ino¬
culation, showing a few mononuclear cells scattered in the dermis of





Some form of reaction was observed at sites where each of the antigens
were inoculated. Differences were seen however, in the magnitude of the
response as indicated by changes in skin thickness and also in the degree of
cellular infiltration at each antigen inoculation sites. Most marked changes
were observed in animals that had experienced an infection previously when
compared with naive animals.
The reaction of naive animals used in this study would be comparable to
animals being exposed to trypanosomiasis in the field for the first time. They
all responded to the intradermal inoculation of the parasites and parasite
components by developing a palpable swelling at the site of antigen inoculation
(ANTIGENS 1-5). Swellings of a lesser magnitude were observed at sites
where the control solution was injected indicating that the bulk of increased
skin thickness observed at the sites of antigen inoculation was due to the
trypanosome or trypanosome components injected into those areas. A similar
observation was made by Dwinger (1985) who considered that these increases
in skin thickness and cellular activity at sites of antigen inoculation were
associated with trypanosomal factors. The swellings observed in the present
study showed all signs of acute inflammation - hotness, red colouration and
pain 2 and 24 hours after antigen inoculation. By 48 hours after the antigen
inoculation, reactions at the sites of inoculation were less intense. While the
swellings at the site of inoculation of live trypanosomes in the naive animals
increased throughout the period of observation, swellings at the sites where the
rest of the antigens (ANTIGENS 3 to 5) and the control solution were injected
were observed to reduce 48 hours after inoculation.
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The continuous increase in skin thickness observed at sites where live
trypanosomes were injected in the naive animals (Figure 6.2A) compared with
that obtained with infected (Figure 6.2B) and the infected and drug treated
rabbits (Figure 6.2C) which showed a reduction in the skin thickness by 48
hours after the inoculation of the trypanosomes, is probably the result of the
fact that absence of trypanosome-specific antibodies in the naive animals,
allowed more parasite multiplication to take place in the skin of naive animals
before the invasion of the circulatory system by the parasites (Emery and
Moloo, 1980). Specific antibodies produced by trypanosome-infected animals
are known to destroy the parasites in the skin by trypanolysis (reviewed in
Vickerman and Barry, 1982).
The general reduction in skin thickness when the other antigens and
control solution were injected in all groups of animals is probably due to the
fact that the preparations were cleared rapidly from the site of inoculation by
the host immune system.
All the animals showed varying degrees of response to both the surface
and the non-surface components of the parasites, a probable indication that the
host immune response to the two components of the parasite, demonstrated in
the previous studies reported in Chapter 3 and 4 is effective at the first point
of contact between the host and the parasite at the skin level. The fact that
the host response was strong against the surface (ANTIGEN 4) than the
internal (ANTIGEN 5) components in all the animals is in agreement with
previous findings of this study reported in Chapter 4 and the findings of Le
Ray (1975). The fact that these responses and in particular those against the
surface components were most marked in the animals that had previously
experienced an infection by the same parasites (Figure 6.2C and Figure 6.2B)
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when compared with those of the naive animals (Figure 6.2A) may be an
indication that absolute protection against reinfection by a homologous
trypanosome population due to the activities of VSG-specific antibodies
produced by the host (Herbert and Wilkinson, 1977; Morrison et al., 1982;
Hall and Esser, 1984) may be equally effective at the skin level, as in the
bloodstream.
Apart from the role of antibodies in destroying the parasites, it is possible
that effector cells sensitised as a result of the previous exposure to the antigen
could play an important role in the generation of immune response on second
exposure of the animal to the antigen at the skin level. This is likely as a
greater amount of cellular reaction was observed in the infected animals than
in the naive animals. The reduced level of reactions observed in animals still
carrying patent infections by the time they were challenged (Figure 6.2B) in
comparison with the drug treated animals (Figure 6.2C) could be associated
with an inhibited immunological response reported in trypanosome infected
animals (Murray et al., 1974c).
The cells types identified in the cellular infiltrate at the sites where the
antigens were injected two hours after administration (Figure 6.3A and B) and
particularly the greater magnitude of response seen in animals previously
exposed to infections by homologous parasites are characteristic of immediate
type hypersensitivity reaction. Furthermore, the cell types in the infiltrate and
also the magnitude of response in sensitised animals 48 hours after the
administration of the antigens (Figure 6.5A and B) are characteristic of
delayed type hypersensitivity reactions (Roitt et al., 1989). Similar reactions
have been reported by Dwinger (1985) in sensitised goats exposed to bites from
T. congolense infected tsetse flies which he thought were normal reactions that
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precede the establishment of the chancre.
The presence of activated neutrophils at sites where the surface
components (ANTIGEN 4) were injected (Figure 6.4A to C) which were
absent from sites where the rest of other antigens (ANTIGENS 1, 2, 3 and 5)
and the control solution (Figure 6.4D) were injected, probably suggests that
the surface component of the trypanosome might be an important factor in the
induction of intense inflammatory responses routinely observed at sites where
trypanosomes or trypanosome components are injected into the skin of an
animal such as those of Seed (1969) and Dwinger (1985).
In conclusion, the results of the experiments conducted in this chapter
have demonstrated that both the surface and non-surface components of the
parasite induce a response at the skin level when introduced into both naive
and sensitised hosts, with the surface components eliciting more intense
reactions than the non-surface components. Furthermore, there were
indications that the development of a state of immediate type hypersensitivty
reaction, which preceded the development of a delayed type reaction, may also
be important in influencing the outcome of challenge of previously infected
animals with T. evansi. The overall effect of such conclusions is that the
reactions at the skin level could be important in the development of T. evansi
infections and probably operating in a similar way to those described for the




COMPLEMENT (C3) LEVELS AND ACTIVATION




Complement has long been known to have important effector functions in
the immune response, such as the opsonization of particles for ingestion by
phagocytic cells (Staines et al., 1985; Klaus and Ursul, 1986), promotion of
lysis of microorganisms (Murray and Urquhart, 1977; Shirazi et al., 1980) and
the development of inflammatory responses (Frank, 1975; Staines et al., 1985).
A fundamental property of the complement system is its component
nature which involves the breakdown or activation of certain of the
complement components which in turn gives rise to new products which then
act directly or indirectly to trigger off a series of effector reactions ultimately
leading to the elimination of an infective agent. Some of these reactions affect
the host itself such as mediating changes in vascular permeability with
consequent attraction of polymorphonuclear and mononuclear leucocytes into
an area where foreign bodies or infectious agents are present (Frank, 1975).
The products of complement activation are also known to bring about directly
T-cell independent B cell activation which leads to the differentiation of B cells
into plasma or antibody producing cells (Pryjma et al., 1974). The activities of
the complement system act in concert with other arms of the immune system
in the elimination or control of invading microorganisms in an infected animal.
A total of 30 individual proteins are recognised as part of the complement
system (Lambris, 1988). Nine of which (CI to C9) are the major ones which
are directly involved in what is commonly referred to as the complement
cascade whose activation leads to the elimination of the intruding pathogen.
The activation of the complement cascade is brought about through two
interrelated routes referred to as the classical and alternative pathways. The
ultimate result of both pathways is the elimination of the offending pathogen
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through cell lysis, phagocytosis, opsonization or other chemotactic processes
that lead to the development of inflammatory responses. Such responses serve
to localise the foreign particles before they are destroyed by host defensive cells
(Staines et al., 1985; Roitt et al., 1985).
The most thoroughly studied of the two pathways of complement
activation, is the classical pathway. This is initiated by the presence of
antigen-antibody complexes and requires the binding of antibodies to the
antigen before it can be activated. The presence of antibody belonging to the
immunoglobulin classes IgG and IgM in the complexes are considered to be
the only ones that can activate the classical complement pathway (Bowry,
1984). The alternative pathway can be activated in the absence of antibodies
with some proteins such as bacterial cell walls and trypanosome components
bringing about the direct activation of the pathway (Table, 1982; Staines et al.,
1985). Of the five classes of antibodies only IgA and IgE are known to bring
about the activation of the alternative pathway (Frank, 1975). In practice
both pathways act together to bring about the destruction and removal of the
foreign particles or infectious agents.
Of the many individual elements identified as part of the complement
systems, a single component - C3 - has been the focus of intensive studies
mainly due to its functional versatility and the fundamental role it plays in the
activiation of both the classical and alternative pathways (Lambris, 1988). C3
can be activated via the alternative pathway by the direct action of parasites or
their fragments or indirectly via the classical pathway by an enzyme known as
C3 convertase. This enzyme is only formed after the antigen/antibody complex
formed as a result of the host's response to the presence of the parasite has
activated a single complement component - CI which subsequently cleaves two
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further components - C4 and C2. The activation of C3 by both pathways leads
to the activation of the complement cascade, a chain of complicated events
that serves to eliminate the pathogen. The range of activities that result in the
activation and development of the two pathways - classical and alternative, are
shown in Figure 7.1.
The cleavage of C3 results in the production of two new complement
components - a smaller C3a, and a larger fragment, C3b. These fragments
either react with other complement components resulting in enzymes that play
an important role in the development of the appropriate pathways or act
directly mediating the development of other host effector functions such as
opsonization. C3b will combine with the existing enzyme C3 convertase to
form another enzyme which cleaves another complement component - C5.
The cleavage of C5 ensures the subsequent activation of the rest of the
complement components (C6 to C9) to the point that lysis of the
microorganism is achieved. C3b also plays a major role in the activities of the
alternative pathway by combining with factor B to produce an enzyme complex
with C3-splitting activity and also in the opsonization of parasites (Gigli and
Nelson, 1968). Furthermore, it has been shown that a number of defence cells
in the body such as B lymphocytes, polymorphonuclear neutrophils and
macrophages have surface receptors for C3b (Lay and Nussenzweig, 1968).
Subsequently, host cells or pathogens with C3b on their surface will adhere to
any of these cells with C3b receptors. The consequence of this adherence will
depend upon the particular cell type, in the case of phagocytic cells, such
adherence will lead to the ingestion of opsonized particles etc.
C3a can act directly and mediate the formation of inflammatory responses
through its chemotactic activities and effect on mast cells which cause them to
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FIGURE 7.1
Schematic representation of the complement activation through
classical and alternative pathways.
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release histamine (Dias et al., 1967; Staines et al., 1985).
Apart from the role of C3 in the activation of the complement cascade
and subsequent destruction of parasites, C3 has also been demonstrated to play
a major role in the generation of B memory cells (Klaus and Humphrey,
1977). These cells are a specialised subgroup of B lymphocytes, which
represent a small percentage of the total B cell population in circulation when
the immune system encountered a particular antigen the first time. The
memory cells bear the memory of the initial exposure and are expanded in
number when the host immune system encounters the same antigen again.
This response boosts the immune response to the particular antigen at the time
of a secondary immune response (Irvine, 1979). C3 has also been
demonstrated to enhance cellular cooperation possibly by facilitating antigen
processing and presentation (Pepys, 1972; Pepys et al., 1976). Furthermore it
has been suggested that the binding of activated C3 to C3 receptors on B cells
(Bianco et al., 1970) might provide a necessary "second signal" for T-cell-
independent B-cell activation (Dukor and Hartmann, 1973) leading to the
production of antibodies by B cells without the influence of T cells.
Studies conducted on the role of complement in trypanosome infection
particularly C3, are limited and the results obtained often equivocal. For
instance, in mice depleted of complement and infected with T. cruzi,
significant increases in parasitaemia and mortality were recorded when
compared with non-complement depleted T. cruzi infected mice (Budzko et al.,
1975; Keirzenbaun, 1976). This demonstrated that complement is important
for in vivo control of parasitaemia in trypanosomiasis. This finding was also
confirmed by Cunningham et al. (1978) who conducted similar studies on
mice infected with T. cruzi. Flemming and Diggs (1978) showed that
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antibody-mediated cytotoxicity in trypanosomiasis was dependent upon
complement activation while Balber et al. (1979) demonstrated the absolute
complement requirement for the lysis of antibody treated T. brucei and T.
congolense populations. Other studies that demonstrated the importance of the
complement system in the elimination of trypanosomes were reviewed in
Nielsen (1985). The principal observation in these studies is that
trypanosomiasis affects the level of complement in infected individuals with a
consequent worsening of the clinical state of the animals if parasites were not
eliminated by chemotherapy.
A reduction in the level of circulating complement components has been
reported in infections with salivarian trypanosomes of man (Greenwood and
Whittle, 1976), rhesus monkeys (Nagle et al., 1974) and cattle (Kobayashi and
Tizard, 1976; Nielsen et al., 1978; Rurangirwa et al., 1980; Table et al., 1980).
These authors established that the reduced level of complement observed in
these infections affected the course of the disease by worsening the clinical
state of the infected animals. Other studies in which reduced levels of
complement components have been observed include those of Basson et al.,
(1977) in which the reduction in the levels of C4 and factor B were indications
that the activation of both the classical and alternative pathways occur in
trypanosomiasis.
Although the importance of complement in the control of parasitaemia in
trypanosomiasis has been demonstrated by several workers, some other workers
such as Shirazi et al. (1980) did not find a significant difference in the level of
parasitaemia between normal and C3-depleted mice. Dalmasso and Jarvinen
(1980) while studying the infection of mice and guinea-pigs with T. cruzi did
not find any difference in the level of parasitaemia in mice genetically deficient
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in C5 and normal mice. Similarly, studies with guinea-pigs genetically
deficient in C4 and normal guinea-pigs gave no indication of differences in the
course of the infection. This result according to the authors suggests a minor
role for the classical if at all, but not the alternative pathway in the control of
parasitaemia. Other studies by the same authors (Jarvinen and Dalmasso,
1976) with T. lewisi-infected rats however, showed a tremendous decrease in
serum complement C3 and C4 levels with C3 levels highly correlated to
parasitaemia. Another complement component - C6 was not decreased as
measured by haemolytic assay, and the parasitaemia in C4-deficient rats were
not significantly different from those of normal rats. Nielsen et al. (1978a)
also found that while the levels of some early complement components such as
CI and C3 were depleted in calves infected with T. congolense, that the levels
of some late complement components such as C8 were not reduced. These
results led these authors to doubt the importance of the classical complement
pathway in the elimination of trypanosomes since without the utilization of the
late complement components the effector process of the system will not be
achieved.
One mechanism responsible for the reported hypocomplementaemia in
trypanosomiasis could be extensive activation of complement by antigen-
antibody complexes (Musoke and Barbet, 1977). Such a process would reduce
the level of complement in circulation as complement fragments would be
utilised in the process of parasite elimination, probably by both the classical
and alternative pathways. The complex nature of complement in the host,
makes it much easier to study the complement system using in vitro systems
that are much easier to control. One of such in vitro systems is that used by
Klaus et al. (1979) to study the activation of the classical and alternative
complement pathways.
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In trypanosomiasis few in vitro studies have been conducted on the
activation of complement (Musoke and Barbet, 1977; Cunningham et al.,
1978). Each of these workers adopted the technique developed by Clark and
Freeman (1968) based on two-dimensional immunoelectrophoresis which
distinguishes between native C3 and its activated products which other
techniques used for assessing complement activation such as lytic assays
(Ferrante and Allison, 1983) are incapable of doing. The electrophoretic
technique exploits differences in electrophoretic mobility of the native
complement component and its activated products. With this technique
Musoke and Barbet (1977) demonstrated the activation of human complement
by an isolated variant-specific surface antigen of T. brucei through the classical
pathway while Cunningham et al. (1978) showed that viable trypanosomes and
trypanosome culture supernates activate complement primarily also through the
classical pathway.
In view of the central role that C3 plays in the activation of the classical
and alternative complement pathways, and its established importance in the
control of parasitaemia in trypanosomiasis, the series of experiments reported
in this chapter were designed to evaluate:
(1) The changes of C3 levels in rabbits infected with T. evansi during the
period of primary infection and after drug treatment.
(2) The extent of C3 activation in vivo in these animals.
(3) Complement activation using in vitro systems specific for the classical
and alternative pathways; and




T. evansi TREU 2147 described previously in Chapter 3 was used for all
the infections and preparation of soluble antigens used for the production of
complexes for the C3-cleavage assays. It was also the source of parasites used
for the C3-cleavage assays involving the use of whole trypanosomes.
Animals
Four adult female New Zealand White rabbits were used for the
experiment, each infected with 4 x 10^ motile trypanosomes through the ear
vein. The trypanosomes had been separated from the blood of mice with
fulminating infections with DEAE cellulose (DE52 Whatman Biochemicals) as
described previously. Twenty-four days after infection each infected rabbit was
treated with 7 mg (active principle) kgbody weight of diaminazene aceturate
(Berenil^, Hoechst, W. Germany). Rabbits were bled into bottles containing
EDTA (Sigma Ltd.) before infection, days 7, 11, 18, 21 and 24 post infection
and days 8 and 14 post drug treatment, for the preparation of plasma and
parasite estimation. Plasma samples were aliquoted into small volumes and
stored at -79°C until needed.
Blood for serum preparation was collected on equivalent days. These sera
samples were used for the determination of C3 activation and extraction of
immunoglobulin classes. Sera for immunoglobulin extraction were prepared as
previously described in Chapter 2 and stored at -20°C until needed, while
blood from which sera used for the determination of C3 activation were
obtained, was kept on ice for 20 minutes before the sera were aspirated and
processed as described in Chapter 2. Resulting sera samples were aliquoted in
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small volumes and stored at -79°C until needed.
Estimation of Relative C3 Levels
C3 levels in the plasma samples were measured by rocket
immunoelectrophoresis (Laurell, 1966) in a 1% agarose gel, pH 8.6, in
barbitone acetate buffer (Appendix 15) containing 2.5% sheep anti-rabbit C3
(ICN Immunobiologicals, UK) and 3% PEG 6000 (Sigma Ltd.).
Ten pi of plasma was placed into each well with a diameter of 5 mm cut
out of the gel with a metal punch. Current was applied at a constant voltage
of 150V and the proteins allowed to run across the agarose gel containing C3
antisera for about 18 hours. The gels were subsequently washed in PBS
(Appendix 1) for 24 hours and in destain solution for an hour to fix the
protein before being dried in a stream of hot air from a hair-drier. The dried
gels were stained with Coomassie Blue as described previously in Chapter 2 to
enhance contrast and expose the components bound to the gel.
In vivo C3 Activation Assay
The presence of cleavage products of C3 in serum of rabbits infected with
T. evansi was assayed using a two-dimensional immunoelectrophoretic
technique (counter-electrophoresis) of samples as described by Hudson and
Hay, (1976) and Johnstone and Thorpe (1987).
This was conducted as described previously for the estimation of the
relative C3 levels in the plasma samples. The only modifications were that 250
volts were used and electrophoresis was allowed to run for about seven hours.
No C3 antisera was included in the agarose gel. Tracks of separated proteins
from the first dimensional electrophoresis were cut off from the agarose gel
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and laid on one edge of a Gelbond^ film (Pharmacia). Fifteen ml of warm
1% agarose in barbitone acetate buffer pH 8.6 (Appendix 15) containing 2.5%
sheep anti-rabbit C3 (ICN Immunobiologicals, UK) and 3% PEG 6000 (Sigma
Ltd.) was then poured onto the Gelbond in such a way that the liquid agarose
merged smoothly with the solidified track of agarose containing the separated
proteins. Electrophoresis was then carried out for about 16 hours with a
constant voltage of 150V in such a way that the track of agarose containing the
separated serum proteins was on the cathodic side of the electrophoresis plate
so that when the current was applied the separated proteins migrated across the
agarose gel bed containing the C3 antisera. All electrophoresis was carried out
with the barbitone acetate buffer (Appendix 15). Gels were subsequently
processed and stained with Coomassie Blue as described previously in the
section dealing with the estimation of relative C3 levels in the plasma.
Fractionation of Immunoglobulins in Sera from T. evansi-infected rabbits
The immunoglobulins from T. evansi infected and uninfected rabbits for
the assessment of C3 activation were fractionated by salt precipitation, gel
filtration and ion-exchange chromatography.
(a) Isolation of IgG by anion exchange chromatography: DEAE-Affi-Gel
Blue was used according to the manufacturer's instructions for the isolation of
serum IgG.
Briefly, a column of DEAE Affi-Gel Blue with a total bed volume of 5
ml gel was used for each 1 ml of the serum processed. After packing the
column, the gel was washed free of residual dye with at least five bed volumes
of 0.1M acetic acid, adjusted to pH 3.0 containing 1.4M NaCl and 40% (v/v)
isopropanol. After washing, the gel was equilibrated with at least 12 bed
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volumes of buffer consisting of 0.02M Tris-HCl, pH 8.0, 0.028M NaCl, and
0.02% NaN3.
Serum from infected and non-infected rabbits was dialysed against 0.02M
Tris-buffer pH 8.0 (Appendix 16) respectively overnight. The samples from
the infected animals were made up of a mixture of equal volumes of sera
collected 14 and 18 days after infection from rabbits infected with T. evansi
TREU 2147. The dialysed serum samples were then applied to columns of
DEAE-Affi Gel Blue at the rate of 2 ml per 10 ml of equilibrated gel bed.
Unbound materials were then eluted with three bed volumes of the
recommended buffer (Appendix 16) and 3 ml fractions of the eluate were
collected. The absorbence of each fraction at 280 nm was determined with a
spectrophotometer and the fractions showing the highest absorbences were
pooled together. These pooled fractions were dialysed against distilled water
for 24 hours at 4°C, freeze-dried, reconstituted to a volume of 1 ml with
distilled water and stored at -20°C until required.
(b) Isolation of IgG by DEAE cellulose method (DE52): The DE52
method for the extraction of IgG of Shubbar (1978) was used. The practical
steps for the extraction adopted were those described in detail by Woldehiwet
(1981).
Briefly, DE52 (Whatman Biochemicals, U.K.) swollen in phosphate
buffer (KH^PO^, 0.5M) for 24 hours was transferred into a stoppered
Buchner flask and degassed under pressure. The pH of the slurry was then
adjusted to 7.6 by the addition of IS^HPO^, 0.5M. The slurry was then
washed by sedimentation and filtered twice with 0.1M phosphate buffer pH 7.6
through Whatman 54 filter paper under reduced pressure. Washing was
continued until the pH of the filtrate was the same as that of the buffer, after
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which the slurry was then used to pack a 40 cm by 2.5 cm column.
Fifteen ml of a mixture of serum consisting of equal volumes of serum
collected 14 and 18 days post infection were dialysed against tap water adjusted
to pH 6.1 at 4°C for 72 hours. The precipitate was removed by centrifugation
at 2000 g for 30 minutes at 4°C. The resulting supernatant was used as the
starting sample for IgG extraction. Fifteen ml of serum from uninfected
rabbits was treated similarly.
Fifteen to 20 ml of a 50% saturated solution of ammonium sulphate was
added to the supernatant. The precipitate formed was centrifuged at 2000 g
for 30 minutes at 4°C and the resulting supernatant discarded. The precipitate
was redissolved in distilled water to a final volume of 15 ml. The ammonium
sulphate precipitation and redissolution in distilled water were repeated twice.
The final precipitate was redissolved in 5 ml of distilled water, loaded in
dialysis tubes and dialysed against 0.02M phosphate buffer pH 7.6 for 24
hours. The dialysed material was then loaded onto the DE52 ion-exchange
column. Unbound materials were eluted in 10 ml volumes sequentially with
0.01M, 0.02M and 0.05M phosphate buffer pH 7.6 (Reid et al., 1971). The
second, third and fourth fraction had the highest absorbences at 280 nm
wavelength. These fractions were pooled together, dialysed against distilled
water for 24 hours at 4°C, freeze-dried and reconstituted in 5 ml of distilled
water and stored at -20°C in 200 pi volumes until required.
Isolation of IgM by Gel Chromatography on Sephadex G200
Thirty g of Sephadex-G200 (Pharmacia Ltd., London) was allowed to
swell at 4°C for three days in two litres of 0.1M Tris-FICl buffer + 1M NaCl,
pH 8.0, containing 0.02 per cent sodium azide (Jonas, 1969; Shubbar, 1978).
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The slurry was put into a stoppered Buchner flask and degassed under
pressure.
The slurry was then used to fill a 90 cm by 2.5 cm glass column and the
gel bed allowed to pack under a flow rate of 24 ml per hour for three days
with 0.1M Tris-HCl buffer plus 1M NaCl, pH 8.0. The homogeneity of the
gel bed was determined by running a volume of a 2 mg per ml solution of blue
dextran 2000 (Pharmacia Fine Chemicals) through the column. After this the
gel bed was again washed clean with excess buffer.
Thirty ml of a mixture of equal volumes of serum collected 14 and 18
days post infection were dialysed against tap-water adjusted to pH 6.1 at 4°C
for 72 hours. The precipitate was then separated from the supernatant by
centrifugation at 2000 g for 30 minutes at 4°C. The resulting precipitate was
redissolved in 0.1M Tris-HCl buffer pH 8.0 to a final volume of 5 ml. This
was then applied to the Sephadex G-200 column and left to fractionate at a
flow rate of 24 ml per hour with Tris-HCl buffer plus 1M NaCl pH 8.0. Five
ml fractions representing the unbound material were collected and the
absorbences monitored by the column monitor at 280 nm. The fractions
having the highest absorbance were pooled together. The pooled fractions
were dialysed against distilled water for 24 hours at 4°C, freeze-dried and
redissolved in distilled water to make a volume of 5 ml. This was then
aliquoted into 200 jxl volumes and stored at -20°C until required. The same
IgM extraction process was repeated with 15 ml of serum from uninfected
rabbits.
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Evaluation of the Purity of Immunoglobulin Fractions by Double
Immunodiffusion Test
In order to test the purity of the fractionated immunoglobulins, the
double immunodiffusion test described by Johnson and Thorpe (1987) was
used. Briefly, 15 pi of undiluted samples of the individual pooled fractions
from chromatography were placed into one of the three 5 mm diameter
centrally located wells cut in a 1% agarose gel, pH 8.6, in barbitone acetate
buffer (Appendix 15) containing 3% PEG 6000 (Sigma Ltd.). Ten pi of
affinity purified antisera (Nordic ) raised in goats to rabbit IgG, IgM and IgA
were then placed into three 5 mm diameter satellite wells which formed an arc
around the centrally located wells containing the extracted fraction. The gels
were then placed in a moistened lunch box and kept at 4°C until precipitation
lines were formed. Unreacted materials were removed from the gels by
washing in PBS for 24 hours; transferred to destain for an hour to fix the
proteins before being dried in a hot air stream from a hair drier. The dried
gels were then stained in Coomassie Blue as described previously in Chapter 2.
Immune Complex Formation for Studies on In vitro C3 Activation
(a) Complex formation with whole trypanosomes and trypanosome
O
soluble antigens: One x 10 motile trypanosomes separated from the host
blood cells with DE52 (Whatman Biochemicals, U.K.) as described previously
in Chapter 2 were mixed with 200 pi of a mixture of equal volumes of serum
collected 14 and 18 days post infection or serum collected from uninfected
rabbits respectively. T. evansi soluble antigens obtained by freeze-thaw and
O
centrifugation from 1 x 10 trypanosomes were similarly mixed with 200 pi of
the two sera samples as described above. These mixtures were incubated at
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37°C for 30 minutes and at 4°C for 24 hours. The resulting precipitates were
separated and washed twice with veronal buffer (Appendix 17) by centrifuging
at 1,200 g for five minutes before use.
(b) Immune complexes formed with fractionated immunoglobulins and
whole trypanosomes
O
(i) Complexes formed with IgG: 1 x 10 motile trypanosomes separated
from host blood cells with DE52 (Whatman Biochemicals, U.K,) were mixed
with 200 jjlI of IgG, containing 1000 jxg of proteins, obtained by fractionation
of post infection and normal rabbit serum. These mixtures were incubated at
37°C for 30 minutes and 4°C for 24 hours. The resulting precipitates were
separated and washed twice with veronal buffer (Appendix 17) by centrifuging
at 1,200 g for five minutes before use.
8
Complexes formed with IgM: 1 x 10 motile trypanosomes separated
from the host blood cells with DE52 (Whatman Biochemicals) were mixed
with 200 p.1 of IgM, fractionated from post infection serum and serum
obtained from uninfected rabbits containing 1,000 p,g of proteins. These
mixtures were incubated at 37°C for 30 minutes and 4°C for 24 hours. The
resulting precipitates were separated and washed twice with veronal buffer
(Appendix 17) by centrifuging at 1,200 g for five minutes before use.
In vitro C3 Activation Assay
The ability of the products of reaction between the parasites or T. evansi
soluble antigens and post infection or normal rabbit serum, to activate C3 in
vitro was assayed using the two dimensional electrophoretic technique described
by Klaus et al. (1979).
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The technique involved the analysis of rabbit complement (C^a^) (fresh
rabbit serum stored at -79°C) with first and second-dimensional
immunoelectrophoresis (Hudson and Hay, 1976; Johnstone and Thorpe, 1987)
after treatment with the complexes. The ability of the complexes formed with
sera collected from infected rabbits to activate C3 through the classical and
alternative pathways was investigated. The ability of the complexes formed
with IgG or IgM to activate C3 through the classical pathway alone was also
investigated. For each of the systems a control was incorporated and these
were the products of incubation of the normal rabbit serum or
immunoglobulins (IgG and IgM) fractionated from normal rabbit serum with
either whole trypanosomes or their soluble antigens.
C3 Activation through the Classical Pathway
All the complexes mentioned above were individually resuspended in 50
ixl veronal buffered saline (Appendix 17) containing 1.0 mM MgC^ and 0.15
mM CaC^. Fifty |xl of fresh rabbit serum (C^a^) was added to each tube
before the tubes were incubated at 37°C for 45 minutes. For each of the
systems a control was incorporated. After the incubation antigen-antibody
crossed electrophoresis (Laurell, 1965) was performed as described previously
for the one dimensional system in agarose gels containing 0.01M EDTA. The
second dimension was run as described previously in the presence of 2.5%
sheep anti-rabbit C3 (ICN Immunobiologicals, UK) (Pryjma et al., 1974),
after which the gels were processed as described previously and stained with
Coomassie Blue.
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C3 Activation through the Alternative Pathway
Complexes formed between whole trypanosomes or T. evansi soluble
antigens and trypanosome specific sera with their controls were individually
resuspended in 50 jxl of veronal buffered saline (Appendix 17) containing 25
mM MgC^ and 25 mM ethylene-glycol tris-(aminoethyl)-tetra- acetic acid
(EGTA, Sigma Ltd.). This buffer provides conditions for activation of the
alternative complement pathway only (Sandberg and Osier, 1971). Fifty p.1 of
fresh rabbit serum (C^a^) was added and the tubes incubated at 37°C for 45
minutes. Antigen-antibody crossed electrophoresis (Laurell, 1965) was
performed as described previously for the one dimensional system in agarose
gels containing 0.01M EDTA, the second dimension being run as described
previously in the presence of 2.5% sheep anti-rabbit C3 (ICN
Immunobiologicals, UK) (Pryjma et al., 1974). Gels were subsequently
processed and stained with Coomassie Blue as described previously.
RESULTS
Relative C3 Levels during T. evansi Infection
There was an initial increase between 5 and 7% in circulating C3 levels in
all the animals by seven days after infection when compared with preinfection
levels. This was followed by a gradual decrease up to 11 days after infection in
all the rabbits. Thereafter, a rapid fall in the levels of circulating C3 was seen
which continued up to around 21 days after infection. A reduction of 70% of
the preinfection C3 level was attained in one of the four rabbits (Figure 7.2A,
No. 21) at this time. A rise in the C3 level immediately before drug treatment
occurred in the same rabbit 24 days after infection (Figure 7.2A, No. 24).
After drug treatment, an increase in the level of circulating C3 was recorded in
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all the rabbits (Figure 7.2A to C: Nos. 32 and 38). The day 8 post drug
treatment serum sample of one of the rabbits (Figure 7.2B, No. 32) was
misplaced.
Parasitaemia Levels in T. evansi Infected rabbits
Parasites were first detected in the blood of each rabbit seven days after
infection. This was followed by a general increase in parasite counts until 11
days post infection. Thereafter, the level of parasitaemia fluctuated in
individual rabbits before they were drug treated 24 days after infection (Figure
7.3A to D). No parasites were detected in the blood of all the rabbits up to 14
days after drug treatment when the last samples were collected.
C3 Activation in T. evansi Infected Rabbits
A single precipitation peak was observed in the gel after the analysis of
serum samples collected before infection, seven days after infection and 8 days
after drug treatment (Figure 7.4, Nos. 9, 10 and 13). Two precipitation peaks
were observed when serum samples collected 21 and 24 days after infection
were analysed (Figure 7.4, Nos. 11 and 12). The height of the faster moving
precipitation peak was greater in the serum sample collected 21 than 24 days
post infection.
Assessment of the Purity of Ig Isotype (IgG and IgM) Preparation
(1) A single broad precipitation line was formed when the Affigel-Blue
extract (Figure 7.5, No. 1) was tested against antisera to rabbit IgG (Nordic)
(Figure 7.5, la). No precipitation lines were seen when the extract was
probed with antisera against IgM (Figure 7.5, No. lb) or IgA (Figure 7.5, No.
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lc).
(2) A single fine precipitation line was formed when the Sephadex G-200
extract (Figure 7.5, No. 2) was probed with antisera against IgM (Figure 7.5,
No. 2b). No precipitation lines were formed when the same extract was
probed with rabbit IgG (Figure 7.5, No. 2a) and IgA (Figure 7.5, No. 2c)
antisera respectively.
(3) A single fine precipitation line was formed when the DE52 extract
(Figure 7.5, No.3) was probed with antisera against rabbit IgG (Figure 7.5,
No. 3a). No precipitation line was formed when the same extract was probed
with antisera against rabbit IgM (Figure 7.5, No. 3b) and IgA (Figure 7.5,
No. 3c) respectively.
In vitro C3 Activation by Immune Complexes
Complexes formed with whole trypanosomes: Two precipitation peaks
were seen in the gels after the electrophoresis of the product of reactions
between the complexes and rabbit complement (C^a^) under the conditions
for activation by both the classical (Figure 7.6, No. 5) and alternative
pathways (Figure 7.6, No. 7). Differences were seen in the height of the
cleavage products, with the precipitation peak to the right side of the cathode,
higher in the classical than the alternative pathway. In both the classical
(Figure 7.6, No. 6) and the alternative (Figure 7.6, No. 8) pathways,
incubation with products of trypanosomes and normal rabbit serum yielded a
single precipitation peak.
Complexes formed with T. evansi soluble antigens: Five precipitation
peaks were observed after immunoelectrophoresis of the products of reactions
between the complexes formed with the soluble antigens of T. evansi and the
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post infection serum with rabbit complement (C^a^) under the conditions of
activation of complement through the classical (Figure 7.6, No. 1) and three
precipitation peaks by the alternative (Figure 7.6, No. 3) pathways. In both
the classical (Figure 7.6, No. 2) and alternative (Figure 7.6, No. 4) pathways a
single precipitation peak was seen with the control system in which the soluble
antigens had been incubated with normal rabbit serum and rabbit complement
(CRab).
Complexes formed with whole trypanosomes and immunoglobulin
isotypes: Two over-lapping precipitation peaks were observed after
immunoelectrophoresis of the products of reactions between the complexes
formed with whole trypanosomes and IgG with rabbit complement (C^"a^)
(Figure 7.7, No. 1) and two small precipitation peaks with the products
formed with IgM (Figure 7.7, No. 4) under the conditions of activation of
complement through the classical pathway. With both preparations only a
single precipitation peak was observed with the control system in which the
complexes were formed between the whole trypanosomes and IgG (Figure 7.7,
No. 3) and IgM (Figure 7.7, No. 6) fractionated from normal rabbit serum
and rabbit complement (C^a^). Figures 7.7, Nos. 2 and 5 are sketches for
Figures 7.7, Nos. 1 and 4 respectively.
FIGURE 7.2
C3 complement levels and parasitaemia in four rabbits experimentally
infected with T. evansi.







Levels of C3 in plasma of rabbits infected with T. evansi.
0 Normal rabbit plasma.
7-24 Days 7, 11, 18, 21 and 24 post infection plasma respec¬
tively.
32 and 38 Days 8 and 14 post treatment plasma respectively.
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FIGURE 7.4
Activation of C3 in serum of rabbits infected with T. evansi.
Numbers 0-38 C3 complement levels in days 0, 7, 11, 18, 21, 24 post
infection and days 8 and 14 post treatment plasma
respectively.
Numbers 9-13 C3 activation in days 0, 7, 21, 24 post infection and
day 8 post treatment serum respectively.
Number 14 Schematic representation of No. 11.
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FIGURE 7.5
Double immunodiffusion test for the verification of the purity of the
immunoglobulin extracts.
Number
1. Extract from Affigel
(a) Antiserum against rabbit IgG
(b) Antiserum against rabbit IgM
(c) Antiserum against rabbit IgA.
2. Extract from Sephadex G200
(a) Antiserum against rabbit IgG
(b) Antiserum against rabbit IgM
(c) Antiserum against rabbit IgA.
3. Extract from DEAE cellulose (DE52)
(a) Antiserum against rabbit IgG
(b) Antiserum against rabbit IgM
(c) Antiserum against rabbit IgA.
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FIGURE 7.6
In vitro C3 activation through the classical and alternative pathways.
1. Activation of C3 through the classical pathway by complexes
formed with T. evansi soluble antigens and post infection serum.
2. Activation of C3 through the classical pathway by products of
normal rabbit serum and T. evansi soluble antigen incubation.
3. Activation of C3 through the alternative pathway by complexes
formed with T. evansi soluble antigens and post infection serum.
4. Activation of C3 through the alternative pathway by products of
normal rabbit serum and T. evansi soluble antigen incubation.
5. Activation of C3 through the classical pathway by complexes
formed with live trypanosomes and post infection serum.
6. Activation of C3 through the classical pathway by products of
normal rabbit serum and live trypanosome incubation.
7. Activation of C3 through the alternative pathway by complexes
formed with live trypanosomes and post infection serum.
8. Activation of C3 through the alternative pathway by products of
normal rabbit serum and live trypanosome incubation.
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FIGURE 7.7
In vitro C3 activation through the classical pathway by complexes
formed with immunoglobulin isotypes.
1. Activation of C3 by complexes formed with live trypanosomes
and IgG fractionated from post infection serum.
2. Schematic representation of 1.
3. Activation of C3 by products of reactions between live trypano¬
somes and IgG fractionated from normal rabbit serum.
4. Activation of C3 by complexes formed with live trypanosomes
and IgM fractionated from post infection serum.
5. Schematic representation of 4.
6. Activation of C3 by products of reactions between live trypano¬




A consistent feature observed in all the rabbits infected with T. evansi was
a fall in the C3 levels as the infection progressed. Similar observations have
been reported by other workers for cattle infected with T. congolense and T.
vivax (Kobayashi and Tizard, 1976; Nielsen et al., 1978a; Rurangirwa et al.,
1980) and in rats infected with T. lewisi (Jarvinen and Dalmasso, 1976). One
possible cause of this drop in C3 levels could be C3 activation by antigen-
antibody complexes (Musoke and Barbet, 1977) that occurs during the
elimination of the parasites by the host immune system through complement
dependent effector mechanisms (Murray and Urquhart, 1977; Greenblatt et
al., 1983; Ngaira et al., 1983). The observations made in the current study
that the lowest levels of C3 were seen in rabbits during periods of highest
parasitaemia (Figure 7.3a to d) and in one rabbit, an increase in C3 level with
a fall in the level of parasitaemia (Figure 7.2A, No. 24 and Figure 7.3a) and a
rapid increase in C3 levels after chemotherapy in all the rabbits (Figure 7.2A
to C, Nos. 32 to 38) suggest a possible relationship between C3 levels and the
parasite burden. Increasing number of parasites would probably require more
C3 for their removal compared to lower parasites numbers. The number of
parasites in circulation could also have a direct effect on the level of C3 in
circulation as there is evidence that live trypanosomes release large quantities
of complement activating factor (Cunningham et al., 1978) which would again
link parasite number with complement reduction.
During the early part of the infection an initial rise in C3 levels was
observed in all the rabbits used in the present study (Figure 7.2A to C). A
similar observation was made by Shirazi et al. (1980) although of a greater
magnitude. In the present study an initial rise of 5 to 7% of the preinfection
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C3 level was recorded, while Shirazi and his colleagues observed a two to
three-fold increase. The reason for this initial rise is probably associated with
the fact that C3 is produced in large amounts during the acute phase of
infections (Horning and Arquembourg, 1965) and also that mononuclear
phagocytes, which are known to secrete C3, are highly active in the initial
stages of trypanosome infections (Longstaffe, 1974). Reported increases in
numbers and activity of the cells of the mononuclear phagocytic system (MPS)
of the liver a few days after trypanosome infection (Murray et al., 1974b) may
probably play a role in the initial rise in C3 levels as the liver is known to
secrete about 90% of C3 (Lambris, 1988). The activation of C3 results in the
splitting of C3 into subunits, which migrate with different speeds in the electric
field and the principle of complement activation assay relies on the property of
the activated products to move faster across the electrophoresis field than the
native component which usually appear as a precipitation peak behind the
faster moving precipitation peak(s) on the right side of the cathode, the
cleavage products (Clark and Freeman, 1968; Pryjma et al., 1974).
The results of the experiments on C3 activation in serum of rabbits
infected with T. evansi showed that with the normal rabbit serum, serum
collected seven days after infection and eight days after drug treatment only
one precipitation peak was recorded respectively (Figure 7.4, Nos. 9, 10 and
13). With serum samples collected 21 and 24 days after infection two peaks
were observed (Figure 7.4, Nos. 11 and 12). The presence of more than one
precipitation peak is indicative of C3 activation while a single peak depicts
non-activation of C3 (Pryjma et al., 1974). The activation products of C3
namely C3a and C3b, move faster than the native C3 over the electrophoretic
field and appear on the right side of the cathode whilst the native C3 appears
behind the activation products. The two cleavage products of C3 appear as a
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single peak because they have shared antigenic determinants (Hudson and
Hay, 1976). The identification of these cleavage products by antibodies
against the native C3 indicates that the breakdown products have some
antigenic determinants in common with the native C3. The observation of
activation of C3 during infection probably confirms our earlier suggestion that
C3 hypocomplementaemia may be due to activation of C3. The fact that the
highest degree of C3 activation occurred at a period of highest parasitaemia
(Figure 7.4, No. 11 and Figure 7.2a) in comparison with when the
parasitaemia was low (Figure 7.4, No. 12 and Figure 7.2a) probably shows
that the demand for C3 activation was linked to the level of parasitaemia.
When whole trypanosomes and T. evansi soluble extracts were used for
the formation of immune complexes with the post infection serum, all the
complexes caused the activation of C3 to some degree. Complexes formed
with soluble antigen complexes differed in their activation in that more
cleavage products were produced as seen by a large number of precipitation
peaks obtained (Figure 7.6, Nos. 1 and 3) than when complexes were formed
with live trypanosomes which resulted in the formation of a single cleavage
product was observed (Figure 7.6, Nos. 5 and 7) were used. The presence of
multiple peaks is thought to be due to a further breakdown of C3 cleavage
products. Factors such as C3b inactivator present in the serum are known to
break down the cleavage products, C3b, further into C3c and C3d which could
result in the appearance of multiple peaks on the gel, particularly when C3b
binds to a cell membrane (Frank, 1975). The fact that multiple component
formation was not seen with complexes formed with whole trypanosomes
suggests that other, internal, components of the parasite present in the soluble
antigen preparation could have the ability to break down C3 cleavage products
further or stimulate C3b inactivation. The absence of multiple peaks from the
- 242 -
in vivo assay for C3 activation (Figure 7.4, Nos. 11 and 12) may be an
indication that multiple component formation could also be an artifact arising
from the effects of chemicals or immunochemical processes (Nielsen and
Duncan, 1988). The absence of such a finding in the serum from infected
rabbits could suggest that a situation that can give rise to such extensive
parasite lysis and soluble antigen release is unlikely in natural situations.
IgG was observed to be more efficient than IgM in activating C3 based on
the height of the activated C3 products formed that was higher with IgG than
IgM (Figure 7.7, Nos. 1 and 4). A similar observation was made by Ishizaka
et al. (1968), Scott and Russell (1972), Klaus et al. (1979) and Van der Zee
et al. (1986). Ishizaka et al. (1986) showed that rabbit IgM is more effective
in activating complement when it reacts with a particulate antigen than when
the same antigen is used in a soluble form. One possible explanation for the
observation made in the present study could be that the IgM antibodies
produced in T. evansi are not as antigen specific as the IgG and therefore may
not bind very well to the trypanosome antigens to form complexes that would
bring about complement activation. This view is supported by the findings of
other workers (Hudson et al., 1976; Terry et al., 1980) that most IgM
produced in trypansomiasis are non-specific to the antigen, probably produced
as a result of polyclonal B cell stimulation.
The observation of larger and greater numbers of peaks in the classical
pathway assay (Figure 7.6, Nos. 1 and 5) than the alternative pathway (Figure
7.6, Nos. 3 and 7) probably indicates that C3 activation in T. evansi is more
effectively brought about through the classical than the alternative pathway, as
the two immunoglobulins, IgG and IgM, were also found to cause varying
degrees of C3 activation through the classical pathway (Figure 7.7, Nos. 1 and
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4). This observation is in agreement with those of Jarvinen and Dalmasso
(1976) who demonstrated that the classical pathway is superior to the
alternative in activating C3 in T. lewisi infections. The fact that T. evansi
infections had an effect on C3 is important because this could have far
reaching effects on how the host not only reacts to an ongoing infection, but
could also compromise the host's ability to respond to subsequent infections as
C3 has been shown to play an important role in the development of
immunological memory (Klaus and Humphrey, 1977).
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CHAPTER EIGHT
THE ROLE OF COMPLEMENT (C3) IN THE
GENERATION OF B MEMORY CELL FUNCTION




Although a major function of the immune system is to overcome current
infection, it also has an equally important role in protecting animals from
subsequent infections (Bowry, 1984; Roitt et al., 1985). Such secondary
responses of the host's immune system to an antigen differ from the primary
response in both the magnitude and rapidity with which secondary responses
are brought about. The ability of a host to mount a secondary response is
dependent on "immunological" memory, a system by which the host immune
system retains a record of an antigen it had experienced previously which it
uses to react very rapidly and in a highly specific manner to the antigen on
subsequent exposure. The concept of immunological memory is fundamental
to the control of pathogens by vaccination. At the cellular level expression of
immunological memory is linked to the expansion of populations of
lymphocytes which were originally generated during the primary response but
have persisted after recovery.
During maturation a proportion of the host lymphocytes after formation
in the bone marrow migrate to the thymus for maturation into T-cells from
where they eventually migrate to, and settle in the spleen and lymph nodes.
During their passage through the thymus they become subtly altered in that the
cells acquire functional specificity in the range of antigens they could
recognise. Other lymphocytes do not pass through the thymus but settle
directly in the lymph nodes and spleen. There they also mature, differentiate
and develop functional specificity in the type of antibodies they can secrete.
This second group of lymphocytes are called the B lymphocytes (Staines et al.,
1985). Each B cell carries on its surface an antibody molecule which acts as a
receptor for antigens. In effect, each B cell is programmed to make just one
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antibody, which is placed on its surface as an antigen receptor. Although
these individual effector cells are somewhat restricted in their numbers and
ability to recognise or react with antigens an effective immune response is
brought about by the process of selection and clonal expansion of these effector
cells. A B cell when exposed to an antigen that combines with its antigen-
specific receptors becomes activated and divides several times to form a clone
of daughter cells which start secreting antibody of the same type as that
expressed originally on the surface of the parent cell, which in turn initiates a
chain of events that culminates in the probable destruction of the antigen.
Similar expansion of the parent cells on antigenic stimulation occurs with T-
cells with the result that many daughter T-cells with the same range of
antigenic specificity are produced.
After recovery from the infection, most of the T and B cells disappear but
a small population of the lymphocytes persist and remain in circulation for
many years charged with maintaining the memory of exposure to the antigen.
These cells are referred to as T-memory (Tm) or B-memory (Bm) cells and are
responsible for initiating the rapid and highly specific responses generated when
the immune system of the host is exposed to the same antigen again.
Although the direct binding of an antigen to the appropriate surface
receptor of the B memory cells is known to stimulate its proliferation and
maturation into antibody-producing cells, other factors have been implicated in
the process. The role of non-immunoglobulin receptors on B lymphocytes in
the initiation of cell triggering by antigen has received particular attention in
recent years (Klaus and Humphrey, 1977). Results from these studies suggest
that the binding of activated C3 to the C3 receptors on B cells (Bianco et al.,
1970) may provide a necessary "second signal" for T-cell-independent B-cell
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activation (Dukor and Hartmann, 1973). To investigate this possibility, Klaus
and Humphrey (1977) evaluated the role of C3 complement component in the
generation of B memory cells. Their observations led them to suggest that the
stimulation of B-memory cells is greatly enhanced by the formation of
antigen-antibody-C3 complexes on dendritic cells in lymphoid follicles. In
effect they proposed that C3 stabilises and enhances the presentation of the
antigen by the dendritic cells to the Bm cells, a sequence of events that would
lead to the rapid proliferation and maturation of the B memory cells into
antibody producing daughter B cells. Results from a later study (Klaus, 1979)
indicated that the localisation of antigen-antibody (Ag-Ab) complexes in
lymphoid follicles is abrogated by the depletion of C3 levels which could have
an adverse effect on secondary immune response. These observations, together
with evidence from other studies (reviewed by Thorbecke and Lerman, 1976)
strongly suggests that the activation of Bm cells requires the deposition of Ag-
Ab-C3 complexes in lymphoid follicles as an important first step. These
complexes are envisaged as providing an antigen-specific B-cell trap within the
developing germinal centre (Ponzio et al., 1977). Further support for this
concept was provided from studies that showed that preformed Ag-Ab
complexes induce Bm cell generation more effectively and more rapidly than
soluble antigens (Klaus, 1978).
It is likely, therefore, that C3 plays an important role in the response of
an animal during secondary exposure to an antigen, through the activation of
Bm cells (Klaus and Humphrey, 1977), although there is no direct evidence of
its importance in responses to infections with pathogens such as trypanosomes.
Most of the studies on the importance of C3 levels in trypanosomiasis had
concentrated on the relationship of C3 with parasitaemia in infected animals
(reviewed in Nielsen, 1985). Information on the ways in which C3 could
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affect the ability of an animal to mount an immune response particularly
during secondary infections is unavailable.
One well established consequence of trypanosome infection, is C3
depletion which results in lowered C3 levels throughout infection (Jarvinen and
Dalmasso, 1976; Nielsen et al., 1978a; Nielsen et al., 1978b). In consideration
of the fact that C3 is probably involved in the sequence of immunological
activities that lead to the generation of secondary immune response and that
C3 levels are depressed thoughout infection with T. evansi, studies in this
chapter were designed to evaluate the influence of C3 depletion (Chocrane et
al., 1970; Klaus, 1978) on the ability of rabbits primed with T. evansi antigens
to respond to the same antigen on subsequent exposure. The changes in
antibody production by the primed animals during the challenge period were
used as an indirect measure of Bm cell function.
Two experiments were carried out, one involved the evaluation of the
ability of rabbits primed with T. evansi soluble antigens to produce antibodies
when exposed to the same soluble antigens alone or to complexes formed
between the soluble antigens and T. evansi specific sera from rabbits. The
second study involved the evaluation of the effect of C3 depletion on the
ability of rabbits primed with T. evansi soluble antigens to produce antibodies
when exposed to complexes formed between the soluble antigens and T. evansi
specific sera from rabbits.
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MATERIALS AND METHODS
1. ANTIBODY PRODUCTION IN RABBITS PRIMED WITH T. EVANSI
SOLUBLE ANTIGENS ON CHALLENGE WITH
HOMOLOGOUS ANTIGENS OR IMMUNE COMPLEXES
FORMED WITH T. EVANSI SPECIFIC SERA
Trypanosomes
T. evansi TREU 2147 described previously in Chapter 3 was used in this
study for the preparation of soluble antigens (Ag) and soluble antigen-7\ evansi
specific serum (Ag-Ab) complexes. Separation of the trypanosomes from host
blood cells was achieved with DEAE cellulose (DE52, Whatman Biochemicals)
as described in Chapter 2. T. evansi soluble antigens used for the priming and
challenge of rabbits and making of immune complexes were prepared as
described in Chapter 2 by lysing the trypanosomes with three cycles of freezing
and thawing with solid carbon dioxide and separation of the supernatant
fraction, the soluble antigens, by centrifugation.
Animals
Four female adult New Zealand White rabbits were used. Blood samples
were collected from each rabbit before they were inoculated with T. evansi
soluble antigens (day 0) and on days 1, 10, 14, 17, 21, 24, 32 and 38 post-
antigen inoculation. A second batch of blood samples was collected from these
animals on days 2, 7, 14 and 21 after challenge with soluble antigens or the
immune complexes. Serum was prepared from these blood samples as
described in Chapter 2.
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Protein Estimation
The protein concentration in all samples of both antigen and immune
complexes were estimated photometrically by the BCA^ technique as
described in Chapter 2.
Formation of Antigen-Antibody (Ag-Ab) Complexes
Immune complexes were formed by incubating 2 mg of the soluble
antigens with 500 pd of a pooled serum sample consisting of equal volumes of
sera collected on days 14, 17 and 18 from two rabbits infected with
TREU 2147. The mixture was incubated at 37°C for 30 minutes and then at
4°C overnight. Any complexes formed were centrifuged at 1,200 g for 10
minutes and washed once with PBS before use.
Response of Rabbits to Challenge with Soluble Antigens or Complexes
Each of four rabbits was inoculated through the ear vein with 1 mg of the
soluble antigen of T. evansi TREU 2147 made up to 1 ml in PBS. Sixty-three
days after the first administration of the soluble antigens, two rabbits were
then inoculated through the ear vein with 0.5 mg of the soluble antigen made
up to 1 ml in PBS, while the two other rabbits were inoculated through the
same route with 0.5 mg of Ag-Ab complex made up to 1 ml in PBS.
Enzyme-linked Immunosorbent Assay (ELISA) for the Estimation of
Antibody Levels to T. evansi Soluble Antigens
To quantify the level of class-specific antibodies, IgG, IgM and IgA,
produced by the primed animals on secondary challenge with soluble antigens
alone or with immune complexes, the double "sandwich" ELISA technique was
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used.^the detection of the class-specific antibodies a modification of the
practical steps of ELISA described by Luckins (1977) was used.
Briefly, 100 p,l of l(xg/ml of T. evansi TREU 2147 soluble antigen in
coating buffer (Appendix 18) was used to coat the micro-ELISA plates
overnight. After coating, the plates were washed with PBS/Tween 20 three
times at intervals of three minutes per wash and the parts of the plate not
coated with the antigens were blocked with 1% bovine serum albumin in PBS
(w/v) (BSA, Sigma Ltd.) to prevent the non-specific binding of reagents to the
plate. After blocking for 60 minutes at 37°C the plates were again washed as
described above. Thereafter, 100 p,l of the sera samples diluted 1:200 for IgG
and 1:100 for IgA and IgM were added to the wells and incubated for 30
minutes at 37°C. The plates were again washed as before. After washing,
100 |xl of affinity purified antisera (Nordic ) raised in goats to the heavy
chains (Fc) of rabbit IgG, IgM or IgA at a dilution of 1:6000 for IgG and
1:1000 for IgM and IgA respectively were added into the wells and incubated
for 30 minutes at 37°C. After another cycle of three washes, 100 |xl of
affinity purified antisera (Nordic^) raised in rabbits to the heavy and light
chains of goat IgG conjugated to peroxidase were added to each well of the
micro-ELISA plate at a dilution of 1:4000. After an incubation period of 30
minutes at 37°C, reactions were visualised by the addition of a substrate
solution. The substrate used was 3,3',5,5'-tetramethyl-benzidine (TMB, Sigma
Ltd.), 10 mg of which was dissolved in 1 ml dimethyl sulphoxide and then
added to 99 ml citrate acetate buffer (0.1M, pH 6.0), followed by 15 p.1 of
30% hydrogen peroxide immediately before use. The reaction was stopped
after 15 minutes by the addition of 50 jjlI 1M sulphuric acid and the optical
density (OD) of each test well was read at 450 nm wavelength using a
spectrophotometer.
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2. THE EFFECT OF C3 DEPLETION ON THE ABILITY
OF RABBITS TO PRODUCE A SECONDARY RESPONSE
TO T. EVANSI ANTIGENS
Trypanosomes, soluble antigen administration and serum preparation were
as described for the previous group of animals referred to in the first part of
this chapter. In the present study the complement of some rabbits in this
experiment was depleted by the administration of cobra venom factor
(Chocrane et al., 1970; Klaus, 1978) after which the animals were challenged
with immune complexes only.
C3 Depletion
Fifty |xg of pure cobra venom factor, CVF (Sigma Ltd.) made up to 1 ml
in PBS was injected into two rabbits 46 days after the administration of the
soluble antigens followed by a second injection three days later. Two control
rabbits were also injected with the soluble antigens on the corresponding days
which did not receive the CVF injection.
Secondary Exposure to T. evansi Antigens
Each of the four rabbits were inoculated through the ear vein with 0.5 mg
of T. evansi (TREU 2147) Ag-Ab complex prepared as described in the first
part of this chapter one day after the first administration of the first CVF
injection.
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Serum and Plasma Collection
Blood for the preparation of serum was collected from each of the rabbits
before they were injected with the soluble antigens (day 0) and on days 7, 14
and 21 after the soluble antigen injection. Another batch of blood samples
were collected from the animals on 1, 3, 7, 14 and 21 days after the
administration of the first CVF injection.
On each of the days blood samples were collected for serum, separate
blood samples were collected in bottles containing EDTA (Sigma Ltd.) for the
preparation of plasma for the estimation of C3 levels in circulation by rocket
immunoelectrophoresis (Laurell, 1966) as described in Chapter 7. Plasma
samples were aliquoted into smaller volumes and stored at -79°C until needed.
RESULTS
1. ANTIBODY PRODUCTION IN RABBITS PRIMED WITH
T. EYANSI SOLUBLE ANTIGENS ON CHALLENGE WITH
HOMOLOGOUS ANTIGENS OR IMMUNE COMPLEXES
FORMED WITH T. EVANSI SPECIFIC SERA
Each rabbit produced the three classes of immunoglobulins, IgG, IgM and
IgA, that recognised the soluble antigens of T. evansi as indicated from ELISA
results (Figure 8.1A to D). The pattern of immunoglobulin isotype production
was similar in all the rabbits during the period following the administration of
the soluble T. evansi antigens. Basically, a rise in the level of IgM was
recorded in the four rabbits between 10 and 14 days after the administration of
the soluble antigens until about 21 days after the soluble antigen administration
when the level of IgM was observed to wane in all the rabbits. IgG levels
increased in all the animals from 10 days after the administration of the soluble
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antigen and remained fairly stable, although with some decrease in levels in
individual animals, until 63 days after the administration of the soluble
antigens when the animals were either challenged with soluble antigens or Ag-
Ab complexes. IgA levels although lower than IgG and IgM produced by the
animals during the period, remained fairly stable all through the period
following the administration of the soluble antigens in three of the animals.
The IgA level was found to be consistently low in one rabbit (Figure 8.ID).
Response to Challenge
In the case of both rabbits challenged with soluble antigen there was an
increase in the level of antibodies (Figure 8.1A and B, Nos. 63 to 84). A
slight increase in IgG antibody production was followed by a gradual increase
in the IgM and lastly IgA antibodies which showed a slight increase in level.
Differences were, however, seen between the level of antibody produced by
individual rabbits based on the ELISA readings (Figure 8.1A and B, Nos. 63
to 84). One of the rabbits responded earlier to the rechallenge by producing
higher levels of antibodies two days after the administration of the soluble T.
evansi antigens (Figure 8. IB, Nos. 65 to 84) compared to the second rabbit
that showed a comparable increase in antibody level seven days after the
administration of the soluble antigens (Figure 8.1A, Nos. 70 to 84).
There was also a rapid and marked increase in the level of antibodies
produced by the two rabbits challenged with the Ag-Ab complexes. In both
rabbits there was a clear increase in the level of IgG and IgM produced seven
days after the administration of the complexes (Figure 8.1C and D, Nos. 70 to
84). About a three-fold increase in the level of IgG produced by the animals
after the injection of the soluble antigens (Figure 8.1C and D, Nos. 1 to 38)
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were observed from seven days after the administration of the immune
complexes (Figure 8.1C and D, Nos. 70 to 84). After the initial increase, IgG
levels remained stable with minor fluctuations until the observation was
discontinued. About a one-and-a-half to two-fold increase of the IgM
produced by the animals after being injected with soluble antigens were
observed after they were challenged with the immune complexes. Thereafter a
gradual decrease in the level of IgM was observed until the observation was
discontinued (Figure 8.1C and D, Nos. 70 to 84). Slight increases in IgA
levels were observed in the two rabbits within the period of observation.
2. EFFECT OF C3 DEPLETION ON SECONDARY RESPONSE TO T.
EVANSI ANTIGEN
Rocket electrophoresis of the plasma samples collected from the two
control rabbits primed with the soluble antigens of T. evansi which did not
receive the CVF injection showed that C3 levels remained stable in the two
rabbits throughout the period of observation (Figure 8.2A and B).
Rocket electrophoresis of the plasma samples collected after the rabbits
were injected with CVF however, showed that C3 was completely removed
from the plasma samples collected one and three days after the animals were
injected with CVF (Figure 8.2B and D, Nos. 47 and 49). Analysis of plasma
samples collected on 7, 14 and 21 days after the first administration of CVF
showed a gradual restoration of plasma C3 levels in both rabbits (Figure 8.2C
and D, Nos. 53 to 67).
FIGURE 8.1
Class-specific antibody production in primed rabbits challenged with T.
evansi soluble antigens of immune complexes.
A and B Rabbits challenged with T. evansi soluble antigens.
C and D Rabbits challenged with immune complexes formed with T.
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FIGURE 8.2
C3 levels in plasma of cobra venom treated and non-treated rabbits.
A and BC3 levels in rabbits not treated with cobra venom factor.
C and DC3 levels in rabbits treated with cobra venom factor.
(Cobra venom factor was administered on day 46 after the rabbits
were injected with T. evansi soluble antigens and a second injection










Response of of Rabbits to T. evansi Soluble Antigens Prior to the
Administration of the CVF Injection
The pattern of antibody production as revealed by ELISA readings were
similar to those of the four rabbits in the first part of the experiment
conducted in this chapter, where T. evansi primed rabbits were challenged with
either soluble T. evansi antigens or with immune complexes. All the animals
in the present part of the study produced the three classes of antibodies, IgG,
IgM and IgA against the T. evansi soluble antigens (Figure 8.3A to D, Nos. 14
and 21). Variations in the antibody level produced by individual rabbits were
also similar to those in the first part of the experiment.
ANTIBODY RESPONSE BY RABBITS CHALLENGED WITH IMMUNE
COMPLEXES
The two T. evansi antigen-primed control rabbits produced the three
classes of antibodies, IgG, IgM and IgA to T. evansi soluble antigens as shown
by the ELISA readings after they were challenged with the immune complexes
(Figure 8.3C and D, Nos. 47 to 67). Two- to three-fold increases in levels of
IgG and IgM were seen in both animals after challenge compared to pre-
challenge levels (Figure 8.3C and D, Nos. 53 to 67). The IgG level remained
stable after the initial rapid increase, but gradual reductions in the IgM levels
were seen in both rabbits in the remaining period of observation. IgA levels in
both rabbits appeared unaffected during the post-immune complex
administration period.
In the case of the two rabbits primed with T. evansi soluble antigen but
treated with CVF, the administration of complexes produced a response
consisting of the three classes of antibodies under consideration, IgG, IgM and
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IgA. During this period the two rabbits produced more IgM than IgG
antibodies with IgA ranking last in the amount produced based on the ELISA
readings. Two- to three-fold increases in the IgM level produced before the
animals were C3 decomplemented was produced from three days after the
rabbits were injected with the CVF injection until day 21 post-CVF
administration when the observation was terminated (Figure 8.3A and B, Nos.
49 to 67). About one-and-a-half times the IgG levels produced before the
animals were injected with CVF was produced seven days after CVF injection
and the immune complex administration until day 21 post-CVF administration
when the observation was discontinued (Figure 8.3A and B, Nos. 53 to 67).
The IgA level in one rabbit remained stable (Figure 8.3A, Nos. 47 to 67)
while slight increases in IgA levels were observed in one rabbit from days 14 to
21 post-CVF administration.
FIGURE 8.3
Class-specific antibody production by cobra venom treated and non-
treated rabbits.
A and B Rabbits injected with cobra venom factor.




























It is impossible to measure directly the numbers of Bm cells or their direct
response to antigens without reverting to the use of complex procedures, such
as labelling the cells with radioactive reagents. To overcome this, an indicator
of Bm cell function was based on an estimation of antibody levels produced by
the animals during the period of secondary exposure. The suitability of such an
index of Bm cell function stems from the fact that Bm cells are responsible for
the antibody production during the period of secondary immune response via
the activities of their antibody-secreting progeny (Irvine, 1979; Roitt et al.,
1989). The greater the Bm cell response then the greater the antibody
response.
Results from the present study indicated that Ag-Ab complexes were
more potent than soluble antigens alone in the activation of Bm cell function as
higher levels of antibodies were produced by the animals challenged with the
immune complexes (Figure 8.1C and D, Nos. 70 to 84) than those challenged
with soluble antigens alone (Figure 8.1A and B, Nos. 70 to 84). The
predominant IgG production by the animals during this period is thought to
support the fact that the antibodies produced reflect the Bm cell function
because Bm cells are more potent than unprimed B cells in the production of
IgG (Roitt et al., 1989). This observation is in agreement with the findings of
Klaus (1978) who found that Ag-Ab complexes used in his study elicited
stronger antibody responses than soluble antigens alone.
The complete absence of detectable levels of C3 in the plasma samples
collected from rabbits soon after the injection with CVF (Figure 8.2C and D,
Nos. 47 and 49) confirms the pharmacological property of CVF as a potent C3
decomplementing agent (Cochrane et al., 1970) and that both rabbits could be
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considered to be decomplemented at the time of challenge with the immune
complexes.
There was a difference in the nature and magnitude of antibody
production between the C3 intact (Figure 8.3C and D) and C3 depleted
animals (Figure 8.3A and B). Higher levels of antibodies were produced
during the challenge period by the C3 intact rabbits which were predominantly
IgG (Figure 8.3C and D, Nos. 49 to 67) while the C3-depleted rabbits
produced lower levels of IgG with high levels of IgM within the same period of
observation (Figure 8.3A and B, Nos. 49 to 67). This result indicates that C3
has a role to play in the response of these primed animals to re-exposure to the
homologous antigen, probably by stimulating the activation of Bm cells (Klaus
and Humphrey, 1977). The reduced immune response observed in the C3-
depleted animals compared to the complete absence of response observed by
Klaus and Humphrey (1977) in thymectomized mice whose C3 levels were
depleted before challenge, probably indicates that some C3 independent factors
may be affecting the secondary immune response in the C3-depleted animals in
our study. This might be linked to T-cell dependent secondary responses since
we used thymus-intact rabbits for our studies.
The enhanced IgM production observed in the C3-depleted animals in the
present study could be due to the fact that a factor that sustained the antibody
production in animals in the absence of C3, may be more specific in
stimulating IgM producing Bm cells than IgG or IgA producing Bm cells.
Alternatively, it could indicate a state of non-stimulation of Bm cell function
in these animals because of the absence of C3. In the absence of C3 which
completes the bridge between the dendritic cells and the Bm cells (Klaus and
Humphrey, 1977) that brings about Bm cell activation, it is likely that the
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immune system of these animals reacted to the immune complexes as if they
were being introduced into the animal for the first time and therefore,
produced more IgM antibodies, which are characteristic of primary infections
(Irvine, 1979; Roitt et al., 1985).
The observations made in the present study could be of practical
significance in the control of trypanosome infections due to the well
documented reduction in C3 levels in trypanosomiasis (reviewed in Nielsen,
1985) which was also observed in the present study reported in Chapter 7.
These results provide evidence that apart from the depletion of C3
compromising the ability of the immune system of the infected animals from
eliminating the parasites via complement mediated effector mechanisms
(Murray and Urquhart, 1977), it may also be important in determining the
way in which an animal responds to a secondary exposure to trypanosome
infections probably by breaching the sequence of events that leads to the
activation of "immunological" memory.
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CHAPTER NINE
PATHOLOGICAL CHANGES IN SELECTED
ORGANS OF RABBITS EXPERIMENTALLY
INFECTED WITH TRYPANOSOMA EVANSI
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INTRODUCTION
After infection with African trypanosomiasis the mammalian host mounts
an antibody response against the parasite. This response appears to be directed
strongly against the variable surface antigens of the parasite, and feebly against
the non-surface components (Le Ray, 1975). The antigen-specific antibodies
enable the host to eliminate the parasites in the bloodstream by a combination
of antibody-dependent phagocytosis (Greenblatt et al., 1983; Ngaira et al.,
1983) and/or complement-mediated lysis (Murray and Urquhart, 1977).
Extravascular localisation has been demonstrated for T. brucei (Losos and
Ikede, 1970) and T. rhodesiense (Nagle et al., 1980) with the suggestion that
such parasite populations serve as the source of parasites that give rise to new
antigenic variants that re-invade the circulatory system. A variety of tissue
lesions arising from the effects of these localised parasite populations may,
complicate the trypanosome disease syndrome subsequently leading to the
death of the host (Koten and Raadt, 1969; Omerod, 1970; Hutt and Wells,
1971; Losos and Ikede, 1972; Sadun et al., 1973; Murray et al., 1974a; Poltera
et al., 1976). Although some of these findings have been well documented,
the exact nature of the changes undergone by these organs during trypanosome
infection and the sequence of events that lead to the death of an infected host,
particularly in animals such as rabbits that die without experiencing fulminating
infections is still unresolved (Seed, 1969). Results of some studies indicate that
immune responses of the host to the parasites while providing a means of
eliminating the parasite through the activities of the antibodies (Greenblatt et
al., 1983; Ngaira et al., 1983) can contribute to the development of
pathological events such as the deposition of immune complexes in organs such
as the kidney (Nagle et al., 1974; Van Marck Vervoort, 1980), leading to
kidney damage and subsequently the death of the host. Immune complex-
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mediated damage akin to type III allergic reactions has also been suggested to
occur and also constitute another way through which the immune response of
the host animal aimed at alleviating the plight of the infected animal could
lead to the development of some undesirable consequences. Such reactions are
thought to arise following the repeated destruction of trypanosome populations
by the host antibody and the continuous shedding of antigens by live
trypanosomes into the antibody-laden surrounding (Vickerman and Barry,
1982). The development of autoimmune reactions against host components
such as immunoglobulins (Klein et al., 1970), liver, brain, kidney and heart
tissues (Mackenzie and Boreham, 1971; Mansfield and Kreier, 1972), spleen
cells (Mitry-Martin et al., 1979), thymocytes (Kobayakawa et al., 1979), and
erythrocytes (Kobayakawa et al., 1979; Rickman et al., 1981) have been
OA
demonstrated in trypanosomiasis and is^undesirable consequence of the host
immune response against the parasites.
The third complement component (C3), which plays an important role in
both the generation of B memory (Bm) cells, (Klaus and Humphrey, 1977)
and lysis of trypanosomiasis is affected by trypanosome infections. Studies
conducted by several workers reviewed by Neilsen (1985) have amply
demonstrated that marked C3 decomplementaemia occurs in trypanosomiasis,
which suggests that apart from trypanosome infection having an immediate
effect on the animal as a result of the activities of the parasites and possibly
other consequences of the disease, it is likely, therefore that the infection may
also compromise the ability of an infected animal to deal with a current
infection and mount a significant secondary response. The pathological
consequences of trypanosomiasis on some organs, e.g. glomerular
hypercellularity which subsequently leads to the development of proteinuria
and death of infected animals have been associated with the deposition of C3
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and some antibody classes particularly IgG and IgM in the renal glomeruli.
Furthermore, the liver which produces more than 90% of C3 (Lambris, 1988),
is also known to be damaged in infections caused by trypanosome species
transmitted by tsetse flies such as T. congolense (Morrisen et al., 1982b).
The implication of these observations is that while some changes taking
place in the organs of trypanosome infected animals may be associated with the
direct activities of the parasites, some other changes may be the consequences
of the host's defence response which could be both to the advantage and
disadvantage of the host. Based on this premise, the studies in this chapter
were designed to evaluate the changes occurring in some selected organs
considered to be associated with the immunobiology and/or pathology of
trypanosomes with a view to distinguishing between changes that are
pathological and consequently destructive from those that are physiological and
protective. The organs selected for evaluation included the kidneys, lymph
nodes, liver and the spleen. The selection of other organs was based on the
routine observation that they are usually inflamed in rabbits infected with T.
evansi and included the vulva, the ears and the eyelids.
MATERIALS AND METHODS
Six adult female New Zealand White rabbits were used for the study.
Four of the rabbits were infected with 4 x 10^ motile trypanosomes, TREU
2147, from mice with fulminating infections. The trypanosomes were
separated from the host blood cells using anion-exchange chromatography with
DEAE cellulose (DE52, Whatman Biochemicals) as described previously in
Chapter 2, resuspended in 0.5 ml aliquots in ice-cold PSG (Appendix 2) and
injected into rabbits through the ear vein. The two other rabbits were
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sacrificed as uninfected control animals.
Two of the rabbits infected with T. evansi were treated with the
trypanocidal drug, diaminazene aceturate (Berenil^, Hoechst, W. Germany)
(7 mg active principal per kg body weight) 28 days after infection. The two
remaining infected rabbits were sacrificed 28 days after infection. The two
uninfected rabbits were also sacrificed at the same time.
HISTOLOGY
Control Animals
Animals were killed with Pentobarbitone sodium, Euthatal (May and
Baker (U.K.) Ltd.) by intravenous injection. Tissues were collected from the
prefemoral and prescapular lymph nodes, the spleen, liver, kidneys and the
vulva, from the tip of the ear and the eyelid from each animal.
Infected Animals
Tissues were obtained with a 3 mm diameter tissue punch (Baker
Laboratories, USA) under Xylocaine-HCl local anaesthesia from the vulva,
through the outer skin 7 and 17 days after infection from two rabbits.
Twenty-eight days after infection the two rabbits were killed with Euthetal
(May and Baker (U.K.) Ltd.) and tissues also collected from all the organs
under study in this experiment. Tissue preparation and staining were carried
out as described for the tissue samples collected from the control rabbits.
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Infected and Drug Treated Animals
Tissues were obtained with the 3 mm diameter tissue punch from the
vulva of the two rabbits 7, 17 and 28 days after infection.
The two rabbits were killed 3 and 20 days after drug treatment with
Euthetal respectively. On each of these days, tissues were collected from all
the organs under study and sections prepared and stained as described
previously. All tissues were then fixed in 10% buffered formal saline before
sections 5 jxm thick were cut from paraffin-embedded blocks and stained with
Mayer's haematoxylin and eosin or Giemsa (Cook, 1974).
RESULTS
The histopathological examination of stained tissue sections revealed the
presence of some changes in the organs of the infected animals which were not
present in the sections collected from tissues of T. evansi uninfected animals as
described below.
The Liver
The livers of the non-infected animals at necropsy were firm, had sharp
edges and were not swollen. Sections of tissues collected from the livers of the
non-infected animals showed radiating hepatic cords, well defined sinusoids
and no cellular infiltration (Figure 9.1A) indicative of normal hepatic
architecture (Wheater et al., 1987). The livers of the infected rabbits were,
however, grossly swollen had rounded edges, were tarry red in colour and
friable. Marked cellular infiltration mainly in the portal tracts, and fatty
degeneration of the hepatocytes, were the main features observed in the tissue
sections prepared from tissues collected from the livers of rabbits killed 28 days
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after infection (Figure 9.IB). Cell types in the filtrate were mainly small and
large lymphocytes, plasma cells, macrophages and a few neutrophils in the
blood vessels (Figure 9.1C). In many sections the hepatic cords were
disorganised with small foci of centrilobular hepatocyte degeneration. There
was an increase in the number of Kupffer cells lining the hepatic sinusoids.
Vacuolations of variable sizes, disruption of the sinusoids, some evidence of
nuclear fragmentation and periportal haemorrhages were some of the other
findings seen in the stained tissue sections. No trypanosomes were identified
in any of the liver sections examined (Figure 9.IB). Sections prepared from
tissues obtained from the liver after drug treatment showed a marked reduction
in cellular infiltration and this was more evident in the sections from the tissues
collected 20 days after than three days after drug treatment.
The Vulva
Grossly, the vulva of the non-infected animal was not swollen.
Histological sections revealed a well defined epidermis, dermis and a thick
fatty layer with a few mononuclear cells scattered around the dermis (Figure
9.2A). Grossly the vulva of the infected rabbits were swollen from around 17
days after infection and remained so until day 28 after infection. Microscopal
examination of stained sections of tissues obtained from the vulva seven days
after infection revealed no obvious histopathological changes other than signs
of cellular infiltration. Sections from tissues collected 17 and 28 days after
infection revealed the presence of extensive oedema, massive cellular
infiltration into the dermis of the vulva skin and vulva parenchyma (Figure
9.2B). The cell types in the infiltrate include numerous small and large
lymphocytes, plasma cells and macrophages. The most striking observation
made was the presence of a large population of trypanosomes throughout the
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vulval dermis. Trypanosomes were seen in the sections prepared from tissues
collected 17 days after infection with the highest parasite numbers observed
from sections obtained from tissues collected 28 days after infection (Figure
9.2C). Parasite counts from the blood at this time, 28 days after infection,
were found to be lower than counts obtained 17 days after infection. In the
case of drug treated animals much trypanosome nuclear debris was observed in
the tissue section obtained from the vulva (Figure 9.2D) which appeared to be
smaller in size, in sections obtained 20 days after than three days after drug
treatment. Cellular infiltration was also reduced in the sections from tissues
collected after drug treatment than in sections from tissues obtained 28 days
after infection. Many plasma cells and some macrophages were however, seen
in the sections after the animals had been drug treated.
The Spleen
Grossly the spleens of the infected animals were about three to five times
larger than those of the non-infected animals. Sections from tissues obtained
from the spleens of the uninfected rabbits showed well defined splenic cords
lined by macrophages with about one neutrophil seen in about three
microscopic fields. Many erythrocytes with well defined outlines were
identified in the venous sinuses (Figure 9.3A). The most extensive change
following T. evansi infection in the spleen was observed in the red pulp which
was found to be more extensive, engorged and hyperplastic. The sinuses were
distended by erythrocytes and macrophages, with some of the macrophages
containing trypanosomal nuclei. Trypanosoma! nuclei were also observed
scattered throughout the red pulp. Extensive vacuolar spaces were observed in
the pulp cords with one to two neutrophils identified per microscopic field.
Some plasma cells were also identified in the red pulp parenchyma (Figure
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9.3B). After drug treatment lesser amounts of cellular infiltration and
engorgement were observed in stained sections. Few trypanosomal nuclear
materials were still evident at this time in the red pulp which appeared to be
smaller in size than in sections of tissues obtained 28 days after infection.
The White Pulp: The white pulp of the spleens of the control animals had
defined boundaries and were clearly demarcated from the adjoining red pulp
(Figure 9.4A). Microscopal examination of stained sections through the white
pulp of the control rabbits revealed the presence of many small and large
lymphocytes and macrophages. Plasma cells and erythrocytes were not evident
in the sections. In comparison with the control animals, the lymphoid nodules
of the white pulp of spleen tissue collected 28 days after infection were
hyperplastic and diffuse in nature with the lymphoid nodules merging into the
extensive red pulp in many places (Figure 9.4B). Microscopal examination of
the stained sections of the white pulp from the spleen of the infected animals
revealed the presence of predominantly large and some small lymphocytes,
many macrophages within the periarteriolar sheath and nodules. Some red
blood cells were also present in the sections. No trypanosomes were detected
in the white pulp of the infected animals. After drug treatment, there was a
reduction in the number of cells identified in the white pulp. Plasma cells,
however, were still evident in the sections by this time.
The Lymph Nodes
The lymph nodes of the infected animals in comparison with those of the
controls were swollen. Stained sections of tissues obtained from the lymph
node of uninfected control animals had well defined follicular areas in the
cortex. The paracortical and medullary zones appeared normal (Wheater et
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al., 1978). There was no evidence of cellular proliferation into the different
zones of the lymph node (Figure 9.5A).
Similar histological changes were observed in the stained sections of the
prefemoral and prescapula lymph nodes obtained from the rabbits 28 days after
infection. The cortical follicles were poorly defined due to very active
hyperplasia with many large lymphocytes, plasma and macrophages evident in
the sections. Active proliferation of macrophages, indicated by the presence of
the "starry-sky" appearance of such areas was evident in some sections of the
paracortex and the medulla. Marked cellular infiltration into the substance of
the lymph node was generally evident (Figure 9.5B). The medulla of the
lymph nodes from infected animals was extensive and the medullary cords were
filled with many plasma cells, large and small lymphocytes. Tingible body
macrophages were seen in large numbers. No trypanosomes were seen in any
of the sections. After drug treatment, there was a reduction in the amount of
cellular infiltration in both the follicular and paracortical areas of the lymph
nodes. The follicular areas were, however, still diffuse with most areas of the
paracortex still retaining the starry-sky appearance.
The Kidneys
The microscopal appearance of the stained sections of kidney tissues
collected from uninfected animals (Figure 9.6A) was as described for the
normal kidney (Wheater et al., 1987). Grossly, kidneys from the infected
animals were slightly swollen and the microscopal examination of stained
sections of tissues collected 28 days after infection revealed evidence of
glomerulitis and cloudy swelling. There was an increase in cellularity and
cellular infiltration in all the sections of the kidney and in particular around
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the renal pelvis (Figure 9.6B). Marked mononuclear cellular infiltration into
the renal corpuscles and papillae with most of the cells appearing as clusters in
the collecting tubules was a common feature in the sections of the kidneys
from the infected animals (Figure 9.6C). The cell types in the infiltrate were
mainly plasma cells, small and large lymphocytes and macrophages. Some
scattered haemorrhagic foci were seen all over the cortex and in the" renal
corpuscles (Figure 9.6B). No trypanosomes were observed in any of the
sections of the kidneys examined. After drug treatment there was a reduction
in the magnitude of cellular infiltration in the renal papilla but not in the
corpuscles.
The Ear and the Eyelids
The stained sections of the tissues obtained from the ear and eyelids of
the uninfected animals were clearly divided into the epidermal and dermal
sections with no evidence of cellular infiltration. Grossly, the ear and eyelids
of infected animals were swollen. Microscopal examination revealed the
presence of many macrophages and large lymphocytes with some small
lymphocytes, plasma cells and few neutrophils. Many trypanosomal nuclei
were evident in the sections with many of them detected in the macrophages
(Figure 9.6D). After drug treatment, there was a reduction in the magnitude
of cellular infiltration in the stained sections of the ear and eyelid.
FIGURE 9.1A
Giemsa's stained section of the liver of a non-infected rabbit showing
radiating hepatic cords and well defined sinusoids, x 150.
FIGURE 9.IB
Giemsa's stained section of the liver of a rabbit 28 days after infection
showing marked cellular infiltration in the portal tracks and fatty
degeneration of the hepatocytes. x 150.
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FIGURE 9.1C
Giemsa's stained section of the liver of a rabbit 28 days after infection
showing marked mononuclear cellular infiltration and the presence of




Giemsa's stained section of the vulva of a non-infected rabbit showing
well defined epidermis, dermis and thick fatty layer with some
mononuclear cells scattered in the dermis, x 50.
FIGURE 9.2B
Giemsa's stained section of the vulva of a rabbit 17 days post infection
showing oedema and extensive cellular infiltration. x150.
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FIGURE 9.2C
Giemsa's stained section of the vulva of a rabbit 28 days after-infec¬
tion showing many trypanosomes (T) x1,500.
FIGURE 9.2D
Giemsa's stained section of the vulva of a rabbit after drug treatment





Section of the spleen of an uninfected rabbit through the red pulp
showing well defined splenic cords, lined by macrophages and
engorged with erythrocytes (H & E x 1,500).
FIGURE 9.3B
Section of the spleen of a rabbit through the red pulp from tissues col¬
lected 28 days after infection showing extensive vacuolar spaces with
cellular infiltration of plasma cells, lymphocytes and macrophages (M)
(T)
with some of the trypanosomal nucleiAphagocytosed by macrophages
(M) (H & E x 1,500).
 
FIGURE 9.4A
Giemsa's stained section through the spleen of a non-infected rabbits
showing non-proliferating lymphoid nodules (L) clearly demarcated
from the adjoining red pulp, x 50.
FIGURE 9.4B
Giemsa's stained section through the spleen of an infected rabbit col¬
lected 28 days post infection showing hyperplastic and diffuse lym¬
phoid nodules (L) merging into the extensive red pulp, x 50.
 
FIGURE 9.5A
Giemsa's stained section through the lymph nodes of a non-infected
rabbit showing well defined follicular areas (F) in the cortex, paracort-
ical and medullary zones, x 50.
FIGURE 9.5B
Giemsa's stained section through the lymph node collected 28 days
after infection showing poorly defined and hyperplastic follicular areas
(F) in the cortex and starry-sky appearance(S) of some areas in the
paracortex and the medulla, x 50.
 
FIGURE 9.6A
Giemsa's stained section of the kidney of the non-infected rabbit
showing collecting tubules devoid of
any cellular infiltration, x 150.
FIGURE 9.6B
Giemsa's stained section of the kidney collected 28 days post infection
showing signs of marked glomerulitis, cloudy swelling and marked cel¬
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Giemsa's stained sections of the kidney collected 28 days post infection
showing clusters of mononuclear cells (M) in the collecting tubules, x
150.
FIGURE 9.6D
Giemsa's stained section of tissues from the eyelid collected 28 days
after infection showing marked mononuclear cellular infiltration and
the presence of many trypanosome nuclei (T). Many trypanosome




The findings in this study show that pathological changes occurred in the
organs of rabbits infected with T. evansi which were not seen in organs of
non-infected rabbits. These changes were thought to be due to the infection
except in the case of the spleen where the effect of the anaesthetic agent was
thought to have contributed to the engorgement observed because such agents
are known to cause the pooling of blood in the spleen of animals.
The changes in the liver are thought to be a direct consequence of the
activity of the parasites or the effects of the products of the infection. Apart
from the direct involvement of the liver in nutrition, it has the other role of
producing more than 90% of the third complement component (C3) (Lambris,
1988) which plays a central role in the activation of both the classical and
alternative pathways, the routes through which the effector functions of the
complement system during an infection is brought about (Roitt et al., 1985).
Antibody-dependent effector mechanisms such as cell lysis, one of the ways
trypanosomes are known to be eliminated by the immune system of the host
(Greenblatt et al., 1983; Ngaira et al., 1989) are also known to be dependent
on the complement system (Staines et al., 1985). Furthermore, the ability of
the immune system of animals previously exposed to an antigen to mount an
adequate and specific secondary immune response has been linked with the
role of C3 in the generation of B memory cells (Klaus and Humphrey, 1977).
The liver damage due to T. evansi infection would therefore, affect some of
these important hepatic functions and may probably explain the decreasing
levels of C3 with increasing levels of parasitaemia and duration of infection in
trypanosomiasis observed by several workers (reviewed by Nielsen, 1985).
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The initial increase in C3 levels during the early stages of infection
reported in Chapter 7, is in agreement with the findings of Shirazi et al. (1980)
and is thought to be associated possibly with an initial attempt of the liver to
cope with the increasing C3 requirement of the immune system for the
elimination of the parasites by producing more C3, which possibly failed
because of the pathological effects of the infection on the liver. Thereafter,
the level of C3 was thought to have consistently dropped with the increasing
duration of infection because of the imbalance between C3 production by the
apparently damaged liver and use by the immune system with increasing
parasitaemia.
The observation of restorative changes such as reduced inflammatory
changes in the liver after drug treatment may possibly explain in part the
increased C3 levels observed in infected animals after drug treatment reported
in Chapter 7. The elimination of the parasites by chemotherapy and the return
to normality of the liver and consequently its functions, such as C3 production,
would therefore, boost the level of C3 in the blood as limited amounts of C3
would be consumed by the immune system in the absence of parasites.
The marked increase in the number of these mononuclear cells seen in
sections of vulval tissues collected 28 days after infection is thought to be
associated with the defence response of the host to the trypanosome infection
and the presence of considerable numbers of parasites in the vulval connective
tissue. The cells present were largely lymphocytes, plasma cells and
macrophages indicating that these changes are protective, in response to the
presence of the infection (Bowry, 1984). Of particular interest is the antibody
class most likely to be secreted by the cells in the vulval dermis which are
likely to be predominantly IgA considering the seromucosal nature of the cells
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beneath the vulva (Roitt, et al., 1985). The increased serum IgA levels
observed during the late infection periods in animals reported in Chapter 5, is
thought to be in part attributable to the antibody response of the host to the
numerous parasites localised in extravascular sites such as the vulva. The
increase in the lymphoid cells and macrophages in the vulval dermis in this
study is therefore thought to have been engendered by the localisation of many
trypanosomes in the vulva during the late infection periods (Figure 9.2C).
Similar localisations of other trypanosome species belonging to the brucei group
such as T. b. brucei (French and Hornby, 1934-1935; Losos and Ikede, 1970)
and T. b. rhodesiense (Nagle et al., 1980) in different extravascular sites have
been reported. These extravascular sites in T. evansi infections may be playing
the role of providing sites for trypanosome antigenic diversification and escape
of parasites from the hostile immunological climate in the blood and the
provision of parasites for relapsing infections that has been suggested for the
tsetse transmitted species of trypanosomes (Jennings et al., 1978; Nagle et al.,
1980).
Although T. evansi is naturally transmitted by biting flies, it is closely
related to T. equiperdum which is transmitted sexually (Hoare, 1972).
Consideration should therefore be given to the possibility of sexual transmission
of T. evansi at least in occasional circumstances considering the localisation of
large parasite populations in the vulval dermis observed in this study. The
difference in the appearance of the parasites in the vulva before and after drug
treatment respectively, show that while the parasites still retained their
morphology before drug treatment (Figure 9.2C), after chemotherapy all that
was left were fragments of the nuclear material (Figure 9.2D). The ability of
the drug to enter tissue fluid is important, because once the disease is
diagnosed and chemotherapy appropriately administered whatever role the
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extravascular parasite pool may be playing would be compromised if not
completely abrogated.
The changes observed in the spleen (red and white pulp respectively) and
the lymph nodes are also considered to be mainly protective in nature, in
response to the infection. The extensive distension of the sinus lumina of the
red pulp with erythrocytes and macrophages, with some of the latter observed
to contain trypanosomal nuclei (Figure 9.3B) are similar to the observation
made by Brown and Losos (1977). While it is suspected that the anaesthetic
agent, Euthatal used for killing the animals may have contributed to the
pooling of blood in the spleen, the presence of large numbers of macrophages
is thought to be a direct response of the host immune system to the presence of
the parasites. Additionally the presence of many lymphocytes and plasma cells
in the red pulp is suggestive of an increased immunological activity of the
spleen during T. evansi infection. These findings support the view that
trypanosomes are destroyed in the red pulp in great numbers which is in
agreement with the findings of several workers (Wallhausen and Mansfield,
1979; Albright et al., 1977).
The presence of large numbers of trypanosomal nuclei in the splenic
sinuses (Figure 9.3B) may indicate vigorous splenic phagocytosis of parasites.
The increased number of lymphocytes, plasma cells and macrophages in the
white pulp of the spleen of rabbits infected with T. evansi (Figure 9.4B) in
comparison with those of the control animals (Figure 9.4A) is considered
further evidence of increased cellular activation probably linked to increased
immunological activity of the white pulp which is thought to be associated with
the infective process. Similar changes were also observed in the lymph nodes.
The proliferative activity and diffuse nature of the follicular areas in the cortex
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of the lymph nodes of rabbits infected with T. evansi (Figure 9.5B) in
comparison with those of the control animals which had a clearly defined and
well demarcated follicular area from the adjoining paracortical zone (Figure
9.5A) is similar to the observations made in T. congolense infected mice
(Morrison et al., 1982b) and rats infected with T. congolense and T. brucei
respectively (Brown and Losos, 1977). The follicular area was expanded due
to the active proliferation of the lymphocytes and plasma cells. The
paracortical areas in our studies, as was the case in those of Morrison et al.
(1982b), Brown and Losos (1977) were not very active. In some areas of the
paracortex however, proliferative activity was observed in the present study.
These areas in the paracortex were found to contain many macrophages which
probably explains the starry-sky appearance of such areas, a phenomenon that
is associated with the presence of large numbers of activated macrophages.
The marked proliferative activity observed in the follicular (B cell) areas in
comparison with the paracortical (T cell) areas (Roitt et al., 1985; Wheater et
al., 1987) probably signifies that antibody dependent effector mechanisms
(Murray and Urquhart, 1977; Greenblatt et al., 1983; Ngaira et al., 1983)
rather than the cell-mediated process are more important in the elimination of
trypanosomes. Our observations however, differed from those of Brown and
Losos (1977) and Morrison et al. (1982b) in one respect, in that we could not
demonstrate any trypanosomes in the lymph nodes. It is possible that the
different host/parasite systems used influenced the findings or that the rate of
destruction and elimination of T. evansi by the phagocytic system of the lymph
node is both efficient and rapid so that little if any components of the parasites
are left. Alternatively, it may be that for some reason T. evansi does not
become established in the lymph node. Our findings however, are in
agreement with those of Seiler et al. (1981) who failed to find any parasites in
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the lymph nodes of horses that died of T. evansi infections. The major
difference however, between our findings and those of Seiler et al. (1981) is
that we found trypanosomes in some organs such as the spleen (the red pulp)
(Figure 9.3B), the vulva (Figure 9.2C), the ear and eyelid (Figure 9.6D)
which these authors did not report.
The changes observed in the kidneys of rabbits infected with T. evansi in
this study are probably a direct effect of the infection on the kidneys and/or an
undesirable consequence of the immunological response of the host. The
extensive mononuclear cellular infiltration in which some of them appear in
clusters in the tubules (Figure 9.6C) marked tubular degeneration with nuclear
fragmentation and glomerulitis with scattered haemorrhagic foci (Figure 9.6B)
are all indicative of severe pathological processes possibly brought about by the
T. evansi infections. The presence of many plasma cells in the renal
corpuscles, collecting tubules, in addition to numerous lymphocytes and
macrophages are thought to be developments that could lead to the formation
and accumulation of immune complexes that may build up to block glomerular
filtration and cause kidney damage and possibly renal failure. This observation
has been made with different trypanosome species infecting different hosts by
several workers (Nagle et al., 1974; Van Marck and Vervoort, 1980).
The results of the present studies show that T. evansi infected animals
mount a vigorous conventional defence response both locally and systemically
to the presence of the parasite. The studies have further shown extensive
pathological changes directly related to the presence of the parasites in the
tissues, liver damage which could lead to depression of defence responses and
extensive kidney damage that could lead to the development of toxic changes
due to retained metabolites and acid/base imbalance. The possibility that
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vulvo-vaginal localisation of the parasites
of T. evansi deserves further investigation.






The interaction of the parasite and the host immune system has attracted
a lot of attention over the years, principally from the point of view of evolving
efficient control measures such as the development of vaccines. The
interpretation of results from such studies have often been complicated by the
multicomponent nature of the parasite antigens overlaid by a consequently
complex immune response by the host. In the case of trypanosome infection
this is further complicated by the process of antigenic variation and antigenic
diversity of different stocks of the same species of parasite. The host can
produce antibodies belonging to one or more of the five main classes of
immunoglobulins, IgG, IgM, IgA, IgD and IgE which can be directed against
one or all of the many parasite components. Furthermore, in the case of
trypanosome infections, the host immune system can produce immunoglobulins
which are not specific to the invading organism (Hudson et al., 1976; Terry et
al., 1980) which adds to the complexity of the host response to the parasite.
Of principal importance in the study of the role of the immune system in
host/parasite interactions is the assay system used. An assay system of choice
should not influence the nature of results obtained, in order that the
interpretation of the observations should truly reflect changes in the
host/parasite relationship. Most assays have tended to use crude extracts of
trypanosomes as antigens, which makes it impossible for the host's response to
individual antigens of the parasite to be evaluated. To obtain the maximum
amount of information on host/parasite relationship, however, an assay system
the
should be capable of dissecting^host response to individual antigens of the
parasite.
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In the present study SDS-PAGE was used to separate the components of
T. evansi on the basis of molecular weight which was then probed for
antigenicity with "Western" blotting (Towbin et al., 1979) using sera samples
collected from rabbits infected with T. evansi. The system was also adapted so
as to provide information on the immunoglobulin class response to the
separated components. Of importance in an assay system involving extensive
comparative studies such as the present study is reproducibility of results and
avoidance of artifacts. This often involves the development of assay systems
specifically tailored for the identification of host response to the individual
parasite components. An integral part of this process, therefore, was the
identification of factors having the greatest influence on reproducibility of
results with special reference to the rabbit/T. evansi system under study.
The factor having the greatest influence on results was identified as the
blocking condition which controlled the effect of background reactions on
specific host/parasite interactions and ensured that labelled components could
be clearly identified. A 4% goat serum preparation in blocking buffer (v/v)
provided maximum reduction of background staining.
In the case of trypanosome infection, host antibody response to the
surface antigens is considered to play a principal role in the host/parasite
interaction as the surface coat is the first point of contact between the host and
the parasite and probably the first point of activation of the effector process
that could lead to the elimination of the parasite. The host response to the
surface of trypanosomes is important because VSG-specific antibodies are
possibly the main resource which the host uses to eliminate the parasites and
also get protected against reinfection with the same parasite population (Wellde
et al., 1975, 1981; Emery et al., 1980; Morrison et al., 1982b; Hall and Esser,
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1984). The host reaction to the surface of the trypanosome however, is
complicated by the changing nature of the surface coat of the parasites during
the course of infection brought about by the process of antigenic variation
(Soltys, 1963) which helps the parasite to evade the host immune system.
improbable
Antigenic variation also renders^the use of immunoprophylaxis for the control
of trypanosomiasis (Cardoso de Almeida and Turner, 1983).
The identification of the surface component of trypanosomes and the
evaluation of the host's response to it during the course of infection is
important for a better understanding of the host/parasite relationship. It is also
important that the surface components can be identified in crude extracts so
that they could be excluded as reagents for the development of diagnostic
probes as their variable nature limits their usefulness in this respect. The
SDS-PAGE/"Western" blotting system used in the present study separates the
components of the parasite into individual elements but clearly cannot
distinguish the components that are surface related from those that are non-
surface in origin. For the analysis of responses to the individual antigenic
components of the parasite, it is important to identify the origin of the
components in the intact trypanosome.
The identification of surface components of parasites is usually undertaken
by labelling the surface of organism and the most commonly used label for this
125is radioactive iodine ( I) which can be attached to the surface of the parasite
by a variety of methods such as the IODO-GEN-mediated technique (Fraker
and Speck, 1978). After such surface iodination of T. evansi stocks in the
present study two components with molecular weights of 67,000 and 60,500
daltons were identified as being associated with the surface of the organism.
Differences were, however, seen between the number of these components
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exposed on the surface of the different stocks of T. evcinsi studied. In some
stocks, both components were labelled while in other stocks, only one of the
components was visualised. In one stock the particular iodination technique
used in the present study failed to label any component, despite the fact that
both of these components were present in the total protein profile of the stock
and also that electron microscopy revealed that the particular stock of T. evansi
appeared to have a normal surface coat. Further studies on the characteristics
of the surface elements of the T. evansi stocks studied using reagents directed
at specific parts of the VSG molecule suggested that the number of surface-
associated components identified in the different stocks by the IODO-GEN
labelling technique is probably a function of the types of amino acid molecules
exposed on the surface glycoprotein coat of individual parasite stocks.
Results from studies on the various aspects of T. evansi infection carried
out during the present study, clearly demonstrated that the host produces
antibodies to a large number of T. evansi antigens during the course of the
infection. From these results it is clear that the immune response to infection
was not limited to the surface of the parasite as antibodies appeared to a range
of non-surface components as well. Apart from being able to identify
individual antigenic components of T. evansi the assay system was also used to
follow the host's immune response to the surface and non-surface components
during the course of the infection.
The host's response to the surface components of T. evansi involved the
production of antibodies belonging to each of the three main immunoglobulin
isotypes studied - IgG, IgM and IgA, while responses to the non-surface
components were predominantly IgG in nature. The difference in the pattern
of response is likely to be related either to the different effector roles of the
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individual antibody classes or differences in antigen processing of the surface
and non-surface components of the parasites. It is likely that while the
surface-specific IgM response serves to destroy the intact trypanosomes by lysis
(Mitchel and Pearson, 1983), the IgG response may be important in handling
the consequences of the parasite lysis and dealing with less particulate antigens
released after the lysis of the trypanosomes.
Naive animals were observed to mount a response to the intact parasites
and parasite extracts when introduced directly into the skin as in the case of a
natural infection. The isolated surface components appeared to induce the
most severe form of skin reaction in the animals in comparison with the non-
surface components. In the case of previously infected animals two types of
reactions, classed as immediate and delayed type hypersensitivity reactions
based on their time of development and cell types present in sections prepared
from tissues collected from sites of antigen inoculation, were observed. These
reactions were thought to constitute the early events leading to the
development of the chancre (Dwinger, 1985). It is likely that if these types of
hypersensitivity reactions occur in animals in the field, they may be important,
as suggested by Dwinger (1985) in hampering the multiplication of the
parasites in the skin and possibly delay their subsequent escape to the
bloodstream.
An outstanding feature of the host response observed in this study was the
persistence of trypanosome-specific antibodies with antibodies recognising
particular antigens of the parasite remaining in circulation for up to 28 days
after infection and for up to 39 days after drug treatment, despite the fact that
the parasites had been eliminated by the drug. This persistence was a feature
of the antibodies to both the surface and non-surface components of the
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parasite. Persistence of antibodies to surface components of the parasite
during infection might have been engendered by the re-expression of particular
VATs such as predominant VATs (pVATS). Such persistence would be of
advantage to both host and parasite as the presence of antibodies to the
pVATS could serve to limit variable antigen development, thereby acting as a
selection pressure against the emergence of the pVATs which are often more
pathogenic than the later emerging non-predominant VATs. The persistence
of non-surface antibodies may be due to the continuous destruction of
emerging new parasite populations by VSG-specific antibodies and the
consequent release of internal components, antibodies to which would be
continuously produced by the infected animal. The persistence of antibodies
after drug treatment may be as a result of the persistence in circulation of
antibodies produced by the host before the parasites were eliminated by
chemotherapy. The persistence of antibodies to non-surface components
constitutes one of the major problems facing serological diagnosis of
trypanosomes in that the majority of assays cannot distinguish between
currently infected animals and those in which the infection has been eliminated
by drug treatment.
The predominance of IgG antibodies as opposed to IgM antibodies to T.
evansi antigens during the course of the infection is another important finding
of this study because the observation is not in agreement with those of several
authors that recorded predominant IgM production in trypansomiasis. The
analysis of our finding suggests that the high IgM levels often recorded in
trypanosomiasis by other workers (Seed et al., 1969; Zahalsky and Weinberg,
1976) might be related to the assay system used which biased the results
obtained towards a particular antibody class such as the propensity of
agglutination tests for IgM antibodies or are the products of polyclonal B
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lymphocyte stimulation which occurs with the IgM class of immunoglobulins in
trypanosomiasis (Hudson et al., 1976; Terry et al., 1980).
The change in IgA levels observed in rabbits in this study during late
infection periods and after drug treatment is considered to be associated with
the intrusion of the parasites into seromucosal extravascular surfaces. Such
sites are associated with IgA secretion (Roitt et al., 1985) and the high levels
of IgA recorded in the serum in this study was thought to be due to a spill¬
over of IgA produced in such places as the vulva where many parasites were
identified during the late periods of infection. Studies of changes taking place
in some selected organs of rabbits infected with T. evansi showed that while the
changes in the kidney and the liver are pathological and more likely to the
disadvantage the host, changes in other organs like the lymph node and spleen
appeared to be more of an enhancement of their physiological functions against
the parasite which are linked to the immunological responses of the infected
animals.
Based on the observation of clinical signs, animals in this study could be
divided into two broad groups: susceptible and resistant. Results obtained
from evaluating the immune responses of these two groups to the antigens of
the parasites showed that the extent the animals were able to mobilise their
immune system against the presence of parasites was directly linked to their
status of resistant or susceptible. However, once an animal has experienced
infection with T. evansi other factors appeared to influence the outcome of
infection, the major one being whether or not the animal had experience of the
particular antigenic type in the challenge population. If it had experienced the
particular parasite population or VAT previously and still had antibodies to it,
no infection occurred, as the animal was protected against the homologous
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parasite population a clearly established phenomenon in trypanosomiasis
(Fulton and Lourie, 1946; Wiesenhutter, 1970; Wellde et al., 1975; Nantulya et
al., 1980b). If the animal had not however, experienced the VAT previously,
some other factors, possibly non-humoral, appeared to influence the response
of previously infected animals to challenges. Such a factor which appeared to
hinder the establishment of some challenge populations of T. evansi did not
appear to be linked to the presence of trypanosome specific antibodies. In the
case of T. brucei, the late establishment and low level of challenge parasitaemia
is considered to be associated with the large number of antigens of this stock of
T. brucei that reacted with the antibodies produced against T. evansi. In the
case of T. vivax and T. congolense there was no apparent protection of animals
previously infected with T. evansi probably due to the fact that few, if any,
antigens of these two parasites were common to T. evansi.
Accessory systems such as the complement system that are known to play
an important role in the elimination of parasites by the host immune system
were seen to be affected in the present study. Studies on the principle
component of the complement system, C3, (Lambris, 1988) showed that there
was a general reduction in C3 levels during infection with T. evansi. Such a
reduction in the level of C3 can compromise the ability of the animal to
eliminate parasites via complement mediated lysis (Murray and Urquhart,
1977). The reduction in complement (C3) levels probably arose from a
disturbance in the balance between C3 production, and consumption by the
host immune system. Results from the present study provided evidence that
the reduction may have been as a result of changes on both sides of the
production/consumption equation. The damage of the liver which produces
more than 90% of C3 (Lambris, 1988) and the continuous cleavage of C3 as
were observed in the present study were thought to have contributed largely to
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the reduction of C3 levels in circulation with the progress of the infection.
Evidence was obtained from the present study which indicated that reduced C3
level could be detrimental in the way in which an animal reacts to a second
exposure to the same antigens of T. evansi probably by influencing the
functions of the special B cell population (B memory cells) responsible for the
retention of memory (Klaus and Humphrey, 1977).
Results from the present study indicate the importance of broadening the
baseline of trypanosome research with the adaption of a more integrated
approach taking into consideration the fact that no parts of the trypanosomes
or their mammalian hosts act in isolation both in health and in disease. In this
respect emphasis in trypanosome research should go beyond the antibody
interaction with the surface coat of the parasite to include other areas such as
the humoral and non-humoral host response to the non-surface component of
the parasite, better appreciation of the role of accessory systems such as the
complement system and changes taking place in other organs of the host during
infection that may not be completely pathological but protective in nature.
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Appendix 1
Phosphate buffered saline (PBS)
Sodium chloride (Analar, BDH) 8.0 g
Potassium chloride (BDH) 0.2 g
Disodium hydrogen phosphate, anhydrous (BDH) 1.15 g
(Disodium hydrogen orthophosphate, anhydrous)
Potassium dihydrogen phosphate (BDH) 0.2g
(Potassium dihydrogen orthophosphate)
Made up to one litre with distilled water
pH 7.3
Appendix 2
Phosphate saline glucose (PSG)
Disodium hydrogen phosphate, anhydrous (BDH) 13.48 g
(Disodium hydrogen orthophosphate, anhydrous)
Sodium dihydrogen phosphate (BDH) 0.78 g
(Sodium dihydrogen orthophosphate)
Sodium chloride (Analar, BDH) 4.25 g
Made up to one litre with distilled water
For use, dilute solution prepared above in the ratio of 6:4 with distilled water
and add 10 gm of glucose (BDH) to give a 1% solution, adjusted to pH 8.0
with 5% phosphoric acid (BDH).
Appendix 3
Enzyme protectant solution
2 mM 6-Amino-n-hexanoic acid
(E-Amino-caproic acid) (BDH)
2 mM DL-Dithiothreitol (Sigma Ltd.)
2 mM Ethylenediamine tetraacetic acid (EDTA) (Sigma Ltd.)
Appendix 4
(a) Stock 30% acrylamide solution
Acrylamide (Sigma) 154g
N,N methylene bisacrylamide (Sigma) 4 g
Mixed bed ion exchanger (Duolite MB6113, BDH) lOg
Made up to 500 ml with distilled water by heating slowly until dissolved. The
mixture is finally filtered to remove the mixed resins.
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(b) Lower Tris x4
*Tris (Sigma) 36.4 g
**SDS (Sigma) 0.8 g
Distilled water to 200 ml
pH changed to 8.8 using concentrated HC1 (BDH)
*Tris = trishydroxymethylamine
**SDS = sodium dodecyl sulphate
(c) Upper Tris x4
Tris 12.12 g
SDS 0.8 g
Distilled water to 200 ml
pH changed to 6.8 using concentrated HC1
(d) Ammonium persulphate solution
Ammonium persulphate (BDH) 1.0 g
Distilled water to 10 ml
Stored at 4°C for one week.
(e) Stacking gel (4.5% acrylamide)
Upper Tris x4 50 ml
30% acrylamide 30 ml













Distilled water to 200 ml
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Appendix 5
Electrophoresis tank buffer (pH 8.3)
Tris 3.03 g 25 mM
Glycine (BDH) 14.14g 0.192M
SDS 1.0 g 0.1%
Distilled water to 1,000 ml
Appendix 6
Destain solution
Methanol (BDH) 2,500 ml (25%)
Glacial acetic acid (BDH) 1,000 ml (10%)









Glacial acetic acid 7%
in distilled water
(iii) Solution 3
Gluteraldehyde (Taab Labs) 5.0%




Sodium carbonate (BDH) 3 g
37% formaldehyde (Analar, BDH) 50 p,l




Tris 60.5 g 50 mM
Sodium chloride (BDH) 87.0 g 150 mM
EDTA 3.72 g 1 mM
Nonidet P40 (NP40) (Sigma) 5.0 ml 0.005%
Gelatin (BDH) 25.0 g 2.5%
Thiomersal 2.0 g 0.2%
Distilled water to 1,000 ml
pH changed to 7.4 using concentrated HC1. For use a xl buffer strength was




(i) Tris buffered saline (TBS)
Tris 4.85 g 20 mM
Sodium chloride 58.48 g 500 mM
Distilled water to 2,000 ml
pH changed to 7.5 with concentrated HQ.
(ii) 60 mg 4-chloro-l-naphthol (Sigma) was dissolved in 20 ml ice-cold techni¬
cal methanol (Solution 1).
Solution 1 was added to 100 ml of TBS. Following this 60 jxl of ice-cold




Prepared from stock solutions
Tris buffer 2.0 M pH 8.0 10 ml 20 mM
Sodium chloride 0.5 M 100 ml 50 mM
NP40 10-0% 20 ml 0.2%




0.2M sodium cacodylate buffer
(Double working strength)
Sodium cacodylate (BDH) 2.14 g
Made up to 500 ml with distilled water. pH adjusted to 7.3 with HC1 and
stored at 4°C. Before use the buffer is double diluted with distilled water to
make a single strength buffer. 12 ml of 25% EM grade gluteraldehyde is then
added to 88 ml of the single strength (0.1 M) cacodylate buffer, pH 7.3.
Appendix 13
(i) Araldite mix
Araldite CY212 (Agar Scientific Ltd.) 50 ml
Dodecyl succinic anhydride (" ") 50 ml
(ii) Accelerator
2,4,6-tri(dimethylaminomethyl) phenol (DMP-30) (Agar Scientific Ltd.) - 1
volume.
Dibutylphthalate (Agar Scientific Ltd.) - 2 volumes
Appendix 14
Sample buffer (Reducing type)
Tris 45 mg (18.5 mM)
EDTA (disodium salt, Sigma Ltd.) 223 mg (30 mM)
SDS 1.0 g (5% w/v)
2-mercaptoethanol (Sigma Ltd.) 0.45 ml
Glycerol (Analar, BDH) 5.0 ml (25% w/v)
Bromophenol blue (Sigma Ltd.) Spatula tip
Distilled water to 20 ml
Appendix 15
Barbitone acetate buffer
Barbitone acetate buffer was prepared as instructed by the manufacturers
(Shandon, U.K.), by dissolving 16.5 g of barbitone acetate (Electrafor®) in




0.02M Tris - HC1, pH 8.0
0.028M NaCl, 0.02% NaN3 (BDH)
Appendix 17
Veronal buffer
Sodium diethylbarbiturate (BDH) 5.15 g
Diethylbarbituric acid (BDH) 0.92 g
Distilled water to 1,000 ml
pH 8.6
Appendix 18
Carbonate bicarbonate buffer, pH 9.6
Sodium carbonate 1.59 g
Sodium bicarbonate 2.93 g
Distilled water to 1,000 ml
Appendix 19
Blotting buffer
For use with semi-dry Ancos blotter (Dako Ltd.)
Electrophoresis tank buffer 100 ml
Technical methanol (BDH) 100 ml
Distilled water 300 ml
Appendix 20
Molecular weight markers
A commercial mixture of six molecular weight protein standards were
used covering a low molecular weight range (Pharmacia). The contents of one
vial were reconstituted in 1.0 ml x 1 SDS sample buffer and heated to 100°C
for three minutes. Aliquots were stored at -20°C and 10 |xl was used per gel
track.
The protein standards present were phosphorylase b (94 kdal), bovine
serum albumin (67 kdal), ovalbumin (43 kdal), carbonic anhydrous (30 kdal),
soyabean trypsin inhibitor (20 kdal) and lactalbumin (14 kdal).
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Appendix 21
Manufacturer' and Suppliers' Names and Address
Agfa Professional Photographic Division, 27, The Great West Road, Brent¬
ford, Middlesex, T88 9AX, England.
Amersham International PLC, Lincoln Place, Green End, Aylesbury,
Berkshire, England.
Anderman and Company Ltd., 145, London Road, Kingston-on-Thames,
Surrey, KT2 6NH, England.
BDH Ltd., Broom Road, Poole, Dorset, BH12 4NN, England.
BioRad Laboratories Ltd., Caxton Way, Watford Business Park, Watford,
Hertfordshire, England.
Dako Ltd., 27, The Arcade, The Octagon, High Wycombe, Buckinghamshire,
England.
Glaxovet Ltd., Greenford, Middlesex, UB6 OHE, England.
Ilford Ltd., Mobberley, Cheshire, England.
Kodak Ltd., Hemel Hempstead, England.
MSE Scientific Instruments, Manor Royal, Crawley, Sussex, RH10 2QQ, Eng¬
land.
Nordic Immunological Laboratories Ltd., P.O. Box 544, Maidenhead,
Berkshire, England.
Nuclear Enterprises Ltd., Bankhead Meadway, Edinburgh, EH11 4EY.
Pharmacia Ltd., Pharmacia House, Midsummer Boulevard, Milton Keynes,
England.
Pierce Chemicals - Suppliers: Life Science Laboratories Ltd., Sedgewick Road,
Luton, LU4 9DT, England.
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Shandon Southern Products Ltd., 93 Chadwick Road, Astmoor, Runcorn,
Cheshire, England.
Sigma Chemical Company Ltd., Fancy Road, Poole, Dorset, BH17 7NH, Eng¬
land.
TAAB Laboratory Equipment, 3, Minerva House, Calleva Industrial Park,
Aldermaston, England.
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Complement levels in rabbits infected with Trypanosoma evansi.
(Presented at the Meeting of the Royal Society for Tropical Medicine and
Hygiene at Glasgow University 24th May, 1989.)
CLASS-SPECIFIC ANTIBODY RESPONSE AND VARIATIONS
BETOEEN SUSCEPTIBLE AND RESISTANT RABBITS
EXPERIMENTALLY INFECTED WITH
TRYPANOSOMA EVANSI
UCHE, U.E., JONES, T.W. & BOID, R.
Centre for Tropical Veterinary Medicine,
Easter Bush, Roslin, Midlothian EH25 9RG,
University of Edinburgh, Scotland.
ABSTRACT
Using SDS-PAGE and Western blotting, IgG antibody response was found
to predominate in rabbits experimentally infected with Trypanosoma evansi
in terms of the number of homologous T. evansi antigenic bands recognised
and the degree to which these bands were labelled during the course of the
infection. Animals that developed parasitaemia later or had low levels of
parasitaemia, as the infection progressed were considered to be more re¬
sistant to the infection. These resistant animals in addition to recognising
the T. evansi antigens earlier, identified more of the antigens than their
susceptible counterparts as the infection progressed. The susceptible
animals as well as developing patent parasitaemia earlier, with higher para¬
site counts being attained as the 'infection progressed were found to
recognise the T. evansi antigens later with fewer bands labelled during
the course of the infection.
Royal Society of Tropical Medicine and Hygiene
Report of Demonstration/Poster at Laboratory Meeting
Author(s) U.E. UCHE, T.W. JONES & R. BOtD
Title Complement levels in rabbits infected with T. evansi
Author(s) Centre for Tropical Veterinary Medicine, University of Edinburgh,
Address(es) ROSLIN, Midlothian, Scotland.
(See reverse for instructions)
C3 levels in rabbits infected with T?. evansi were measured by rocket
Immunoelectrophoresis in 1% agarose gel containing 2.5% sheep anti-
rabbit C3 serum and 3% PEG6000. Plasma samples were collected at regular
intervals over the first 24 days of infection at which point the rabbits
were treated with Berenil (Hoecht) at 7 mg/kg active principle. Further
samples were collected at 8 and 14 days after treatment.
A slight rise in C3 levels was seen early in infection in most animals
probably due to increased mononuclear phagocyte activity during this
stage of the infection. Thereafter, a progressive fall in C3 levels
occurred up to the point of treatment. This fall in C3 levels could be
due to C3 consumption by the immune system undertaking parasite des¬
truction and/or altered activity of certain mononuclear phagocytic
cells due to trypanosome infection leading to reduced C3 production.
After treatment C3 levels showed a progressive rise usually returning to
pre-infection levels by 14 days after treatment.
